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Abstract
 
The present dissertation is devoted, essentially, to the development of new 
ultrasonic-based sample preparation methods for mass-spectrometry-based analysis of 
proteins.  
This dissertation is introduced by a brief overview about general aspects in 
proteomics such as protein identification, quantification and finally, tissue analysis by mass 
spectrometry. Special attention is given to fast methods for protein identification, as for 
example those using tools such as microwave energy and ultrasonic energy to speed-up 
enzymatic digestion. In addition, a general overview of label-based quantification 
approaches, such as SILAC, iTRAQ, ICAT, or 18O and, label-free methods are presented. 
Furthermore, stable 18O-isotopic labeling is described in detail. The last topic covered in the 
first chapter is the analysis of tissue samples by mass spectrometry, a short overview on this 
subject is done to introduce the reader on the importance of tissue analysis by mass 
spectrometry. 
As far as experimental concerns, different types of ultrasonic devices, such as 
ultrasonic bath, sonoreactor, ultrasonic probe and multiprobe were assessed in different 
steps of currents protocols for protein identification through mass spectrometry. Variables 
such as temperature, sonication time, amplitude and ultrasonic frequency were evaluated in 
order to identify the optimum conditions. On the first trial, ultrasonic energy was used to 
accelerate the in-solution enzymatic protein digestion. It was found that the application of 
the ultrasonic energy (ultrasonic probe and sonoreactor) to a liquid medium containing 
protein and trypsin speeds protein cleavage from overnight (12h) to 5min.  
To make the handling easier and faster, the ultrasonic energy was also successfully 
applied to the protein reduction and protein alkylation steps. Overall, the time was reduced 
from 3h to 10min, and from many single cleaning steps to just one for reduction and 
another for alkylation. 
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The efficiency of ultrasonic energy to accelerate the sample preparation for protein 
identification by peptide mass fingerprint was evaluated by comparison with the overnight 
method.  
Once all the experiments were done, it was completed a new sample treatment for 
the identification of proteins by mass spectrometry. For proteins separated by gel-based 
approaches the total sample treatment time was reduced from 12-24h to just 20min whilst 
for proteins separated by off-gel approaches the total time was reduced to just 8min. 
 Regarding protein quantification, we chose to work with isotopic labeling, as this is 
one of the methods most suitable for protein quantification by mass spectrometry. In this 
work proteins separated by gel electrophoresis were inverse labeled with 18O and analysed 
by MALDI-TOF-MS. The inverse labeling approach, allows to select some peptides that 
have reproducible loses in different sets of a given entire proteomic workflow. Those 
selected peptides were used for subsequent protein quantification. 
To help to handle in a simple way the data from inverse labeling experiments and to 
use such data for protein quantification, a bioinformatics tool called “Decision peptide-
driven”, DPD; was developed. The simultaneous use of the inverse labeling approach to 
select the peptides suitable for quantification and the DPD software allowed the accurate 
quantification of targeted proteins. The proposed quantification strategy was successfully 
compared with a classic quantification done with the ELISA method. 
Finally, to get insight into the tissue proteomics, a method was developed to help to 
distinguish, after on-tissue protein digestion, in a rapid manner, and with the aid of mass 
spectrometry, the peptides present in a tissue from other tissue components with similar m/z 
values. The differentiation was achieved by labeling the peptides with 18O. The results 
obtained shown that the labeling can be done decoupling the steps of protein digestion and 
peptide labeling. In addition, it has been also demonstrated that ultrasonication can boost 
the digestion of tissue’s proteins in seconds, thus opening for the first time sample 
treatment of tissues to high throughput. 
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Resumo
 
O presente trabalho descreve a aplicação da energia de ultra-sons a diferentes etapas 
da preparação de amostra para análise de proteínas por espectrometria de massa. A 
dissertação apresentada encontra-se orientada numa perspectiva de desenvolvimento de 
novos métodos com aplicações em proteómica. 
Em primeiro lugar, apresenta-se de forma geral uma introdução que pretende 
contextualizar de forma simples os diferentes temas abordados, por exemplo identificação 
de proteínas, a sua quantificação e a análise directa de proteinas em tecidos biológicos, tudo 
com recurso a espectrometria de massa. No entanto, temas relacionados com a aceleração 
de tratamentos de amostra para identificação de proteínas por espectrometria de massa, 
como por exemplo a utilização de energia de microondas e de ultra-sons serão abordados 
com algum detalhe.  
Tendo em conta a grande importância da quantificação de proteínas para o 
entendimento dos sistemas biológicos foi efectuada uma pesquisa bibliográfica em temas 
chave de quantificação de proteínas por espectrometria de massa, nomeadamente, a 
utilização de marcadores isotópicos como por exemplo SILAC, iTRAC, ICAT e 18O. Este 
ultima, será abordada de forma mais exaustiva. 
O último tema sobre o qual recai a presente dissertação, encontra-se relacionado 
com a análise directa de proteinas em tecidos biológicos por espectrometria de massa. 
Nesta parte pretende-se elucidar o leitor acerca da importância da análise de tecidos por 
espectrometria de massa, bem como esclarecer sobre a forma como se processa a análise de 
tecidos biológicos por espectrometria de massa. 
No que diz respeito à parte experimental da presente dissertação, foram efectuados 
estudos sobre a aplicabilidade de sistemas de ultra-sons, nomeadamente, banho, sono-
reactor, sonda e multi-sonda de ultra-sons a procedimentos normalmente utilizados em 
proteómica.
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Alguns parâmetros, como por exemplo, temperatura, tempo, amplitude e frequência 
de ultra-sons foram avaliados quanto à performance destes sistemas em protocolos de 
identificação de proteínas. 
Numa primeira aproximação, foi testada a aplicação da energia de ultra-sons para 
acelerar a digestão enzimática de proteínas em solução. A aplicação desta energia a um 
meio liquido contendo proteína e enzima produz um efeito de cavitação aumentado os 
processos de transferência de massa, como consequência, a digestão de proteínas foi 
reduzida de 12h para 5 min. A energia de ultra-sons, foi aplicada com sucesso às etapas de 
redução e alquilação de proteínas, que foram reducidas de 3h para apenas 10min. 
A capacidade da energia de ultra-sons para acelerar a preparação de amostra para 
identificação de proteínas por PMF foi avaliada por comparação com o método clássico, 
verificando-se a redução no total de 12-24h para apenas 20min para proteínas separadas em 
gel ou 8min para proteínas em soluçao 
Relativamente ao tema de quantificação de proteínas com utilização de isótopos e 
análise por espectrometria de massa, foi efetuado um estudo de quantificação de proteínas 
separadas por eletroforese em gel. Deste modo as proteínas de interesse foram digeridas e 
marcadas com 18O, seguindo uma estratégia de marcação inversa e análise por MALDI-
TOF-MS. 
A marcação inversa permite a identificação de péptidos que apresentam um 
comportamento reprodutível ao longo das etapas de preparação de amostra e análise. Estes 
péptidos sao seleccionados e são utilizados para a quantificação. Para facilitar o processo de 
quantificação, foi desenvolvida uma ferramenta bioinformática chamada “Decision Peptide-
Driven”, DPD, que se destina ao tratamento de dados provenientes das experiências de 
marcação inversa e analise por MALDI-TOF-MS. A utilização conjunta da metodologia 
proposta e do software permite seleccionar os péptidos adequados e como consequência a 
quantificação é efectuada de forma exacta e rápida. 
Os resultados de quantificação obtidos com a abordagem proposta formam comparados 
com um método clássico de ELISA, utilizado normalmente para a quantificação de 
proteínas em misturas complexas. 
Com o objectivo de diferenciar peptidos de outros componhentes presentes nos 
tecidos biológicos com recurso a espectrometria de massa, foi estudada a possibilidade da 
aplicação da marcação isotópica com 18O de péptidos, em tecidos biológicos após digestão 
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enzymatica. Os resultados obtidos demonstram que quando as duas etapas, digestão e 
marcação, são efectuadas separadamente verifica-se a incorporação de 18O nos péptidos 
formados. Esta metodologia apresenta uma grande aplicação para distinguir péptidos 
endógenos de outros componentes presentes no tecido. Finalemnte, foi demonstrado o 
potencial da aplicação da energia de ultra-sons na digestão enzimática de tecidos 
biológicos. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ix 
Abbreviations
 
1D-LC-MS  One dimension liquid chromatography 
2D-GE  Two-dimensional gel electrophoresis 
2D-PAGE  Two-dimensional polyacrylamide gel electrophoresis 
A&D   Aspirate and dispense 
AmBic  Ammonium Bicarbonate 
cICAT  Cleavable Isotope-code affinity tags 
D&I   Direct and Inverse  
DIGE   Diference gel electrophoresis 
DNA   Deoxyribonucleic acid 
DPD   Decision peptide-driven 
DTT   DL-Dithiothreitol 
ECDs   Endocrine disruptor compounds,  
ESI   Electrospay ionization  
FT-ICR- MS  Fourier transform ion cyclotron resonance mass spectrometry 
GE   Gel elctrophoresis  
HPLC   High pressure liquid chromatography  
IAA   Iodoacetamide 
ICAT   Isotope-code affinity tags 
IEF   Isoelectric focusing 
iTRAQ  Isobaric tag for relative and absolute quantification 
LC   Liquid chromatography 
MALDI-TOF-MS Matrix Asisted laser/desorption ionization time-of-flight mass 
spectrometry 
MRM   Multiple reaction monitoring 
MS   Mass spectrometry 
MW   Molecular weight 
PBS-Tween  Phosphate Buffered Saline with Polyethylene glycol sorbitan 
monolaurate
Abbreviations 
x 
PMF   Peptide mass fingerprint 
PNPP   p-nitro-phenylphosphate  
RP-HPLC  Reverse phase high performance liquid chromatography  
RSD   Relative Standard Deviation 
SDS   Sodium dodecyl sulfate 
SILAC  Stable isotopic labeling with acids in cell culture 
SIM   Selected ion monitoring 
TCA   Trichloroacetic acid 
Vtg   Vitellogenin 
α-CHCA  α-Cyano-4- hydroxycinnamic acid,  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table of Contents 
 
xi 
Table of Contents
 
Chapter I. Introduction ........................................................................................................ 1 
I.1 Proteomics, the new biology .......................................................................................... 5 
I.2 Sample preparation for mass spectrometry-based protein identification ....................... 6 
I.2.1 In-gel protein digestion ................................................................................... 6 
I.2.2 In-solution protein digestion ........................................................................... 7 
I.3 Accelerating protein digestion ....................................................................................... 8 
I.3.1 Microwave energy........................................................................................... 9 
I.3.2 Ultrasonic energy ............................................................................................ 9 
I.3.2.1 Basics on ultrasonic energy.............................................................. 9 
I.3.2.2 Indirect sonication: the ultrasonic bath and the sonoreactor ........ 10 
I.3.2.3 Direct sonication: the ultrasonic probe.......................................... 11 
I.3.2.4 Accelerating protein digestion with ultrasonic energy................... 12 
I.4 Beyond protein identification - quantitative proteomics.............................................. 12 
I.5 Gel-based quantification methods................................................................................ 13 
I.5.1 Differential gel electrophoresis ..................................................................... 14 
I.6 Mass-spectrometry based protein quantification.......................................................... 15 
I.6.1 Label-free methods for protein quantification............................................... 15 
I.6.2 Methods based on isotopic labeling .............................................................. 16 
I.6.2.1 Monitoring ...................................................................................... 16 
I.6.2.2 SILAC Labeling .............................................................................. 18 
I.6.2.3 ICAT Labeling ................................................................................ 18 
I.6.2.4 iTRAQ labeling ............................................................................... 19 
I.7 Isotopic labeling of proteins with 18O .......................................................................... 20 
I.7.1 Chemical reactions involved in the 18O labeling of proteins......................... 20 
I.7.1.1 The direct labeling.......................................................................... 21 
I.7.1.2 The decoupling procedure .............................................................. 21 
I.7.1.3 The use of immobilized enzymes ..................................................... 22 
Table of Contents 
xii 
I.7.2 The problem of the 18O-labeling efficiency .................................................. 23 
I.7.3 Variables affecting 18O labeling of proteins ................................................. 23 
I.7.3.1 The enzymes used for 18O labeling ................................................. 23 
I.7.3.2 The influence of the pH .................................................................. 24 
I.7.4 18O inverse labeling....................................................................................... 24 
I.7.4.1 Applications to proteins separated by gel electrophoresis ............ 25 
I.7.4.2 Applications to proteins in solution ............................................... 28 
I.8. Direct tissue mass spectrometry analysis.................................................................... 29 
I.9. References....................................................................................................................30 
Chapter II. Objectives and working plan .......................................................................... 35 
Chapter III. Improving sample treatment for in-solution protein identification by peptide 
mass fingerprint using matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry...................................................................................................................... 39 
III.1 Resumo...................................................................................................................... 42 
III.2 Abstract ..................................................................................................................... 43 
III.3 Introduction ............................................................................................................... 44 
III.4 Experimental procedures........................................................................................... 45 
III.4.1 Apparatus.................................................................................................... 45 
III.4.2 Ultrasonic devices ...................................................................................... 45 
III.4.3 Standards and reagents ............................................................................... 46 
III.4.4 Sample treatment ........................................................................................ 47 
III.4.4.1 Classic method............................................................................. 47 
III.4.4.2 Protein digestion accelerated method ......................................... 48 
III.4.4.3 Accelerated method ..................................................................... 50 
III.4.5 MALDI-TOF-MS Analysis ........................................................................ 50 
III.4.6 Protein samples from complex mixtures .................................................... 51 
III.5 Results and discussion............................................................................................... 51 
III.5.1 Protein digestion accelerated method......................................................... 51 
III.5.2 Accelerated method.................................................................................... 53 
III.5.3. Proof of the method................................................................................... 56 
III.6 Conclusions ............................................................................................................... 57 
III.7 Acknowledgments..................................................................................................... 58 
III.8 References ................................................................................................................. 59 
Table of Contents 
 
xiii 
III.9 Supporting information ............................................................................................. 60 
Chapter IV. Ultrasonic multiprobe as a new tool to overcome the bottleneck of 
throughput in workflows for protein identification relaying on ultrasonic energy. .......... 61 
IV.1 Resumo...................................................................................................................... 64 
IV.2 Abstract ..................................................................................................................... 65 
IV.3 Introduction ............................................................................................................... 66 
IV.4 Experimental ............................................................................................................. 67 
IV.4.1 Apparatus.................................................................................................... 67 
IV.4.2 Ultrasonic devices ...................................................................................... 67 
IV.4.3 Standards and reagents ............................................................................... 68 
IV.4.4 Sample treatments ...................................................................................... 68 
IV.4.4.1 Classic method ............................................................................. 68 
IV.4.4.2 Accelerated urea method.............................................................. 69 
IV.4.4.3 Accelerated clean method ............................................................ 69 
IV.4.5 A case study................................................................................................ 69 
IV.4.5.1 D. desulfuricans ATCC 27774 ..................................................... 69 
IV.4.6 MALDI-TOF-MS analysis ......................................................................... 70 
IV.4.7 Statistical analysis ...................................................................................... 71 
IV.5 Results and discussion............................................................................................... 71 
IV.5.1 Classic method............................................................................................ 71 
IV.5.2 Accelerated urea method ............................................................................ 71 
IV.5.3 Accelerated clean method........................................................................... 75 
IV.5.4 MALDI spectra........................................................................................... 75 
IV.5.5 Application to a case study......................................................................... 76 
IV.5.6 Final remarks .............................................................................................. 77 
IV.6 Conclusions ............................................................................................................... 78 
IV.7 Acknowledgments ..................................................................................................... 79 
IV.8 References ................................................................................................................. 79 
Chapter V. Decision peptide-driven: a free software tool for accurate protein 
quantification using gel electrophoresis and matrix assisted laser desorption ionization 
time-of-flight mass spectrometry. ..................................................................................... 81 
V.1 Resumo ....................................................................................................................... 85 
V.2 Abstract....................................................................................................................... 86 
Table of Contents 
xiv 
V.3 Introduction ................................................................................................................ 87 
V.4 Materials and methods................................................................................................ 88 
V.4.1 Apparatus..................................................................................................... 88 
V.4.2 Standards and reagents ................................................................................ 88 
V.4.3 In-gel protein digestion................................................................................ 89 
V.4.4 18O labeling: the decoupled procedure ........................................................ 89 
V.4.5 Inverse 18O labeling of peptides .................................................................. 90 
V.4.6 Quantification of peptides............................................................................ 90 
V.4.7 Case study.................................................................................................... 90 
V.4.8 MALDI analysis .......................................................................................... 91 
V.4.9 Software distribution ................................................................................... 91 
V.4.10 Decision peptide-driven experimental workflow ...................................... 91 
V.5 Results and discussion................................................................................................ 93 
V.5.1 Preparing theoretical data ............................................................................ 93 
V.5.1.1 How to obtain the in-silico protein digestion................................ 93 
V.5.1.2 How to obtain the isotopic mass distribution of the peptides ....... 93 
V.5.2 Finding out the DPD peptides ..................................................................... 94 
V.I.5.2.1 First step: loading the in-silico data........................................... 94 
V.5.2.2 Second step: loading experimental data ....................................... 95 
V.5.2.3Third step: creating a label experiment ......................................... 98 
V.5.2.4 Fourth step: intersect peptides...................................................... 98 
V.5.3 Quantification experiment ......................................................................... 100 
V.5.4 Merits and limitations................................................................................ 102 
V.6 Conclusions .............................................................................................................. 103 
V.7 Acknowledgements .................................................................................................. 103 
V.8 References ................................................................................................................ 104 
V.9. Supplementary material……………………………………………………………105 
V.9.SM.1 Step by step description for the preparation of the data to use in the 
DPD software. ................................................................................................................. 105 
V.9.SM.2 How to obtain the in-silico digestion of a target protein .................... 105 
V.9.SM.3 How to obtain the predicted isotopic mass distribution of the peptides110 
Chapter VI. A novel 18O inverse labeling-based workflow for accurate bottom-up mass 
spectrometry quantification of proteins separated by gel electrophoresis ...................... 113 
Table of Contents 
 
xv 
VI.1 Resumo.................................................................................................................... 117 
VI.2 Abstract ................................................................................................................... 118 
VI.3 Introduction ............................................................................................................. 119 
VI.4 Materials and Methods ............................................................................................ 120 
VI.4.1 Apparatus.................................................................................................. 120 
VI.4.2 Standards and reagents ............................................................................. 121 
VI.4.3 Gel electrophoresis ................................................................................... 121 
VI.4.4 Stain and image analysis .......................................................................... 122 
VI.4.5 In-gel protein digestion............................................................................. 122 
VI.4.6 18O labeling: the decoupled procedure...................................................... 123 
VI.4.7 Inverse 18O labeling of peptides ............................................................... 123 
VI.4.8 Analytical and biological sample replicates ............................................. 123 
VI.4.9 Quantification of peptides ........................................................................ 124 
VI.4.10 Case study............................................................................................... 125 
VI.4.10.1 Plasmatic vitellogenin from Cyprinus carpio .......................... 125 
VI.4.10.2 ELISA vitellogenin quantification in Cyprinus carpio fish 
plasma.................................................................................................................. 126 
VI.4.11 MALDI-TOF-MS analysis ..................................................................... 126 
VI.4.12 Software distribution .............................................................................. 127 
VI.5 Results and Discussion............................................................................................ 127 
VI.5.1 Sample treatment workflow ..................................................................... 127 
VI.5.2 Finding out the best peptides for protein quantification........................... 128 
VI.5.3 The use of “DPD peptides” as internal standards..................................... 133 
VI.5.4 A case study: quantifying 17?-estradiol-induced vitellogenin in fish...... 135 
VI.5.5 Merits and limitations............................................................................... 140 
VI.6 Conclusions ............................................................................................................. 140 
VI.7 Acknowledgements ................................................................................................. 142 
VI.8 References ............................................................................................................... 142 
VI.9. Supplementary material.......................................................................................... 144 
VI.9.SM.1 Glycogen phosphorylase muscle from Oructolagus cuniculus ......... 144 
VI.9.SM.2. Comparison of the DPD peptides and the 4 most intense peaks in the 
mass spectra for all the proteins studied. Peak intensities of each peak are shown in 
branches ........................................................................................................................... 145 
Table of Contents 
xvi 
VI.9.SM.3 Peptides assigned by the DPD software as candidates of bovine 
serum albumin, ovalbumin, carbonic anhydrase, trypsin inhibitor and α-lactalbumin... 146 
VI.9.SM.4 Protein precipitation methods............................................................ 148 
VI.9.SM.4.1 Precipitation with Cl2Mg/EDTA.......................................... 148 
VI.9.SM.4.2 Acetone precipitation........................................................... 148 
Chapter VII. On-tissue 18O labeling for mass spectrometry-based applications ........... 149 
VII.1 Resumo .................................................................................................................. 152 
VII.2 Abstract.................................................................................................................. 153 
VII.3 Introduction............................................................................................................ 154 
VII.4 Materials and Methods .......................................................................................... 154 
VII.4.1 Material ................................................................................................... 154 
VII.4.2 Tissue preparation................................................................................... 155 
VII.4.3 On-tissue enzymatic digestion ................................................................ 155 
VII.4.4 On-tissue 18O labeling and matrix coating.............................................. 155 
VII.4.5 Mass spectrometry of peptides ............................................................... 155 
VII.5 Results and Discussion .......................................................................................... 156 
VII.5.1 Preliminary experiments ......................................................................... 156 
VII.5.2 Influence of the digestion time ............................................................... 158 
VII.5.3 Direct on-target proteolytic labeling....................................................... 158 
VII.5.4 Decoupled on-target labeling.................................................................. 159 
VII.5.5 The influence of trypsin concentration in the labeling efficiency .......... 161 
VII.5.6 On-tissue digestion and post-proteolytic labeling................................... 162 
VII.5.7 The influence of time in the on-tissue post-digestion labeling............... 163 
VII.5.8 Effect of ultrasonic energy on tissue digestion....................................... 164 
VII.6 Conclusions............................................................................................................ 165 
VII.7 Acknowledgements................................................................................................ 166 
VII.8 References.............................................................................................................. 166 
Chapter VIII. Conclusions and future prospects ............................................................. 169 
 
 
 xvii 
Index of Figures
 
Figure I. 1. Example of ultrasonic devices: A- ultrasonic bath; B- ultrasonic probe and C- 
Sonoreactor.........................................................................................................................10 
Figure I. 2. N-hydroxy-succinimidyl esters of Cy2, propyl Cy3 and methyl Cy5 used for 
DIGE labeling of lysine residues [37]. ...............................................................................14 
Figure I. 3. Chemical structure of the original ICAT label. Heavy reagent, d8-ICAT (R-
deuterium); Light reagent, d0-ICAT (R-hydrogen) [38]. ...................................................18 
Figure I. 4. Mechanism of the double oxygen incorporation by carboxyl oxygen exchange.
............................................................................................................................................22 
Figure I. 5. Direct and inverse labeling experiments of a target protein and the 
correspondent control sample.............................................................................................25 
Figure III. 1. Classic sample treatment for in-solution protein digestion. ........................47 
Figure III. 2. Sonication time, sonication amplitude, frequency of sonication, and 
temperature of the different sample treatments investigated..............................................49 
Figure III. 3. MALDI-TOF-MS spectra for α-lactalbumin and ovalbumin. (A and D) 
Classic treatment; (B and E) protein digestion accelerated method using ultrasonic probe; 
(C and F) protein digestion accelerated method using sonoreactor. For ultrasonic conditions 
refer to figure III.2. Protein/enzyme ratio was 20:1. Expected protein in the MALDI spot: 
0.01?g.................................................................................................................................52 
Figure III. 4. MALDI-TOF-MS spectra for α-lactalbumin and ovalbumin. (A and D) 
Classic treatment; (B and E) accelerated method using ultrasonic probe for protein 
alkylation, protein reduction, and protein digestion; (C and F) accelerated method using 
sonoreactor for protein alkylation, protein reduction, and protein digestion. For ultrasonic 
Index of Figures 
xviii 
conditions refer to the text. Protein/enzyme ratio was 20:1 (w/w). Expected protein in the 
MALDI spot: 0.01?g..........................................................................................................55 
Figure III. 5. MALDI-TOF-MS spectra for α-lactalbumin and ovalbumin. (A and D) 
Classic treatment; (B and E) accelerated method using ultrasonic probe for protein 
alkylation, protein reduction, and protein digestion; (C and F) accelerated method using 
sonoreactor for protein alkylation, protein reduction, and protein digestion. For ultrasonic 
conditions refer to the text. Protein/enzyme ratio was 20:1 (w/w). Expected protein in the 
MALDI spot: 0.01?g..........................................................................................................57 
Figure III.SM. 1. MALDI-TOF-MS spectra for α-lactalbumin after protein digestion in the 
ultrasonic bath: A: frequency 35KHz, 100% amplitude and 5min sonication time; B: 
frequency 35KHz, 100% amplitude and 15min sonication time; C: frequency 130KHz, 
100% amplitude and 5 min sonication time; D: frequency 130KHz, 100% amplitude and 
15min sonication time. .......................................................................................................60 
Figure IV. 1. This figure shows the new ultrasonic multiprobe coupled to the 96-well plate.
............................................................................................................................................67 
Figure IV. 2. Number of peptides matched and sequence coverage for bovine serum 
albumin and α-lactalbumin as a function of time, and amplitude of ultrasonication. 
Sequence coverage and peptides matched for the overnight method was 61±5 and 39±4 for 
bovine serum albumin and 47±2 and 11±1 for α-lactalbumin, respectively......................73 
Figure IV. 3. MALDI spectra obtained of in-solution digestion of 3?g/?l of bovine serum 
albumin and α -lactalbumin. Panel A, B and C, spectrum of digested bovine serum albumin 
with classic method (A), accelerated urea method (B) and (C) accelerated clean method. 
Panel D, E and F, spectrum of digested α-lactalbumin with classic method (D), accelerated 
method (E) and (F) accelerated clean method....................................................................76 
Figure IV. 4. MALDI spectra of Split-Soret cytochrome c from D. desulfuricans, (A) 
classic method, (B) accelerated urea method and (C) accelerated clean method. .............77 
Figure V. 1. Schematic diagram illustrating steps of the sample treatment workflow 
including gel electrophoresis, labeling, protein identification, DPD analysis of the D&I data 
Index of Figures 
xix 
that allows the best choice of peptides for quantification and finally the DPD quantification 
experiment. .........................................................................................................................92 
Figure V. 2. MALDI-TOF-MS spectra of glycogen phosphorylase obtained for the direct 
(0.84µg of unlabeled protein and 1.68µg of 18O-labeled protein, samples were mixed in a 
1:1 ratio before MALDI analysis) and inverse labeling (0.84µg of 18O-labeled protein and 
1.68µg of unlabeled protein, samples were mixed in a 1:1 ratio before MALDI analysis). 
?peptides assigned by the DPD software, § indicates the peptides used for the quantification 
with the most intense peaks and ?§ indicates peptides that were simultaneously assigned by 
DPD and are the most intense peaks. .................................................................................94 
Figure V. 3. Results obtained with the DPD approach for glycogen phosphorylase, bovine 
serum albumin, ovalbumin carbonic anhydrase, trypsin inhibitor and α-lactalbumin. Panels 
A, C, E, G, I and K: x-axes shows the RSD of the direct (blue colour) and inverse 
experiments (red colour), RSDD&I. Peptides are grouped as a function of the RSDD&I and 
only those included in the group named (I), can be used for accurate quantification. As an 
example in panel A, (I) means that four peptides can be used for accurate quantification. 
The expected direct and inverse ratios are 0.5 for all proteins except for α-lactalbumin for 
which the expected ratio is 0.75. Insets B, D, F, H, J and L show the quantification results 
obtained for each protein using the peptides included in each group. For instance, in inset 
B, the amount of protein is calculated four times. Each value is named as (I), (II), (III) and 
(IV) and correlates with the group of peptides with the same letters that were used for the 
calculation...........................................................................................................................95 
Figure V. 4. DPD protein quantification of 2, 1 and 0.4µg of (1) bovine serum albumin, (2) 
carbonic anhydrase and (3) α-lactalbumin. The quantification was carried out with different 
ratios of protein/18O-labeled internal standard, 1:1, 1:2, 1:5. No statistical differences were 
found between the calculated value and the amount of protein loaded on the 1D-gel 
(p>0.05, t-test, n=4). ..........................................................................................................96 
Figure V. 5. 1D-gel electrophoresis of A- molecular weight marker; B-1µg of Cyprinus 
carpio vitellogenin standard; C- Precipitated plasma with MgCl2/EDTA method (250µL of 
plasma were precipitated and the resulting pellet was reconstituted in 5µL of sample buffer 
and loaded on the gel); D- Plasma precipitated with the acetone method (80µL of plasma 
were precipitated and the resulting pellet was reconstituted in 100µL of sample buffer and 
Index of Figures 
xx 
diluted 1:2 before loading on the gel); E and F- Plasma from control males (non-exposed) 
precipitated by the acetone method; G and H- Plasma from exposed males precipitated by 
the acetone method (dilution 1:50)....................................................................................97 
Figure V. 6. MALDI mass spectrum obtained for the quantification of Vtg (0.5µg of 18O-
labeled internal standard).? DPD-peptides........................................................................97 
Figure VI. 1. Experimental workflow for the identification of DPD (decision peptide 
driven) peptides and subsequent protein quantification...................................................124
Figure VI. 2. In-silico file -excel CSV- containing peptide masses, the theoretical peptide 
sequence assigned to each mass, carboxyamidomethilations present (yes-true or no-false) 
and the isotopic mass distribution for the protein Carbonic Anhydrase. ...........................131 
Figure VI. 3. By clicking in “load in-silico data” the data created as described in sections 
VI.5.1.1 and VI.5.1.2 is introduced in the form of a CSV excel sheet...............................134 
Figure VI. 4. MALDI spectra of carbonic anhydrase obtained for the direct (1µg of 
unlabeled protein and 2 µg of 18O-labeled protein, samples were mixed in a 1:1 ratio before 
MALDI analysis) and inverse labeling (2µg of 18O-labeled protein and 1µg of unlabeled 
protein, samples were mixed in a 1:1 ratio before MALDI analysis).The symbol(“?”) 
denotes the peptides assigned by the DPD software ..........................................................135 
Figure VI. 5. CSV excel sheet in which one column contents the peak mass values whilst 
other contents their corresponding MALDI intensities......................................................136 
Figure VI. 6. By clicking in “load labeling data” the data created as described in sections 
3.3 for the direct (n=4) and inverse (n=4) experiments are introduced in the form of a CSV 
excel sheet. The user is also asked to introduce a value for the minimum peak intensity for 
which a peak will be considered as different from noise. ..................................................138 
Figure VI. 7. This figure shows the result of the execution which is a report containing the 
values of the input parameters and the generated output data including: (i) a list of peptides 
identified in the raw data input files, (ii) a list of non-labeled peptides, (iii) a list of filtered 
peptides, (iv) a list of intersection peptides and finally (v) a list of reproducible peptides, 
those that can be used for quantification................................................................................  
Index of Figures 
xxi 
Figure VI. 8. DPD application showing a ready-to-run quantification experiment where the 
user-defined parameters can be specified. ...........................................................................101
Figure VI. 9. Protein quantification results computed by the DPD application once an 
experiment is executed ........................................................................................................102 
Figure VII. 1. Schematic diagram of the sample treatment workflow including: tissue 
washing, on-tissue trypsin digestion, 18O labeling and matrix application. .....................156 
Figure VII. 2. MALDI spectra of a liver tissue from Mus musculus spiked with carbonic 
anhydrase (0, 0.1, 0.5, 2.5?g) and digested with 40ng/mm2 of trypsin in a humidified 
chamber for 3h at 37ºC. ? Indicate the m/z peaks from carbonic anhydrase..................157 
Figure VII. 3. MALDI spectra of 0.5?g of carbonic anhydrase digested over ITO-coated 
glass slide (trypsin 40ng/mm2) in H216O, 1:1 H216O/ H218O and H218O. ..........................159 
Figure VII. 4. MALDI spectra of 0.5?g of carbonic anhydrase digested over ITO-coated 
glass slide (trypsin 40ng/mm2) followed by 20min of labeling with H216O/trypsin 
125ng/?L/ammonium acetate 50mM and H218O/ trypsin 125ng/?L/ ammonium acetate 
50mM. ..............................................................................................................................160 
Figure VII. 5. MALDI spectra of 0.5?g of carbonic anhydrase digested over ITO-coated 
glass slide (trypsin 40ng/mm2) followed by 20min of labeling with H218O/ ammonium 
acetate 50mM with 0.1?g, 0.05?g, 0.01?g and 0?g of trypsin. .......................................162 
Figure VII. 6. MALDI spectra of a liver tissue from Mus musculus digested with 
40ng/mm2 of trypsin in a humidified chamber for 3h at 37ºC followed by 20min of labeling 
at room temperature with H216O/ 50mM ammonium acetate, H216O/H218O/ ammonium 
acetate 50mM and H218O/ 50mM ammonium acetate......................................................162 
Figure VII. 7. MALDI spectra of a ovary tissue from Mus musculus digested with 
40ng/mm2 of trypsin in a humidified chamber for 3h at 37ºC followed by 20 min of 
labeling at room temperature with H216O/ 50mM ammonium acetate, 10 min of labeling 
with H218O/ ammonium acetate 50mM and 20min of labeling with H218O/ 50mM 
ammonium acetate. ...........................................................................................................163 
Index of Figures 
xxii 
Figure VII. 8. MALDI spectra of a liver tissue from Mus musculus digested with 
40ng/mm2 of trypsin in sonoreactor with 50% of Sonication amplitude for 30s, 90s, 180s, 
300s and for comparative purposes the same experiments were carried out without 
ultrasonication. .................................................................................................................165 
 
 xxiii 
 
Table I. 1. Protein staining for gel electrophoresis-based quantification of proteins [35].13 
Table III. 1. Number of Peptides Matched and Protein Sequence Coverage (%) for the 
Classic and Accelerated Methods. Initial protein concentration: a 2 µg/µl; b 10 µg/µl;c 20 
µg/µl. ..................................................................................................................................56 
Table IV. 1. Protein sequence coverage and number of peptides matched for the in-solution 
protein digestion: overnight method, accelerated method with urea and ZipTip® and clean 
method in H2O/acetonitrile (n=4, pt=0.05a).......................................................................72 
Table IV. 2. Comparison of handling and time consumed for the three methods studied in 
this work. ............................................................................................................................78 
Table V. 1. Peptides assigned by the DPD software as candidates to be used for 
quantification of glycogen phosphorylase, muscle from Oryctolagus cuniculus. Direct 
labeling: 0.84µg of unlabeled protein and 1.68µg of 18O-labeled protein, samples were 
mixed in a 1:1 ratio before MALDI analysis. The expected direct ratio is 0.5 corresponding 
to the unlabeled/labeled ratio (0.84/1.68). Inverse labeling: 0.84µg of 18O-labeled protein 
and 1.68µg of unlabeled protein, samples were mixed in a 1:1 ratio before MALDI 
analysis. The expected inverse ratio is 2 corresponding to the unlabeled/labeled ratio 
(1.68/0.84). (note: the inverse ratio is expressed in the table as (inverse ratio)-1 for 
simplicity. In this way the direct and inverse ratios may be compared easily since both have 
the same value of 0.5). For the direct method the amount of protein calculated was the 
lower of 0.84µg whilst for the inverse method was the higher of 1.68µg. DPD software 
parameters: Peak intensity - 5; Peptide mass tolerance ± 0.25Da; experimental overlapping 
- 2; Ratio I4/I0 - 0.15. ?Significant differences between D&I ratios (p<0.05, t-test). n=4; ‡ 
Expected values. ...............................................................................................................130 
Table V. 2. Amounts of different proteins loaded into the 1D-gel for the direct and inverse 
labeling and the respective quantification using (i) the DPD methodology, (ii) the most 
Index of Tables
Index of Tables 
xxiv 
intense peak of the mass spectra and (iii) the four most intense peaks of the mass spectra. 
For the quantification done with the DPD methodology the number of peptides used is 
indicated between branches..............................................................................................132 
Table V. 3. Peptides assigned by the DPD software as candidates for quantification for 
vitellogenin from Cyprinus carpio. Direct labeling: 1µg of unlabeled protein and 2µg 18O-
labeled protein, samples were mixed in a 1:1 ratio before MALDI analysis. The expected 
direct ratio is 0.5 corresponding to the unlabeled/labeled ratio (1/2). Inverse labeling: 1µg 
of 18O-labeled protein and 2µg of unlabeled protein, samples were mixed in a 1:1 ratio 
before MALDI analysis. The expected inverse ratio is 2 corresponding to the 
unlabeled/labeled ratio (2/1). (note: the inverse ratio is expressed in the table as (inverse 
ratio)-1 for simplicity. In this way the direct and inverse ratios may be compared easily 
since both have the same value of 0.5). For the direct method the amount of protein 
calculated was the lower of 1µg whilst for the inverse method was the higher of 2µg. DPD 
software parameters used: Peak intensity - 5; Peptide mass tolerance ±0.25Da; experimental 
overlapping - 2; Ratio I4/I0 - 0.15. ?Significant differences between D&I ratios (p<0.05, t-
test). ..................................................................................................................................137 
Table V. 4. Quantification of Vtg from Cyprinus carpio fish plasma by enzyme-linked 
immunosorbent assay (ELISA) and by DPD. Nonparametric Mann-Whitney U-test: no 
statistical differences were found between both quantitation methods............................139 
Table V. 5. Relative labeling efficiency of peptides formed by the tryptic digestion of 
vitellogenin and postdigestion labeling in the presence of 97% H218O. ..........................141 
V.9.SM.2. Comparison of the DPD peptides and the 4 most intense peaks in the mass 
spectra for all the proteins studied. Peak intensities of each peak are shown in branches 
..........................................................................................................................................146 
V.9.SM.3. 1. Peptides assigned by the DPD software as candidates for quantification of 
BSA. Direct labeling: 1.04µg of unlabeled protein and 2.08µg 18O-labeled protein, samples 
were mixed in a 1:1 ratio before MALDI analysis. The expected direct ratio is 0.5 
corresponding to the unlabeled/labeled ratio (1.04/2.08). Inverse labeling: 1.04µg of 18O-
labeled protein and 2.08µg of unlabeled protein, samples were mixed in a 1:1 ratio before 
MALDI analysis. Software parameters: Peak intensity - 3; Peptide mass tolerance ±0.25Da; 
 xxv 
experimental overlapping - 2; Ratio I4/I0 - 0.15. ?Significant differences between D&I 
ratios (p<0.05, t-test); ‡ Expected values ..........................................................................146
V.9.SM.3. 2. Peptides assigned by the DPD software as candidates for quantification of 
ovalbumin. Direct labeling: 1.84µg of unlabeled protein and 3.68µg 18O-labeled protein, 
samples were mixed in a 1:1 ratio before MALDI analysis. The expected direct ratio is 0.5 
corresponding to the unlabeled/labeled ratio (1.84/3.68). Inverse labeling: 1.84µg of 18O-
labeled protein and 3.68µg of unlabeled protein, samples were mixed in a 1:1 ratio before 
MALDI analysis. Software parameters: Peak intensity - 5; Peptide mass tolerance ±0.25Da; 
experimental overlapping - 2; Ratio I4/I0 - 0.15. ?Significant differences between D&I 
ratios (p<0.05, t-test); ‡ Expected values ..........................................................................146 
V.9.SM.3. 3. Peptides assigned by the DPD software as candidates for quantification of 
carbonic anhydrase. Direct labeling: 1.04µg of unlabeled protein and 2.08µg 18O-labeled 
protein, samples were mixed in a 1:1 ratio before MALDI analysis. The expected direct 
ratio is 0.5 corresponding to the unlabeled/labeled ratio (1.04/2.08). Inverse labeling: 
1.04µg of 18O-labeled protein and 2.08µg of unlabeled protein, samples were mixed in a 1:1 
ratio before MALDI analysis. Software parameters: Peak intensity - 2; Peptide mass 
tolerance ±0.25Da; experimental overlapping - 2; Ratio I4/I0 - 0.15. ?Significant 
differences between D&I ratios (p<0.05, t-test); ‡ Expected values.................................147 
V.9.SM.3. 4. Peptides assigned by the DPD software as candidates for quantification of 
trypsin inhibitor. Direct labeling: 1.0µg of unlabeled protein and 2.0µg 18O-labeled protein, 
samples were mixed in a 1:1 ratio before MALDI analysis. The expected direct ratio is 0.5 
corresponding to the unlabeled/labeled ratio (1.0/2.0). Inverse labeling: 1.0µg of 18O-
labeled protein and 2.0µg of unlabeled protein, samples were mixed in a 1:1 ratio before 
MALDI analysis. Software parameters: Peak intensity - 2; Peptide mass tolerance ±0.3Da; 
experimental overlapping - 2; Ratio I4/I0 - 0.15. ?Significant differences between D&I 
ratios (p<0.05, t-test); ‡ Expected values ..........................................................................147 
V.9.SM.3. 5. Peptides assigned by the DPD software as candidates for quantification of α-
lactalbumin. Direct labeling: 2.18µg of unlabeled protein and 2.90µg 18O-labeled protein, 
samples were mixed in a 1:1 ratio before MALDI analysis. The expected direct ratio is 0.75 
corresponding to the unlabeled/labeled ratio (2.18/2.90). Inverse labeling: 2.18µg of 18O-
labeled protein and 2.90µg of unlabeled protein, samples were mixed in a 1:1 ratio before 
Index of Tables 
xxvi 
MALDI analysis. Software parameters: Peak intensity - 2; Peptide mass tolerance ±0.3Da; 
experimental overlapping - 2; Ratio I4/I0 - 0.15. ?Significant differences between D&I 
ratios (p<0.05, t-test); ‡ Expected values..........................................................................148 
Table VI. 1. Peptides assigned by the DPD software as candidates for quantification of 
carbonic anhydrase. Direct labeling: 1.04µg of unlabeled protein and 2.08µg 18O-labeled 
protein, samples were mixed in a 1:1 ratio before MALDI analysis. The expected direct 
ratio is 0.5 corresponding to the unlabeled/labeled ratio (1.04/2.08). Inverse labeling: 
1.04µg of 18O-labeled protein and 2.08µg of unlabeled protein, samples were mixed in a 1:1 
ratio before MALDI analysis. Software parameters: Peak intensity - 3; Peptide mass 
tolerance ±0.25Da; experimental overlapping - 1; Ratio I4/I0 - 0.15. ?Significant 
differences between D&I ratios (p<0.05, t-test); ‡ Expected values...................................102 
 
 1 
 
 
 
 
 
 
Chapter I.
Introduction
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
Index
 
I.1 Proteomics, the new biology .......................................................................................... 5 
I.2 Sample preparation for mass spectrometry-based protein identification ....................... 6 
I.2.1 In-gel protein digestion ................................................................................... 6 
I.2.2 In-solution protein digestion ........................................................................... 7 
I.3 Accelerating protein digestion ....................................................................................... 8 
I.3.1 Microwave energy........................................................................................... 9 
I.3.2 Ultrasonic energy ............................................................................................ 9 
I.3.2.1 Basics on ultrasonic energy.............................................................. 9 
I.3.2.2 Indirect sonication: the ultrasonic bath and the sonoreactor ........ 10 
I.3.2.3 Direct sonication: the ultrasonic probe.......................................... 11 
I.3.2.4 Accelerating protein digestion with ultrasonic energy................... 12 
I.4 Beyond protein identification - quantitative proteomics.............................................. 12 
I.5 Gel-based quantification methods................................................................................ 13 
I.5.1 Differential gel electrophoresis ..................................................................... 14 
I.6 Mass-spectrometry based protein quantification.......................................................... 15 
I.6.1 Labeling-free methods for protein quantification ......................................... 15 
I.6.2 Methods based on isotopic labeling .............................................................. 16 
I.6.2.1 Monitoring ...................................................................................... 16 
I.6.2.3 ICAT Labeling ................................................................................ 18 
I.6.2.4 iTRAQ labeling ............................................................................... 19 
I.7 Isotopic labeling of proteins with 18O .......................................................................... 20 
I.7.1 Chemical reactions involved in the 18O labeling of proteins......................... 20 
I.7.1.1 The direct labeling.......................................................................... 21 
I.7.1.2 The decoupling procedure .............................................................. 21 
I.7.1.3 The use of immobilized enzymes ..................................................... 22 
I.7.4 The problem of the 18O-labeling efficiency .................................................. 23 
I.7.5 Variables affecting 18O labeling of proteins.................................................. 23 
I.7.5.1 The enzymes used for 18O labeling ................................................. 23 
Index 
4 
I.7.5.2 The influence of the pH .................................................................. 24 
I.7.6 18O inverse labeling....................................................................................... 24 
I.7.6.1 Applications to proteins separated by gel electrophoresis ............ 25 
I.7.6.2 Applications to proteins in solution ............................................... 28 
I.8. Direct tissue mass spectrometry analysis.................................................................... 29 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter I. Introduction 
5 
I.1 Proteomics, the new biology 
Large-scale DNA sequencing has changed biological and biomedical research in a 
little period of time. As the DNA sequencing technique is spread among the scientific 
community the list of entire genomes decoded or at least entire sequences decoded, is 
growing exponentially. This decodification allows getting a better understanding in the 
insight of the operational parts of an organism [1]. Ultimately, our era has witnessed the 
answer to difficult biological questions thanks to the fact that DNA sequencing has allowed 
the understanding of intricate biological processes [2]. 
Genome, transcriptome, proteome and metabolome are names that generally refer to 
different compartments of biological complexity within a living organism. The part that 
studies the proteome is referred to as Proteomics.  
The study of proteomics, defined as the entire complement of proteins, including the 
modifications made to a particular set of proteins, produced by an organism or system, 
presents many challenges. Nowadays it has been clearly established that a gen or group of 
gens can support the information to produce one protein or proteins, yet this does not 
necessarily means that such protein(s) is(are) presented (expressed) in the proteome of a 
living organism. Furthermore, once a protein has been produced it may suffer a series of 
modifications called post-translational modifications, and therefore the final protein does 
not correspond with the original design corresponding to the information contained in the 
gen or gens. Therefore much of the present attention devoted to proteomics relies in its 
capability to unravel the secrets of the biological systems whilst overcoming the limits of 
classical biochemical approaches [2-4]. 
Originally the word proteomics was associated to the study of a large number of 
proteins from a given organism or cell by means of two dimensional polyacrylamide gels, 
2D-PAGE [5,6]. However, to determine the identity of the proteins was difficult by this 
method. In the 1990s mass spectrometry (MS) emerged as a powerful tool with which 
overcome the limitations inherent to 2D-PAGE and protein identification [2]. Nowadays 
MS-based protein identification by means of peptide mass fingerprint, PMF, or peptide 
fragment fingerprint [7-9] is broadly adopted, and the transition from analyzing one protein 
at a time to analyzing proteins in highly complex mixtures has been made [10,11]. 
Proteomics plays nowadays an important role in biological and biomedical research, 
because research developed under those areas of knowledge has demonstrated that it is 
possible to identify and quantify proteins, to determine the presence of post-translational 
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modifications, to elucidate protein structure and function, and to establish correlations 
between genes and proteins. 
I.2 Sample preparation for mass spectrometry-based protein identification 
The identification of proteins is becoming more important to the scientific 
community due to emerging issues related to proteins critically significant to the society. 
Many hereditary diseases, cancer and other common illnesses, such as diabetes, can be 
distinguished on the basis of the expression of certain proteins, known as biomarkers. As a 
result, disease screening and medical diagnosis take advantage of MS-based technological 
improvements that allow protein identification [12,13]. 
Gel-based and gel-free are the two main approaches used in proteomics research. 
The first one is based in the resolving power, semi-quantitative nature and instant 
visualization of proteins separated by gel electrophoresis in the first or in the second 
dimension. However, gel-based approaches lack in reproducibility, are expensive in the 
second dimension, and are considered labor intensive [14,15]. Gel-free approaches are 
mainly based in the coupling of high performance liquid chromatography, HPLC, and mass 
spectrometry. The proteins are digested into peptides either off- or on-line, and then the 
peptides are separated by HPLC. The identification of the proteins is done through the 
information retrieved from the peptides using mass spectrometry either off-line using 
matrix assisted laser desorption ionization, MALDI, or on-line using electrospray 
ionization, ESI [16]. 
General aspects of sample preparation steps for both, gel-based and gel-free 
proteomics are described on the following sections. 
I.2.1 In-gel protein digestion 
This is by far the most time-consuming and tedious approach. First, proteins must 
be separated and purified. Usually, a complex protein mixture is separated by 2D-GE but 
first, depending on the sample, it may be necessary to concentrate and eliminate interfering 
substances before electrophoresis. In such a case, protein precipitation with a mixture of 
trichloroacetic acid (TCA) / acetone is very useful to remove salts and detergents [17]. To 
guarantee reproducibility in the separation process, protein extracts must previously be 
denatured in urea/thiourea. In addition, thiourea increases the solubility of hydrophobic 
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proteins [18]. To run the first dimension of 2D-GE, samples are loaded into isoelectric 
focusing (IEF) gel strips containing ampholytes. 
When a protein is placed in a medium with a pH gradient and then is subjected to an 
electric field, it will initially move toward the electrode with the opposite charge. During 
migration through the pH gradient, the protein will either pick up or lose protons. As it 
migrates, its net charge and mobility will decrease and the protein will slow down. Finally, 
the protein will arrive in the pH gradient at the point equal to its pI. There, being 
uncharged, it will stop migrating. Once the first dimension is completed, and to prevent 
further re-oxidation, protein-cystine residues must be reduced using dithiothreitol (DTT) 
and the resulting cysteines blocked with iodoacetamide (IAA). 
After focusing, IEF strips are soaked in SDS to prepare proteins for separation by 
molecular weight (MW) in the second dimension. When the separation is complete, 
proteins are visualized in the gel by staining with Coomassie Blue, fluorescent dyes, or with 
MS-compatible silver staining [19]. After protein separation and visualization, protein spots 
are excised and de-stained and usually digested with specific proteases as trypsin or Lys-C. 
The resulting pool of peptides are extracted from the gel peace and analysed by mass 
spectrometry with either ESI or MALDI as ionization technique. The resulting peptide 
profiling is matched against the theoretical masses obtained from the in silico of all protein 
amino acid sequences in the database. Then the protein in the database is ranked according 
to the number of peptides matching their sequence within a given mass error tolerance [20].  
The in-gel digestion protocol presents several drawbacks, namely (i) trapping 
protein substrates in the gel makes some peptide bonds inaccessible to the enzyme, and (ii) 
not all the peptides produced during digestion can diffuse freely from the gel.  
I.2.2 In-solution protein digestion  
In-solution protein digestion, usually applied to whole-protein extracts is the base of 
shotgun proteomics but is also widely used in the analysis of purified proteins. There are 
key steps related to sample preparation issues that guaranty the success of the in-solution 
protein digestion. 
It is widely known that proteins are very heterogeneous in terms of physical and 
chemical properties. In addition the dynamic range of protein expression is also very broad 
and for that reason some general rules should be taken into consideration. For example, the 
presence of most abundant proteins that usually are easier to identify, might interfere with 
Chapter I. Introduction 
8 
the detection of less abundant proteins. So to facilitate the identification of less abundant 
proteins, some fractionation (e.g., organelle purification) or depletion to separate some 
proteins from another is needed [21]. 
As a general rule, protein extracts are first precipitated using cold acetone or TCA 
and then proteins are solubilizeded/denaturated in order to facilitate the action of 
proteolytic enzymes. To achieve this goal, several buffers have been described in literature, 
including some ones for specific types of proteins. As a general role, protein solubilization 
and denaturation are achieved by the addition of chaotropic agents such as urea or 
guanidine hydrochloride in order to break the intra-molecular forces that maintain 
secondary and tertiary structure of the proteins. Finally, to prevent protein renaturation 
before enzymatic cleavage, reduction and alkylation of protein disulfide bridges are 
frequently done using DTT and IAA [22]. 
As previously mentioned, trypsin is one of the enzymes used for protein digestion. 
However, care must be taken, when high urea concentration is used. Normally, trypsin 
retains most of its activity in 2M urea, 2M guanidine HCl or 0.1% SDS. Protein digestion is 
usually performed for 12–24 hours, due to protein heterogeneity in samples. Finally, the 
reaction is stopped by adding an acid, such as trifluoroacetic or formic, to a final pH of 2–3. 
Then, the digest can be analysed by bi-dimensional chromatography coupled to tandem 
mass spectrometry [22]. 
I.3 Accelerating protein digestion 
In the latest years it has been reported in the literature promising results on the 
acceleration of enzymatic protein digestion since is one of the most time consuming steps 
needed for protein identification. The first attempts reported make use of basic knowledge 
in enzymology, such as the role of enzyme concentration and the temperature influence on 
the rate of the enzymatic reaction [23]. However, other approaches to proteomics sample 
preparation have been done in order to accelerate protein digestion. The application of the 
microwave energy and ultrasonic energy, the two most useful tools, will be commented 
below
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I.3.1 Microwave energy 
Microwave-assisted protein enzymatic digestion under controlled microwave 
irradiation was first reported in 2002 [24], and have been used for both in-solution [24] and 
in-gel digestion [25]. Using this methodology, digestion times required to get a complete 
digestion are lowered from 12-24h up to 20 min. 
Critical parameters, as irradiation time, temperature and power require careful 
optimization in order to maintain the benefits of microwave energy. For example, radiation 
power should be maintained below 30% of the total nominal power of the microwave oven; 
otherwise, temperature control becomes difficult [22]. 
Microwaves are known to catalyze reactions by inducing molecular perturbation by 
a stimulation of ionic diffusion, and also, by enhancement of dipole rotation without 
causing any rearrangement of molecular structures. This mechanism differs from 
conventional heating due to the dipole rotation that constitutes an alternative efficient form 
of molecular agitation. It is due to this added molecular agitation that increased molecular 
catalysis is thought to occur.  
I.3.2 Ultrasonic energy 
I.3.2.1 Basics on ultrasonic energy 
When ultrasonic waves cross through a liquid media, an effect known as cavitation 
occurs [26,27]. The name cavitation defines a physical process by which numerous tiny gas 
bubbles are generated. Those bubbles, grow, oscillate, split and finally implode, in such a 
way, that they can be considered as micro-reactors in which temperatures near to 5000ºC 
and pressures of 1000atm are reached. 
Cavitation causes physical phenomena, such as pitting and mechanical erosion of 
solids, including particle rupture, leading to smaller particle size. In addition, chemical 
radicals are formed into the liquid media, which produces the oxidation of chemical 
species. As an example, energy oxidative radicals, such as hydroxyl radical or chemical 
compounds, such as hydrogen peroxide are formed when ultrasonic power is applied to 
water. 
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Nowadays ultrasonication can be applied in two main ways with different devices, 
direct ultrasonication can be applied with the ultrasonic probe whilst indirect sonication can 
be applied with the common ultrasonic bath or with the sonoreactor. Figure I.1 shows three 
examples of ultrasonic devices. 
   
       A            B            C 
Figure I. 1. Example of ultrasonic devices: A- ultrasonic bath; B- ultrasonic probe and C- 
Sonoreactor 
 As a general role the influence of the following variables should it be studied when 
the optimization of a methodology of sample treatment is done through ultrasonication: (i) 
particle size, if a solid is studied; (ii) reagent(s) used in the treatment; (iii) sample volume; 
(iv) sonication time; (v) temperature; (vi) frequency of the ultrasonic energy; (vii) for the 
case of an ultrasonic bath, the position in which the sample container is situated inside the 
bath (vertical and horizontal position) and finally (viii) amplitude of sonication. 
I.3.2.2 Indirect sonication: the ultrasonic bath and the sonoreactor 
Indirect sonication means that the ultrasonic waves need to cross the wall of the 
sample container. The ultrasonic bath is not a powerful tool; the irradiation power given by 
a common ultrasonic bath is comprised between 1 and 5 Wcm−2. When used for analytical 
tasks, the ultrasonic bath lacks in reproducibility. Finding the highest intensity place of 
sonication inside an ultrasonic bath is always a critical issue, to do so, the so-called 
“aluminum foil test”, which is done to find the best place inside the bath in terms of 
sonication intensity [28]. 
The sonoreactor and their equivalent, the cup horn, can be compared to high 
intensity ultrasonic water baths. Samples can be processed in sealed tubes or vials 
eliminating aerosols and cross-contamination. Those devices are ideal for samples, such as 
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sterile or dangerous pathogenic ones. In the cup horn, the titanium probe is held within an 
acrylic cup filled with water. Samples are placed within the cup, above the probe. The 
cavitation produced in the immersed samples is higher than the one given by an ultrasonic 
bath but it is lower than the cavitation produced by direct immersion of the ultrasonic probe 
into the solution. Both systems allow refrigeration. 
I.3.2.3 Direct sonication: the ultrasonic probe 
The ultrasonic probe is directly immersed in the sample, giving direct in-sample 
sonication. Two are the main differences when comparing the ultrasonic probe with the 
ultrasonic bath. Firstly, the ultrasonic probe is immersed directly into the solution, where 
the sonication takes place, and secondly, the ultrasonic power provided by the probe is at 
least up to 100 times greater than the one supplied by the bath. Those major differences 
make each system devoted for a different set of applications. The probe is a powerful 
system for the solid–liquid extraction of analytes that can be extracted but can also be 
degraded. There are dedicated probes for a given range of volumes. It should be stressed 
that the amplitude control of the probes allows the ultrasonic vibrations at the probe tip to 
be set to any desired level. However, to achieve cavitation, normally it is not necessary to 
use high amplitude levels; otherwise the probe will deteriorate rapidly. Temperature is 
another factor that must be controlled. As the ultrasound is delivered into the solution, a 
slow but constant increase in the bulk temperature is achieved and, at one point, the 
physical characteristics of the liquid media changes so that a decoupling of the probe can 
occur and no more cavitation is achieved. At this point the procedure must be stopped and 
the solution refrigerate. If long sonication times are needed the “pulse” mode is 
recommended. 
 Probes are usually made of titanium alloy (titanium probes) and are thermo-
resistant, can be treated in autoclaves and are resistant to corrosive media. The sample 
volume to be treated along with the sample type is crucial to determine the selection of unit 
and the type of probe. It must be always borne in mind that the higher the amplitude 
provided by the probe the more intense is the sonication. 
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I.3.2.4 Accelerating protein digestion with ultrasonic energy 
Ultrasonic-assisted enzymatic digestion was first introduced in 2005 [29].This 
method was successfully applied to the in solution and in-gel protein digestion, thus 
effectively reducing the digestion time from overnight (12 h) to less than 5min [30,31]. In 
the in-solution protein digestion, the procedure entails sonication of small volumes of 
sample, typically 20–50?L while the trypsin digestion proceeds. The ultrasonic treatment 
probably boosts enzyme-substrate kinetics by the enhancement of mass transfers processes 
in the solution. In the in-gel protein digestion, slides of gel containing protein can be 
submitted to the same procedure:  once excised, the gel piece is placed in an Eppendorf cup 
and a small amount of a buffer containing the enzyme is added. The liquid jets produced by 
the ultrasonication act as micro-syringes [32], delivering the enzyme into the gel and 
making the protein digestion faster. The mechanical erosion of the gel surface caused by the 
cavitation associated with ultrasonication enhances peptide release from the gel. 
The recent advances in ultrasonic energy performance have led to the development 
of new and powerful devices, whose many possible applications has only become recently 
to be known [26,33].  
I.4 Beyond protein identification - quantitative proteomics 
Whilst no long ago qualitative protein identification was considered enough to 
describe a biological system, at the present time protein identification and quantification 
have become mandatory to address the same aims. All modern biosciences are given 
special attention to the changes that occur in the proteome as important information can be 
retrieved that may be linked to important medical and biological processes. The changes in 
the expressed proteins in a given type of cells, tissue or organism need to be detected with 
the highest accuracy and precision possible. These changes can be linked to cellular and 
tissue localization, to signaling cascades, and to changes due to disease or drug treatment.  
The aim of quantitative proteomics is to obtain quantitative information about all 
proteins in a sample. Rather than just providing lists of proteins identified in a certain 
sample, quantitative proteomics yields information about differences between samples. For 
that purpose, quantitative proteomics was based essentially in 2D gel electrophoresis and in 
mass spectrometry. The gel-based method has been the method of choice for decades, and 
is still widely used, however, due to the extraordinary development of mass spectrometry-
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based technologies and the development of different types of stable isotopic labeling 
reagents and label-free approaches, mass spectrometry-based quantitative proteomics is, 
nowadays, the ultimate technology used to quantify proteins. In the next sections we will 
briefly describe the above mentioned methods for protein quantification. 
I.5 Gel-based quantification methods 
 Native or denatured proteins can be separated through GE in the first or in the 
second dimension. Once the proteins have been separated they are stained with different 
reagents such as coomassie blue, silver nitrate or fluorescent dyes. 
A general method to quantify proteins separated by GE is densitometry. 
Densitometry is the quantitative measurement of optical density in light-sensitive materials. 
Optical density is expressed as the number of dark spots in a given area. 
Gel densitometry is widely used for protein expression studies; however some 
drawbacks have been reported. For example, the low linearity ranges of work, usually of 1-
2 orders of magnitude [34]. Nevertheless, and depending on the reagent used for staining, 
the order of magnitude can be varied, as it is showed in table I.1. 
Table I. 1. Protein staining for gel electrophoresis-based quantification of proteins [35]. 
Protein Stain 
Lower Limit
of Sensitivity
Linear 
Range 
Cost Imaging System Requirements 
MS 
Compatibility 
Coomassie Blue R-250 stain 10–25 ng 2 orders of magnitude + Densitometer +++++ 
Bio-Safe Commassie G-250 
stain 5–10 ng 
2 orders of 
magnitude ++ Densitometer +++++ 
Silver stain kit - Merril 
method 0.5–1 ng 
1 order of 
magnitude +++ Densitometer Not compatible 
Silver Stain Plus kit 0.5–1 ng 1 order of magnitude +++ Densitometer ++ 
Dodeca silver stain 0.5–1 ng 1 order of magnitude +++ Densitometer +++ 
SYPRO Ruby protein gel 
stain 1–10 ng 
3 orders of 
magnitude +++++ Fluorescent ++++ 
Flamingo fluorescent gel 
stain 0.25–0.5 ng
>3 orders of 
magnitude ++++ Fluorescent +++++ 
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Another drawback is the low reproducibility of the separations done by gel 
electrophoresis in the second dimension. 2D-gel electrophoresis it requires to be done by 
skilled personnel otherwise many problems are encountered when the same sample is run 
several times.  
I.5.1 Differential gel electrophoresis 
Modern gel electrophoresis research offers powerful software-based image analysis 
tools primarily to analyze biomarkers by quantifying individual, as well as showing the 
separation between one or more protein spots on a scanned image of a 2D-GE.  
Difference gel electrophoresis - DIGE can be used to highlight differences in the 
spot patterns. This quantification technique is done on intact proteins, and the differential 
expression determination is based on fluorescence. 
In this technique, three different fluorescent labels (e.g. Cy2, Cy3, and Cy5, see 
figure I.2) with different absorbance and emission characteristics, are used to covalently 
modify the amino group of lysines in proteins via an amide linkage. 
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Figure I. 2. N-hydroxy-succinimidyl esters of Cy2, propyl Cy3 and methyl Cy5 used for DIGE 
labeling of lysine residues [37]. 
In a typical protocol, the control and target samples are separately labeled using 
different dyes (e.g., Cy3 and Cy5, respectively), while a mixture consisting of an equal 
amount of the control and target samples is labeled with Cy2. The labeled samples are 
combined and run in a single 2D gel to allow better spot matching and minimize gel-to-gel 
variations [36]. However, DIGE has some drawbacks that come from the 2D-GE, and 
fluorescence analysis. 
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The 2D-GE itself does not generally allow the resolution of proteins with high 
(150kDa) or low (10kDa) molecular weights, or very basic or hydrophobic proteins. 
The fluorescence analysis itself comes with some problems such as high 
background, the detection of signals from non-protein sources and the overlap of signals 
from different fluorophores [37]. 
I.6 Mass-spectrometry based protein quantification 
Proteomics aims to analyze as much proteins as possible in the same experiment. 
Until recently, mass spectrometry was used to characterize complex mixtures of proteins in 
a qualitative approach. 
Mass spectrometry is nowadays a powerful tool for protein quantification, both in a 
relative or absolute manner, with a continuously growing interest among the research 
community, as it is showed by the large amount of reviews published regarding this item in 
the last years, 183 since 2005 (key searching words: protein quantification and mass 
spectrometry; searching engine: scopus). Those reviews cover a broad area of research 
activities, including proteomics, genomics and medical care or food chemistry. 
The quantification of proteins can be done following two main ways. The first 
approach is named label-free quantification of proteins and it is based on the measurement 
of the area of the mass spectrometry peaks belonging to the specie of interest. 
Theoretically, this area is directly proportional to the concentration of the analyte of interest 
in a given range. 
The second approach it takes advantage of the so called isotopic labeling; the basis 
of which is the increment in the mass of any chemical specie when one atom is substituted 
by one heavier isotope or when a chemical tag is added to the molecule of interest. The key 
of this method is that the mass increment can be easily followed through the mass spectrum 
and in some cases the intensity of the mass peak of interest can be linked to the 
concentration of the analyte studied.  
I.6.1 Label-free methods for protein quantification 
Label-free quantification seems at first to be “easy”, requiring no labeling steps, 
only LC-MS or LC-MS/MS. It has the advantage of eliminating the need for expensive 
labeling reagents, and does not require time-consuming steps as the labeling approach. In 
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addition, those steps can lead to irreproducibility and loss of target peptides. It also 
eliminates the need for the synthesis of expensive isotopically labeled reference peptides. 
However in this methodology there is a greater need for reducing potential interferences 
that could lead to suppression effects. This leads to an increased need for high-resolution or 
multidimensional chromatography to reduce suppression effects and to allow the detection 
of low-abundance proteins. In addition, there is the challenge of normalizing the data so 
that accurate quantification can be done across multiple samples and multiple analyses. 
Two approaches are currently being used to compare samples: normalizing and aligning the 
chromatograms (and using the peptide MS data), or using the MS and/or MS/MS spectra to 
normalize the data [38]. 
Label free methods are far of being fully accepted among the scientific community 
since a number of serious drawbacks seem to be difficult to overcome. As an example in a 
1D-LC-MS it has been reported that only 66% of peptides which were present in one 
analysis were also present in the second LC/MS run, and that ten replicate analyses were 
needed before no new peptides were detected [39]. Furthermore, label-free approaches do 
not allow for sample multiplexing neither can avoid matrix-dependant suppression effects 
[38,40]. For the aforementioned reasons label-free techniques are generally considered 
inferior in their quantification accuracy when compared to methods relying on stable 
isotopes. Furthermore the accuracy and linearity of label free techniques is still in question 
[41]. 
I.6.2 Methods based on isotopic labeling 
I.6.2.1 Monitoring 
Quantification can be done by comparing targeted ions from labeled and unlabeled 
standards with respect to the peak heights or areas of labeled versus unlabeled analytes. 
Quantification of analytes based on isotopically labeled internal standards was first reported 
for GC-MS [42]. In selected ion monitoring, SIM, instead of scanning all of the possible 
m/z values, only selected ions are measured. This approach can improve the limits of 
detection for an analyte by several orders of magnitude. 
The advent of tandem mass spectrometry has allowed the monitorization of 
parent/fragment ions. Thus, multiple reaction monitoring, MRM, has been regularly done in 
triple-quadrupoles for more than 30 years [43]. In a triple-quadrupole mass spectrometer, 
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high sensitivity and specificity are achieved by only allowing a selected peptide to pass 
through the first quadrupole and enter the collision cell (Q2). Inside the collision cell, the 
peptide dissociates into fragments specific to the amino acid sequence of the precursor 
peptide. A second stage of specificity is added in the second MS (Q3), and only a specific 
fragment is allowed to pass through and strike the detector. By repeatedly cycling through a 
list of selected reaction monitoring, SRM, ion pairs associated with a set of specific 
retention times, multiple peptides can be targeted in a single multiple reaction monitoring 
(MRM) experiment. 
The use of MRM technique for the absolute quantification (AQUA) of proteins was 
first introduced by Steven Gygi in 2003 [44]. Absolute quantification workflows include 
stable isotope labeled (2H, 13C, or 15N) versions of the targeted peptides. The endogenous 
and isotopically labeled peptides co-elute (or nearly co-elute in the case of deuterated 
standards) from reversed-phase high performance liquid chromatography (HPLC) columns, 
and will behave identically in the mass spectrometer with the exception of the introduced 
mass shift. Both versions are monitored and quantified, and their concentrations are 
determined from the relative responses (peak heights or peak areas) of the spiked-in 
compound to the target analyte [38]. Normally this approach is limited to a reduced number 
of proteins because suitable internal standards need to be identified and synthesized. The 
internal standard, because it is present in every sample, means that more accurate 
expression ratios can be calculated. It is not possible to calculate an accurate “treated vs. 
control” expression ratio if there is no peptide detected in the control sample. With an 
internal standard, if no signal is detected in the sample, and the internal standard is 
detected, then you can be certain that the level of that peptide in the sample is below the 
detection limit.  
For an experiment with multiple treatments, the use of an internal standard ensures 
that all of the treatments can be compared with each other (e.g. treatment 1 vs. control, 
treatment 2 vs. control, allows the calculation of treatment1 vs. treatment 2). 
In label-free quantification, the control peptide may not always be present or may 
not be detected. The internal standard also corrects for suppression effects or 
irreproducibility in sample processing, at least when these problems occur after the point 
where the standard is added to the sample. Because the internal standard is added after the 
digestion step, this method of quantification cannot correct for variable and unpredictable 
losses that occur during the sample digestion/processing steps that occur prior to the 
addition of the reference standards [45]. 
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I.6.2.2 SILAC Labeling 
SILAC is the acronym of stable isotope labeling with acids in cell culture. In this 
method the labeling of the proteins is done in vivo, since the incorporation of the normal or 
heavy amino acids is done during the grown of two cell populations, that are identical 
except that one of them is make to grown in a medium that contains a form of amino acids 
without heavy isotopes added whilst the other is make to grown in a medium that contains 
such amino acids [46,47]. These “heavy” amino acids have been prepared with stable 
isotopic nuclei, such as 2H, 13C and 15N. The basis of this approach relies in that when the 
labeled analog of an amino acid is supplied to cell in culture it is incorporated into the new 
proteins that are synthesized during the cell growing. The amino acids generally involved in 
this labeling are arginine, leucine and lysine. The main advantage is that the labeling is 
uniformly done in every protein. As main disadvantages may be cited that sample 
complexity is not reduced, it is no applicable to human samples, and that arginine can be 
inter-converted to proline [38]. 
I.6.2.3 ICAT Labeling  
ICAT is the acronym of isotope-coded affinity tags. It was first introduced by Gygi 
and Aebersold in 1999 [48].The reagent consists of three elements as it is showed in figure 
I.3. 
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Figure I. 3. Chemical structure of the original ICAT label. Heavy reagent, d8-ICAT (R-deuterium); 
Light reagent, d0-ICAT (R-hydrogen) [38]. 
The original ICAT reagent is composed by a thiol reactive group, iodoacetamide, a 
spacer that contains either eight oxygen atoms (light) or eight deuterium atoms (heavy) and 
an affinity tag, biotin, this simplifies the analysis of the ICAT reagent-labeled peptides by 
Biotin Linker (heavy or light) 
Thiol-specific 
reactive group 
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selecting and concentrating the cysteine-containing peptides, thereby reducing the 
complexity of the peptide mixture. 
The cleavable ICAT reagent (cICAT) was introduced in 2003 [49,50]. This new 
version of ICAT retains the main structure of the original ICAT, but the oxygen/deuterium 
atoms are substituted by nine 12C atoms (light) and nine 13C atoms in the heavy version.  
The heavy reagent with nine 13C atoms is +9 Daltons heavier than the light reagent. 
Mass spectrometric comparison of peptides labeled with heavy and light reagents provides 
a ratio of the concentration of the proteins of interest. This new reagent eliminates the 
potential confusion of a double ICAT label and an oxidation, both of which would have 
lead to a +16Da mass shift. In addition deuterium causes a slight shift in retention time in 
RP-HPLC, with the heavy form eluting slightly earlier than the light form. Furthermore, 
cleavage of the biotin moiety after affinity purification and before the MS analysis helps to 
improve the quality of the CID spectra, leading to the identification of a larger number of 
proteins. 
The labeling occurs at the protein level and it is a chemical labeling that it takes 
place in the cysteines, which is its main drawback, since only peptides with cysteines are 
labeled, yet this means that, in comparison with the SILAC method, sample complexity 
may be reduced. This is because cysteines are only the 1.42% of all amino acids [51]. It 
also makes impossible to detect changes in the 20% of proteins that do not contain cysteine 
residues [52]. Two disadvantages to be mentioned are that side reactions with methionine 
residues may occur and that only two labels are available, meaning only two samples may 
be compared. 
I.6.2.4 iTRAQ labeling 
The SILAC and ICAT methods allow only the comparison of two treatments in a 
single analysis. The need for the comparison of larger number of treatments led to the 
development of the 4 or 8 plex iTRAQ which may be used to compare up to four or eight 
samples in a single analysis. The iTRAQ technique was first described by Ross et al. in 
2004 [53] and is an isobaric tagging compound consisting of a reporter group (variable 
mass of 114-117Da or 113-121Da) a balance group at lysine side chains and at peptide N-
termini. 
During the initial MS scan, labeled peptides appear as a single peak due to the 
isobaric masses, and in MS/MS the label releases the reporter groups as single charged 
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ions. The isobaric nature of the iTRAQ-labeled peptides allows the signal from all peptides 
to be summed in both MS and MS/MS modes thus enhancing the sensitivity of detection. 
I.7 Isotopic labeling of proteins with 18O 
The use of 18O as a label in isotopic studies in biochemistry can be trace back to the 
work done by Boyer et al. in 1956 [54]. However, the use of 18O-labeling for protein 
quantification and protein differential expression has recently recalled the attention in 
research due to its almost perfect characteristics. Enzymatic labeling with 18O-water is easy 
to do and all the peptides formed during the protein cleavage are labeled. The resulting 
mass shift from 18O incorporation does not alter the chromatographic separation or the 
ionization efficiency of the labeled peptides. The characteristics, variables and applications 
of 18O-labeling will be commented below. 
I.7.1 Chemical reactions involved in the 18O labeling of proteins 
It is generally agreed that the 18O-isotopic labeling of peptides can be considered as 
consisting in two different chemical reactions. The first one is an amide bond cleavage 
whilst the second reaction is a carboxyl oxygen exchange. Both chemical reactions can be 
written as follows [55]: 
(i) First reaction: amide bond cleavage 
RC16ONHR´ + H218O → [RC16O18O]− +[H3NR_] 
(ii) second reaction: carboxyl oxygen exchange 
[RC16O18O]− +H218O → [RC18O18O]− +H216O 
As may be seen peptides incorporate one 18O in the first reaction, during the 
enzymatic cleavage. If this reaction is done in pure 18O-water (normally 95% reach in 
H218O) then it can be considered that almost 100% of the peptides will be labeled with one 
18O. If the reaction is done in mixed 16O/18O-water, then the labeling ratio will be 
proportional to the percentage of H218O in solution: the higher the amount of H218O the 
higher the percentage of peptides labeled. This is the reason why accuracy is only 
guaranteed when the labeling is done in pure H218O (generally 95%). 
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In any case, the labeling cannot be studied without taking into consideration the 
second reaction, the carboxyl oxygen exchange. This reaction is an equilibrium, which 
ideally should be displaced towards the double oxygen incorporation, since the introduction 
of two oxygen in a peptide shifts its mass 4Da, facilitating the identification of the labeled 
peptide and its quantification by mass spectrometry-based techniques. 
Both, the amide bond cleavage and the carboxyl oxygen exchange reactions, can 
take place at the same time, which is the principle of the direct 18O-labeling procedure; or 
separately, in two steps, which is the basis for the decoupling method. In the next sections 
the differences between both procedures along with the variables affecting the performance 
of each one will be commented. 
I.7.1.1 The direct labeling  
Digestion of proteins in the presence of 18O can isotopically label the resulting 
peptides. When the peptide bond is broken one atom of heavy oxygen is incorporated and 
further incorporation is done trough the carboxyl oxygen exchange at the same time. 
Typically the protocol for 18O-labeling is very similar to a normal in-solution 
digestion. First proteins are solubilized/denaturated then reduced and alkylated and finally 
digested with trypsin in the presence of heavy water. The direct labeling can be done 
accelerating each step with the aid of ultrasonic energy or not [55]. 
The main advantage of this procedure is simplicity and speed. In addition, it can be 
used in on-line approaches. The main drawback is the lack in labeling efficiency, which 
makes direct labeling suitable only for relative quantification and for studies regarding 
proteins over-expressed or under-expressed [56]. 
I.7.1.2 The decoupling procedure 
The decoupling procedure was first proposed by Yao et al. who have demonstrated 
that the cleavage of the protein can be done separately from the labeling in such a way that 
almost total double oxygen incorporation can be achieved using the carboxyl oxygen 
exchange process. The carboxyl oxygen reaction is shown in figure I.4 [57, 58]. 
The decoupling procedure consists in a more elaborated, labor-intensive and time-
consuming protocol. 
Chapter I. Introduction 
22 
Figure I. 4. Mechanism of the double oxygen incorporation by carboxyl oxygen exchange. 
In addition to the four main steps of the direct procedure, as described above, it is 
necessary to dry the sample, once the protein has been digested. Then the sample is 
recomposed in a solution of acetonitrile/ammonium bicarbonate, that facilitates peptide 
solubilization and that lowered the pH of the solution to speed the subsequent carboxyl 
oxygen exchange process. Then the sample is dried again and finally recomposed in 18O-
water. Finally, the labeling takes place. 
The advantage of this procedure is that a higher degree of peptides are double 
labeled in an efficient maner, which is extremely important for the accuracy of the 
quantification, as it will be shown in the next sections. Nevertheless this procedure takes 
longer than the direct method, usually 12h, if ultrasonication is used to speed the protein 
digestion step; otherwise it takes 24-48h. In addition, it cannot be done on-line, and 
consequently it is hard of automation.  
I.7.1.3 The use of immobilized enzymes 
Enzymes, such as trypsin, can be immobilized in solid supports that can be used 
either for protein digestion/labeling in a single step (direct labeling) or in different ones 
(decoupling procedure). The main advantage of using immobilized enzymes is that once the 
solution is separated from the solid support, then the protein digestion is stopped and the 
carboxyl oxygen exchanges is slowed down to almost a negligible effect. This is very 
important for online approaches, where the sample will be mixed with solvents containing 
16O-water. This means that some 16O/18O interchange will happen, thus interfering with the 
quantification process. If the enzyme is not present in the solution the interchange can be 
consider small to have a significant effect on the quantification process. In addition, the 
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presence of peptides coming from the autolysis of the enzyme is negligible and thus the 
interferences that they may cause in the subsequent measurements by mass spectrometry 
are avoided [59]. 
I.7.2 The problem of the 18O-labeling efficiency 
The 18O-labeling of peptides following any of the approaches described previously, 
results in a mixture of non-labeled, single labeled or double labeled peptides. The efficiency 
in the labeling depends not only on the protocol followed, but also in different variables 
affecting each protocol, such as pH, type of enzyme used, peptide characteristics, labeling 
time and conditions of labeling. In addition, the contribution to the peak intensities from the 
naturally occurring isotopes, others than 18O, such as 13C and 15N, needs also to be 
considered. 
The variability in the labeling efficiency makes extremely difficult the interpretation 
of data from complex protein mixtures, such as proteomes, making hard to distinguish 
highly up-regulated from highly down-regulated proteins or C-terminal peptides, in studies 
regarding differential proteomics. This problem is even worst when the direct method is the 
choice to perform the labeling. 
To overcome the labeling efficiency problem, different algorithms have been 
proposed [60]. Other approaches to solve this problem focus on the sample treatment itself, 
trying to make the labeling as complete as possible, thus minimizing the effects on the 
efficiency to a residual level. 
I.7.3 Variables affecting 18O labeling of proteins 
I.7.3.1 The enzymes used for 18O labeling 
The enzyme generally used to perform the 18O labeling of proteins is the enzyme 
trypsin, a serine protease that predominantly cleaves peptide chains at the carboxyl side of 
amino acids lysine and arginine, which is also the most common enzyme used to digest 
proteins in proteomic studies. Other enzymes can also be used such as the endoproteinase 
Lys-C, that specifically cleaves peptide bonds C-terminally at lysine; and the 
endoproteinase Glu-C, that cleaves peptide bonds C-terminally at glutamic and aspartic. 
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Different yields of single and double incorporation can be gotten with any of these 
enzymes, yet yields are highly dependent of the labeling conditions [61-67]. 
I.7.3.2 The influence of the pH 
The influence of the pH on the labeling process depends on the way in which this is 
done. In the direct process, the protein is labeled at the same time that is cleaved.  
To guarantee the efficiency of the process, the pH must be the optimum at which the 
enzyme cleaves the protein, for instance the optimum pH for the enzyme trypsin is about 8-
9. If the cleavage is done in pure 18O-water, then all peptides will have one 18O at the C-
termini at least. Interestingly, the double 18O incorporation will depend on various factors, 
such as the type of peptide and the pH of the solution. For instance, lysine terminated 
peptides do not incorporate two oxygen efficiently. 
In addition, Yao et al. have demonstrated that by lowering the pH of the solution, 
the double incorporation can be done faster and with higher efficiency [57]. Precisely, the 
possibility to separate the protein cleavage from the isotopic incorporation doing both 
separately at different pH is the basis of the decoupling procedure, as proposed by the 
former mentioned authors. 
I.7.4 18O inverse labeling 
Since the goal of a protein differential analysis is to extract and to identify the small 
number of proteins that deviate in expression level upon a perturbation, any method that 
enables subtractive analysis of protein signals with unaltered levels would be of great value. 
This is the base of the method called inverse 18O-labeling as first reported by Wang et al. 
[62]. 
In this procedure, parallel inverse labeling experiments are performed where the 
labeling is reversed in the second experiment, i.e., the heavy isotope labeled pool in the first 
experiment is light isotope labeled in the second experiment and vice versa as shown in 
figure I.5. 
The characteristic inverse labeling pattern (i.e., isotope intensity profile swap) 
presented by peptide signals between the two inverse labeling experiments indicate the 
differential expression of proteins from which the peptides are derived. 
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Figure I. 5. Direct and inverse labeling experiments of a target protein and the correspondent 
control sample. 
The strategy works well with labeling methods that result in variable mass 
differences among peptides of different sequences. An MS instrument of high resolution is 
not required. The differentially expressed proteins and proteins of covalent changes 
resulting from an altered state are rapidly identified without ambiguity. The procedure 
presents a logical sequence in approaching the problem: data reduction of irrelevant signals, 
quick focus on signals of interest, detailed analysis on signals of interest only. 
I.7.4.1 Applications to proteins separated by gel electrophoresis 
The absolute quantification of proteins separated in polyacrylamide gels lacks in 
efficiency and accuracy, as it was demonstrated by Havlis and Shevchenko [67]. However 
this method is a powerful tool when applied for relative quantification. The best sample 
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treatment for relative quantification of proteins separated in polyacrylamide gels consists 
firstly in digest the gel spots containing the control sample, a certain amount of a known 
protein, and the target sample in 16O-water, afterward the extracted pool of peptides is dried 
in a speed vacuum. Finally, the control sample is recomposed in 18O-water whilst the target 
sample is recomposed in 16O-water. The same amount of both samples is then mixed and 
submitted to mass spectrometry-based techniques. The signal intensities of the same 
peptides are then compared and the relative 16O/18O ratios are used to calculate the 
concentration of the unknown protein.  
By carrying out 18O-labeling post proteolysis, the amount of 18O-water required is 
substantially reduced [64], since the labeling is performed on the extracted and dried 
peptides not on the excised gel pieces. 
The 18O-labeling of N-glycosylation sites during in-gel deglucosylation has been 
claimed as a way to extend the capabilities of MALDI peptide mass mapping and database 
searching for the identification of gel-separated proteins [68]. There are also some studies 
that report in-gel 18O-labeling as a tool for protein quantification and characterization. For 
instance, Kosaka et al. [69] reported a method for the C-terminal characterization and 
identification of proteins separated by two-dimensional polyacrylamide gel electrophoresis 
(2D-PAGE), based on in-gel digestion/labeling of proteins. After 2D-PAGE of a cell lysate 
of rat liver, 10 different protein spots were in-gel digested during overnight with trypsin in 
a buffer solution of 50% (v/v) 18O enriched water, and analyzed by nano-electrospary 
Fourier transform ion cyclotron resonance mass spectroscopy (nano-ESI FT-ICR MS). Due 
to the high resolution of FT-ICR MS and since the C-terminal peptides were the only 
unlabeled peptides in the protein digests, the authors were able to identify and characterize 
the C-termini of 8 proteins, from the initial 10 chosen, with a high level of confidence. On 
the other side, and following the same strategy, Larsen et al. [69] were unable to 
characterize and identify by MALDI the C-terminal peptides of different enolase-2-forms 
form stressed cells of Saccharomyces cerevisiae, when using trypsin to digest the separated 
proteins from 2D-PAGE. However, when the endoproteinase Asp-N was used to perform 
the in-gel digestion of proteins, in 50% of H218O buffer solution, they were able to fully 
characterize and identify five C-terminal peptides out of seven C-terminally processed 
enolase 2 forms. These results show how important it is the choice of the correct enzyme to 
perform protein digestion and labeling. In this case the authors were only concerned in 
distinguishing the unlabeled C-terminal peptide from the labeled internal peptides, so they 
use an enzyme, endoproteinase Asp-N that only incorporates one 18O atom in the 
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carboxylic group of the peptide whilst trypsin incorporates one or two 18O. This way, they 
were able to control the oxygen incorporation in the peptides, avoiding the presence of a 
mixture of single and double labeled peptides which would be responsible for the spreading 
of the peptide signal over more peaks, thus reducing the intensity in the mass spectra and 
compromising a correct identification. 
The previous examples demonstrate the potential of 18Oisotopic labeling in the 
detection of modified peptides by mass spectrometry thus enhancing the characterization of 
protein modifications, many of them implicated in a large number of disease states. On the 
other hand, there are also a few examples where in-gel 18O-labelingwas successfully used 
for protein quantification and to identify potential biomarkers of disease states.  
Using a combination between in-gel 18O-labeling and nano-LC-MS/MS, Körbel et 
al. [71] were able to identify and quantify approximately 18O low-expressed erythropoietin 
(EPO) receptor-dependent proteins, which are related with signaling pathways and EPO-
dependent cellular responses like cell differentiation and proliferation. The developed 
method relies on immunoaffinity and 1D-PAGE for protein separation; in-gel protein 
digestion in the presence of in H216O or H218O (95% 18O abundance) with non-methylated 
(nonstabilized) trypsin to avoid post-digestion 18O/16O back-exchange; and nano-LC–
MS/MS techniques for the detection of low-fentomole proteins. 
More recently, Chaerkady et al. [72] used lectin affinity enrichment and 1D-PAGE 
to purify and separate glycosylated proteins from liver tissues of healthy patients and 
patients with hepatocellular carcinoma. After in-gel digestion with trypsin in the presence 
of H216Oor H218O and LC–MS/MS analysis they were able to perform relative 
quantification and find differential expressed proteins from non-tumor/tumor samples.   
Finally, the application of in-gel 18O-labeling has been used by Ang et al. [73] in 
the study of the Porphyromonas gingivalis proteome, an oral pathogen related with chronic 
periodontitis. Based on an inverse labeling strategy, where the control sample was first 
digested in H216O and the target sample digested in H218O, whilst in the inverse experiment 
the control sample was digested in H218O and the target in H216O, they found 24 proteins 
up-regulated and 18 proteins down-regulated in target sample. Once more, these examples 
show the reliability and applicability of the in-gel 18O-labeling technique when applied to 
comparative proteomic studies. 
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I.7.4.2 Applications to proteins in solution 
This is by far the most reported use given to 18O-labeling. A combination of tandem 
mass spectrometry and 18O-labeled internal standards provide absolute or relative 
quantification of simple or complex mixtures of proteins in solution. Internal standards 
could be directly obtained by digesting in 18O-water a stock solution of known 
concentration of the protein of interest. 
Since many peptides are quantified in parallel, the resulting estimate of the protein 
concentration is robust and would also be applicable to complex protein mixtures, when 
combined with MS/MS spectrometry, if powered by appropriate software. 
The application of 18O-labeling in assisting sequencing of peptides by helping to 
distinguish a-type ions from b-type ions in tandem mass spectrometry has been reported by 
different authors [74,75]. 
The isomerization of aspartic acid (Asp) to isoaspartic acid (IsoAsp) is a 
spontaneous reaction that can alter protein structure and function, and for this reason the 
identification of this phenomenon in proteins is a biochemical challenge. Xiao et al. [76] 
have proposed a method for the identification and quantification of the above-mentioned 
reaction based on the utilization of 18O labeling and tandem mass spectrometry. 
Wa et al. [76] have proposed a method for the study of the binding sites of proteins 
when they are immobilized in solid supports. The method is simple: the free protein is 
cleaved in 18O-water whilst, after its immobilization, the protein is digested in 16O-water. 
The two digests are mixed and then analyzed by mass spectrometry. Peptides having 
significantly higher 18O/16O ratios than other peptides in the same digest are involved in the 
immobilization. 
Another interesting application consists in using the 18O-labeling for the 
quantification of ribonucleic acids using 18O. RNA labeled and non-labeled samples are 
mixed and then the intensities of the 16O and 18O monoisotopic peaks are then correlated 
through a specific formula. It must be taken into account that for this biomolecules, the 
labeling is only single [78]. 
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I.8. Direct tissue mass spectrometry analysis 
Tissues are one of the most challenging samples in proteomics. The possibility to 
follow and localize changes at the molecular level on a tissue sample, for example from a 
biopsy or a disease model organism is of vital importance in biomedical research. 
The development of methodologies for the analysis of tissue sample at the protein 
level remains a rapidly growing field [79-81]. 
Histological and histochemical characterization of biological and medical tissue has 
been the method of reference for tissue analysis, allowing the discrimination of tissue types 
after specific staining. Histochemical staining techniques can only be used in a targeted 
manner for known compounds, and only a limited number of such targets can be visualized 
from a given sample at the same time [82]. 
Another approach to tissue analysis is the one using tissue homogenization and 2D-
GE or multidimensional chromatography and protein identification by tandem mass 
spectrometry. One of the drawbacks of this type of approaches is that the sample 
preparation removes the relationship between morphology and proteins [83]. 
A further understanding of the role of the components of a biological system can be 
aided by the knowledge of the spatial localization of these components. This understanding 
can be achieved by performing direct tissue analysis by mass spectrometry. This technique 
avoids tissue homogenization and separation step, and it allows to maintain the spatial 
distribution of molecules within the tissue which is preserved. Thus, molecular analysis of 
this type allows for the direct targeting of diseased cells because it can be integrated with 
established histology protocols. Spectra generated directly from tissue sections can be 
highly enriched for a single cell type and thus contain higher concentrations of relevant 
proteins useful for medical purposes. 
Since the development of MALDI ionization in the 80s, that this has become the 
method of choice to analyse biomolecules. With a growing need of molecular information 
on peptides and proteins and because of the characteristics of MALDI ion sources the direct 
tissue analysis was attempted.  
In certain ways, MALDI-tissue analysis is a simple concept. On MALDI ion source, 
the ions are generated by laser irradiation of a solid surface containing matrix and analytes. 
Most of the irradiated energy is transferred in the depth of the irradiated sample with very 
little spreading of energy over the tissue surface. It means that if a sample is irradiated at a 
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precise coordinate the ions will directly come from the cross section between the tissue and 
the laser beam [84].  
The analysis of a tissue surface is done by moving the sample under the laser beam 
in such a way to cover the whole tissue surface. Each acquired spectra represents the 
average of several laser shots in order to obtain a statistically representation of the analyzed 
area. 
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This dissertation aims the development of new methods in proteomics, based on 
ultrasonic energy. The objectives covered by this thesis include: 
(i) The application of ultrasonic energy to speed-up current sample preparation 
methods for protein identification by matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry MALDI-TOF-MS; 
(ii) The development of new approaches based on fast protein digestion and 18O-
labeling for protein quantification along with dedicated bio-informatics 
platform to manage the data generated by mass spectrometry (MALDI-TOF-
MS); 
(iii) The application of ultrasonic energy and stable 18O-isotopic labeling for 
mass spectrometry analysis of tissue samples. 
Working Plan 
To develop the topics described above we chose to test and evaluate the effects of 
three ultrasonic devices, the ultrasonic probe, the ultrasonic bath and the sonoreactor, in the 
different steps of current sample treatments devoted to protein identification, protein 
quantification and mass spectrometry of tissues.  
When possible, and depending on the topic, the following variables affecting the 
performance of ultrasonic-based treatments will be studied: ultrasonication time, 
ultrasonication amplitude, temperature of sonication and ultrasonication frequency. 
Regarding the first topic, and as commented above, we will intend to apply 
ultrasonication in the main steps of current workflows for protein identification, namely 
protein denaturation/solubilisation, protein reduction, protein alkylation and protein 
digestion. The aim is to develop a sample treatment allowing a non intensive sample 
handling whilst speeding the entire procedure from overnight (12h) to minutes. 
Concerning protein quantification, the second topic, we will try to develop a simply 
methodology joining the benefits of a well established technique for protein separation, 
namely gel electrophoresis, with the straightforwardness of 18O labeling of proteins and 
with the simplicity of matrix assisted laser desorption/ionization time-of-flight-based mass-
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spectrometry, the latest as the tool of quantification. To achieve the aforementioned 
objectives we will focus in several main aspects, as commented below. First, it will be 
revised the problems associated with protein quantification using MALDI and 18O-labeling, 
and then it will be tried to find out an approach that might allow to overcome them.  
Second to make things easier and faster, dedicated software to help in the 
quantification process will be developed whenever this would be required.  
 Third, on every occasion possible during the making of the experiments, the 
expertise of our research group in the simplification of sample treatment using ultrasonic 
energy will be used to achieve a better performance in the protein digestion or in the protein 
labeling or in both. 
 On the topic of mass spectrometry of tissues we will focus on two main limitations 
that up to date this technology needs to overcome: the bottle neck of sample throughput and 
the differentiation of the molecules present in the plume formed during the sample 
volatilization induced when the laser is shot over a tissue.  
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III.1 Resumo 
Foram estudadas três fontes de energia ultra-sónica com o objectivo de acelerar o 
tratamento de amostra para identificação de proteínas em solução por PMF (peptide mass 
fingerprint) utilizando MALDI-TOF-MS (matrix assisted laser desorption/ionization time-
of-flight mass spectrometry). As etapas de redução, alquilação e digestão foram realizadas 
em 15min. Nove proteínas incluindo a proteína de resistência ao zinco da bactéria 
Desulfovibrio desulfuricans G20 e a proteína split-soret citocromo c da bactéria D. 
desulfuricans ATCC27774 foram identificadas com sucesso utilizando o novo protocolo.  
Palavras-chave: Digestão em solução, identificação de proteínas, sonda de ultra-sons, 
sono-reactor, banho de ultra-sons, MALDI-TOFMS 
A minha contribuição para este trabalho consistiu na optimização de todas as variáveis 
experimentais, análise de proteínas por MALDI-TOF-MS e o processamento e 
interpretação dos dados. 
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III.2 Abstract 
Three ultrasonic energy sources were studied to speed up the sample treatment for 
in-solution protein identification by peptide mass fingerprint using matrix assisted laser 
desorption/ionization time-of-flight mass spectrometry. Protein reduction, alkylation, and 
enzymatic digestion steps were done in 15 min. Nine proteins; including zinc resistance-
associated protein precursor from Desulfovibrio desulfuricans strain G20 and split-soret 
cytochrome c from D. desulfuricans ATCC27774 were successfully identified with the new 
protocol. 
Keywords: in-solution protein digestion, protein identification, ultrasonic probe, 
sonoreactor, ultrasonic bath, MALDI-TOFMS 
My contribution to this work was the optimization of all experimental variables, MALDI-
TOF-MS analysis and data processing and interpretation.
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III.3 Introduction 
Protein identification is nowadays an issue of primary importance, since proteins are 
involved in virtually all biological processes, such as enzymatic catalysis, ion transport, 
immune protection, and signal transduction [1]. In addition, protein biomarkers are used for 
the identification of bacteria, disease screening, medical diagnosis, and virus identification, 
helping to reduce morbidity and mortality across the globe [2-6]. 
Different strategies can be found in literature for the identification of proteins, in 
which separation and purification steps, previous to protein identification using mass 
spectrometry, are mandatory. Three main approaches for protein identification throughout 
mass spectrometry can be found in literature [7] as follows: 
The first approach is named in-gel protein digestion. In this sample treatment 
mixtures of proteins are first denaturized and then separated through 1D or 2D sodium 
dodecyl sulfate polyacrilamide gel electrophoresis, SDS-PAGE. The proteins are isolated in 
gel bands or spots that are excised. Each gel band or spot containing (theoretically) only 
one protein is mixed with a trypsin enzyme solution and incubated for a certain time. The 
enzyme trypsin is widely used to digest the protein into its peptides because it cleaves the 
protein exclusively after arginine or lysine residues in a reproducible manner; producing 
peptides of an average size of 800-2000Da, very adequate for mass spectrometry (MS) 
analysis. The set of peptides masses obtained is enough for the unambiguous identification 
of the protein. This method is known as peptide-mass fingerprint, PMF, and involves 
comparing the experimental masses from the peptides produced by the digested protein and 
those produced by in silico, theoretical digestion of all the proteins in a particular database 
[8, 9].  
The second and third approaches use HPLC for the separation of peptides or 
proteins [7]. Regarding the second approach, called in-solution protein digestion, a complex 
mixture of proteins is first enzymatically digested into its peptides, and then the peptides 
are separated by HPLC and used for protein identification. Concerning the third approach, 
named in-column protein digestion, proteins are on-line: (i) first separated by HPLC; (ii) 
enzymatically digested in columns with immobilized trypsin to form peptides, and (iii) 
peptides are then separated by HPLC and used for protein identification. 
The first approach previously described was drastically modified after the 
introduction of ultrasonic energy for the acceleration of the enzymatic protein digestion 
step. The total treatment time was reduced ca. 75% [10-12]. The mechanism that is 
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responsible for the enzymatic digestion enhancement using high-intensity ultrasound is not 
completely understood yet. It appears to be related to an increase in diffusion rates as 
consequence of the cavitation phenomena and heating. Although some previous 
experiments have shown that ultrasonic energy provided by an ultrasonic probe can be used 
for the acceleration of the in-solution digestion of proteins [12], it is not clear if all 
ultrasonic devices available on the market, such as sonoreactor or ultrasonic bath with dual 
frequency, can be used for the same purpose. In addition, no data is at present available in 
the literature regarding the effects of ultrasound on sample treatment previous to protein 
digestion with enzymes. 
The aim of this work is to study the applicability of three ultrasonic energy sources, 
the sonoreactor, the ultrasonic probe, and the dual frequency ultrasonic bath, for the 
acceleration of the sample treatment for in-solution protein digestion for protein 
identification using PMF. 
III.4 Experimental procedures 
III.4.1 Apparatus 
Protein digestion was done in safe-lock tubes of 0.5mL from Eppendorf 
(Hamburg,Germany). A vacuum concentrator centrifuge from UniEquip (Martinsried, 
Germany) model UNIVAPO 100H with a refrigerated aspirator vacuum pump model 
Unijet II was used for (i) sample drying and (ii) sample preconcentration. A minicentrifuge, 
model Spectrafugemini, from Labnet (Madrid, Spain), and a minicentrifuge-vortex, model 
Sky Line, from ELMI (Riga, Latvia) were used throughout the sample treatment, when 
necessary. A Simplicity 185 from Millipore (Milan, Italy) was used to obtain Milli-Q water 
throughout the experiments. 
III.4.2 Ultrasonic devices 
Different ultrasonic devices were tested as follows: (i) Ultrasonic bath, model 
Transsonic TI-H-5, from Elma (Singen, Germany). This device provides indirect sonication 
and is supplied with the last technological improvements regarding ultrasonic baths: dual 
frequency of sonication, for choosing between 35 or 130 kHz; power regulation, the 
ultrasonic power is variable from 10 to 100%; three operation modes, sweep, standard, and 
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degas; heating and timer. The highest intensity place of sonication inside the ultrasonic bath 
was located using the called “aluminum foil test”.13 (ii) Sonoreactor, model UTR200, from 
Dr. Hielscher (Teltow, Switzerland). The sonoreactor provides indirect sonication and can 
be considered a high-intensity ultrasonic water bath. Samples can be processed in sealed 
tubes or vials eliminating aerosols and cross-contamination. The intensity of sonication 
produced by the sonoreactor is higher than the one given by an ultrasonic bath, ca. 50 times 
higher, but it is lower than the one produced by the ultrasonic probe, ca. 30 times. (iii) 
Ultrasonic probe, model UP 100H (Dr. Hielscher). The ultrasonic probe is immersed 
directly into solution, where the sonication takes place. This avoids indirect sonication, and 
the ultrasonic energy efficiency of this device is the highest of the three tested in this study. 
III.4.3 Standards and reagents 
The following protein standards were used: α-lactalbumin from bovine milk 
(g85%), BSA (>97%), and carbonic anhydrase (>93%) from Sigma (Steinheim, Germany) 
and albumin from hen egg white (>95%) from Fluka (Buchs, Switzerland). 
Chymotrypsinogen A, catalase bovine, and aldolase from rabbit were standards for gel 
filtration calibration kit high molecular weight from Amersham Biosciences (Piscataway, 
NJ). Trypsin enzyme, sequencing grade, was purchased from Sigma. All materials were 
used without further purification. α-Cyano-4-hydroxycinnamic acid (α -CHCA) puriss for 
MALDI-MS from Fluka was used as MALDI matrix. ProteoMass Peptide MALDI-MS 
Calibration Kit (MSCAL2) from Sigma was used as mass calibration standard for MALDI-
TOF-MS. The following reagents were used for protein digestion: acetonitrile, 
iodoacetamide (IAA), and DL-dithiothreitol (DTT) (99%) were purchased from Sigma; 
formic acid and ammonium bicarbonate (Ambic) (>99.5%) were purchased from Fluka; 
trifluoroacetic acid (TFA, 99%) was from Riedel-de-Haën (Seelze, Germany); and urea 
(99%) was from Panreac (Barcelona,Spain). 
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III.4.4 Sample treatment 
III.4.4.1 Classic method 
Two different protein concentrations, 1 and 0.1?g/?L, prepared in 6.5M urea were 
used and treated according to the protocol schematized in figure III.1. Analyses were done 
by duplicate.  
To 20?L of protein solution, 2?L of a DTT solution (110mM in Ambic 12.5mM) 
were added, and the solutions were incubated at 37 °C for 1 h. Then, 2?L of an IAA 
solution (600mM in Ambic 12.5mM) were added. The solutions were further incubated at 
room temperature in the dark for 45 min. Solutions were diluted to 96?L with Ambic 
12.5mM. Then, to 10?L of this solution, 1?L of the appropriate trypsin solution, in TFA 
0.01%, was added to digest the protein. The protein/trypsin ratio was always 20:1 (w/w) as 
Protein identification
Sample Treatment
STEP 1. 20μl of protein solution in urea 6.5M
STEP 2. Reduction with 2μl of DTT (110mM) and 
incubation at 37ºC for 60min
STEP 3. Alkylation with 2μl of IAA (600mM) and 
incubation at room temperature in the dark for 45min
STEP 4. Buffer addition (72μl of Ambic 12.5mM)
STEP 5. An aliquot of the sample (10μl) was 
transferred to another eppendorf
STEP 6. Trypsin addition (1μl) and incubation  37ºC 
overnight 
STEP 7. Addition of formic acid 50% (1μl)
STEP 8. ZipTip desalting procedure
 
Figure III.1. Classic sample treatment for in-solution protein digestion. 
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recommended by the manufacturer [14]. So, amounts of proteins of 2 and 0.2?g were 
digested with 0.1 and 0.01?g of trypsin, respectively. For the classic method, overnight 
digestion at 37 °C was done. Then, 1?L of formic acid 50% (v/v) was added to stop the 
trypsin activity. Finally desalting using the ZipTip procedure was done, to avoid high saline 
concentration in the MALDI, as follows: (a) activation: aspirate and dispense, A&D, 10?L 
of acetonitrile (1x), then A&D 10?L of [50% acetonitrile + 0.1% TFA] (1x), and then A&D 
10?L of 0.1% TFA (2x); (b) peptide binding: 10?L of sample (A&D the sample 20 cycles), 
(c) washing: A&D 10?L of 0.1% TFA (3x) and (d) peptide elution: 10?L of [90% 
acetonitrile + 0.1% TFA] (A&D the sample 20 cycles). 
III.4.4.2 Protein digestion accelerated method 
In this method, protein reduction and protein alkylation were done using the classic 
times of 60 and 45 min, respectively. The protein enzymatic digestion was reduced from 
overnight to 5 min, and it was performed under the effects of ultrasonic energy, as depicted 
in figure III.2. Ten microliters of sample were sonicated, by duplicate, using the ultrasonic 
bath or the sonoreactor, while 100?L of sample were sonicated with the ultrasonic probe. 
The reason for the difference in the volume of sonication lies with the minimum volume for 
which sonication with an ultrasonic probe can be done without extensively sample 
handling. Nevertheless, it must be pointed out that the protein concentration and the 
protein/enzyme ratio were the same for the different volumes sonicated. The sonication 
time, sonication amplitude, sonication frequency, and sonication temperature for each 
ultrasonic treatment are shown in detail in figure III.2, in which can be seen that short times 
were chosen for the sonoreactor and for the ultrasonic probe (5min), while for the ultrasonic 
bath, the less efficient ultrasonic device, longer times were also tried (15min). In addition, 
for the ultrasonic bath, the two frequencies of sonication were also investigated. After 
sonication, 1?L of formic acid 50% (v/v) was added to the samples to stop trypsin activity. 
ZipTip were used thorough the sample treatment to avoid high saline concentration in the 
MALDI as described above. 
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III.4.4.3 Accelerated method 
In this method, protein reduction and protein alkylation were done reducing the 
times from 60 and 45min to 5 and 5min, respectively, using the ultrasonic probe and the 
sonoreactor. The protein enzymatic digestion was reduced from overnight to 5min. ZipTip 
were used thorough the sample treatment to avoid high saline concentration in the MALDI 
as described above. Duplicate analyses for each protein were done. 
III.4.5 MALDI-TOF-MS Analysis 
A MALDI-TOF-MS system model Voyager DE-PRO Biospectrometry Workstation 
equipped with a nitrogen laser radiating at 337nm from Applied Biosystems (Foster City, 
CA) was used to obtain the PMF. MALDI mass spectra were acquired as recommended by 
the manufacturer and treated with the Data Explorer software version 4 series. 
Prior to MALDI TOF-MS analysis, the sample was mixed with the matrix solution. 
α-CHCA matrix was used throughout this work and was prepared as follows: 10mg of α -
CHCA was dissolved in 1mL of Milli-Q water/acetonitrile/ TFA (1mL+ 1mL + 2?L). 
Then, 2?L of the aforementioned matrix solution were mixed with 2?L of sample, and the 
mixture was shaken in a vortex for 30s. Finally, 1?L of the sample/matrix mixture was 
spotted on a well of a MALDI-TOF-MS sample plate and was allowed to dry. The 
estimated final amount of protein deposited in each spot of the MALDI plate was 0.1 or 
0.01?L depending on the initial protein concentration used, as written above. 
Measurements were done in the reflector positive ion mode, with a 20kV 
accelerating voltage, 75.1% grid voltage, 0.002% guide wire, and a delay time of 80ns. 
Two close external calibrations were performed with the monoisotopic peaks of the 
Bradykinin, Angiotensin II, P14R, and ACTH peptide fragments (m/z: 757.3997, 
1046.5423, 1533.8582, and 2465.1989, respectively). Monoisotopic peaks were manually 
selected from each of the spectra obtained. Mass spectral analysis for each sample was 
based on the average of 500 laser shots. Peptide mass fingerprints were searched with the 
MASCOT [http://www.matrixscience.com/search_form_select.html] search engine with the 
following parameters: (i) Swiss-Prot, 2006 Database; (ii) molecular weight (MW) of 
protein, all; (iii) one missed cleavage; (iv) fixed modifications, carbamidomethylation (C); 
(v) variable modifications, oxidation (M); (vi) peptide tolerance up to 150 ppm. A match 
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was considered successful when the protein identification score was located out of the 
random region and the protein analyzed scores first. 
III.4.6 Protein samples from complex mixtures 
As a proof of the procedure, two different proteins, zinc resistance associated 
protein (Zrap) from Desulfovibrio desulfuricans strain G20 and split-soret cytochrome c 
from D. desulfuricans ATCC27774 were digested according to the accelerated method 
described above and identified by the PMF procedure by MALDI-TOF-MS. D. 
desulfuricans ATCC27774 and D. desulfuricans G20 cells were cultured in sulfate-lactate 
medium [15,16]. Cells were collected by centrifugation (8000 g during 15min at 4 °C), 
resuspended in 10mM Tris-HCl buffer, and ruptured in a French press at 9000 psi. After 
centrifugation (10 000g, 45min) and ultracentrifugation (180 000g, 60min), the supernatant 
was dialyzed against 10mM Tris-HCl buffer. 
Both proteins were isolated from the soluble extract using chromatographic columns 
(anionic exchange, hydroxyapatite column, and molecular exclusion chromatography). The 
purity of the proteins was evaluated by SDS-PAGE and UV-visible spectroscopy. All 
purification procedures were performed under aerobic conditions at 4 °C and pH 7.6. 
III.5 Results and discussion 
III.5.1 Protein digestion accelerated method 
The traditional sample treatment for in-solution protein digestion used in this work 
is presented in figure III.1. As can be seen, the number of total steps is 8, lasting for a total 
time of 2h from step 1 to step 4, and overnight for step 6. Our first approach to speed up the 
traditional procedure for fast protein identification was focused on the enzymatic protein 
digestion process, step 6, which takes as long as 12h. Two proteins with different masses, 
ovalbumin, 45kDa, and α-lactalbumin, 14.4kDa, were chosen as initial targets, in order to 
know whether the size of the protein could be also a variable to take into account. The three 
ultrasonic systems described in the apparatus section were tested with conditions as detailed 
in figure III.2. Two different levels of protein concentration, 1 and 0.1?g/?L, were assayed, 
as described in sample treatment, always maintaining the protein/enzyme ratio in 20:1 
(w/w), as recommended by the enzyme manufacturer [14]. 
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As far as higher concentration concerns, protein identification was successfully 
achieved in all conditions described in figure III.2 (data not shown). As expected, when 
ZipTip desalting was not used, the MALDI analysis was troublesome due to the high saline 
content of the sample, being necessary to increment twice the MALDI laser energy to 
achieve successful protein identification (data not shown). In addition, the sequence protein 
coverage and the number of peptides identified were higher when the sample desalting 
procedure with ZipTip was used (data not shown).  
Regarding the lower protein concentration tested, results showed the effectiveness 
of ultrasonic energy for speeding up the protein digestion process, as it is shown in figure 
III.3, where panels A-C correspond to the protein α-lactalbumin, while panels 3D-F 
correspond to the protein ovalbumin.  
 
Figure III. 3. MALDI-TOF-MS spectra for α-lactalbumin and ovalbumin. (A and D) Classic 
treatment; (B and E) protein digestion accelerated method using ultrasonic probe; (C and F) 
protein digestion accelerated method using sonoreactor. For ultrasonic conditions refer to figure 
III.2. Protein/enzyme ratio was 20:1. Expected protein in the MALDI spot: 0.01?g. 
Thus, unambiguous protein identification was obtained when the digestion process was 
accelerated with the sonoreactor and ultrasonic probe devices, with conditions 
corresponding to letters A and K in figure III.2. Figure III.3, panels B and E, shows the 
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MALDI spectra obtained after protein digestion accelerated with ultrasonic probe, 5min, for 
α-lactalbumin and ovalbumin, respectively, and panels C and F show the MALDI spectra 
obtained after protein digestion accelerated with sonoreactor, 5min, for α-lactalbumin and 
ovalbumin, respectively. 
It can be noted that the number of peptides obtained was similar for the acceleration 
of the digestion process with the sonoreactor or with the ultrasonic probe, thus, indicating 
that both sonic devices can be used to speed up the enzymatic kinetics of the digestion 
process. In addition, the number of peptides and the standard deviations (8±1 peptides for 
α-lactalbumin and ovalbumin) were similar and comparable to the ones obtained with the 
classic method (12h) (9±1 peptides for α-lactalbumin and 13±1 peptides for ovalbumin), 
shown in figure III.3, panels A and D, for α-lactalbumin and ovalbumin, respectively. 
Moreover, the peptides obtained for the three protocols tested were the same as confirmed 
by their m/z ratio. It must be also remarked that to obtain positive identification was 
necessary to do desalting with ZipTip. It must be also pointed out that the background 
obtained was higher for the spectra obtained using ultrasonic probe, and that peak 
intensities were, as a general rule, higher for the method using sonoreactor, figures III.3 C 
and F. On the other hand, sample treatments using ultrasonic bath, corresponding to letters 
C-J in Figure III.2, did not speed the digestion process for low protein concentrations, and 
protein identification was not possible, even for the longer time, 15min (spectra are 
presented in figure III.1.SM of Supporting Information). These data could suggest that to 
speed up the kinetic process for enzymatic protein digestion, there is a minimum threshold 
of ultrasonic cavitation efficiency required, that an ultrasonic bath cannot provide. 
In summary, the best results were obtained with the sonoreactor. In addition, the 
sonoreactor allows higher throughput, six samples at once, while the ultrasonic probe can 
be used only for one sample at a time. Moreover, sample handling is easier with the 
sonoreactor. So far, it was decided to use the sonoreactor instead of the ultrasonic probe for 
accelerating the enzymatic digestion of proteins for further experiments. 
III.5.2 Accelerated method 
The sample treatment was improved using ultrasonic energy in the step in which 
enzymatic digestion is done (step 6, figure III.1), as demonstrated in section III.5.1; 
however, two other steps of the procedure, namely, steps 2 and 3 (see figure III.1) are time-
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consuming. Thus, the protein reduction and protein alkylation steps need 60 and 45min, 
respectively, to be done.  
To investigate the applicability of ultrasonication to speed up these processes, R-
lactalbumin and ovalbumin protein samples (0.1?g) were treated with three different 
sample treatments as follows:  
(i) reduction was done with a sonication time of 2 or 5min, while alkylation was 
done for 45min according to the classic method (step 3, figure III.1);  
(ii) reduction was done for 60min according to the classic method (step 2, figure 
III.1), but alkylation was done with a sonication time of 2 or 5min; and 
finally, 
(iii) alkylation and reduction were both accelerated using ultrasound with a 
sonication time of 2 or 5min, each one.  
In these experiments, for accelerating the steps 2 and 3, the ultrasonic probe and the 
sonoreactor were tested, but for all cases, enzymatic digestion was developed in the 
sonoreactor (50% amplitude and 5min of sonication time). Regarding 2min sonication time, 
protein identification was not possible, neither with sonoreactor nor with ultrasonic probe, 
for any of the three approaches described above (data not shown). However, when the 
sonication time was increased up to 5min, protein identification was possible for the three 
approaches described above, for both proteins and with both sonic devices. The sonoreactor 
was chosen for further experiments because it allows higher throughput and lower sample 
handling when comparing it with the ultrasonic probe. MALDI spectra of the fastest 
procedure, employing 5min for alkylation, 5min for reduction, and 5min for protein 
digestion with the sonoreactor, are shown in figure III.4, where it can be seen that the 
number of peptides obtained is similar for α-lactalbumin and ovalbumin proteins, and 
comparable to the classic approach, also shown in figure III.4. It must be remarked that the 
peptides obtained were the same as confirmed by their m/z ratio. 
To avoid high saline contents and the utilization of ZipTip in the sample treatment, 
some experiments, with the fast ultrasonic method and the classic protocol, were developed 
in which the concentration of the reagents used in the procedure, as described in Figure 
III.1, were 10 times lower, namely, in steps 2 and 3. Results showed, however, that protein 
identification was not possible.  
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Figure III. 4. MALDI-TOF-MS spectra for α-lactalbumin and ovalbumin. (A and D) Classic 
treatment; (B and E) accelerated method using ultrasonic probe for protein alkylation, protein 
reduction, and protein digestion; (C and F) accelerated method using sonoreactor for protein 
alkylation, protein reduction, and protein digestion. For ultrasonic conditions refer to the text. 
Protein/enzyme ratio was 20:1 (w/w). Expected protein in the MALDI spot: 0.01?g 
The new fast sample treatment for protein identification was further applied to the 
identification of the following proteins: aldolase, BSA, catalase, carbonic anhydrase, 
chymotrypsinogen A, α-lactalbumin and ovalbumin. The sonoreactor was the sonic device 
used to accelerate the alkylation (5min), reduction (5min), and enzymatic digestion 
processes (5min). The traditional protocol was also done for comparative purposes. Results 
are presented in table III.1, where it can be seen that protein identification was possible for 
all proteins using the accelerated protocol. In addition, the number of peptides matched and 
the protein sequence coverage were similar for the fast sample treatment and the classic 
one. 
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Table III. 1. Number of Peptides Matched and Protein Sequence Coverage (%) for the 
Classic and Accelerated Methods. Initial protein concentration: a 2 µg/µl; b 10 µg/µl; c 20 
µg/µl. 
III.5.3. Proof of the method 
As a proof of the method, two different proteins, zinc resistance-associated protein 
precursor from D. desulfuricans strain G20 and split-soret cytochrome c from D. 
desulfuricans ATCC27774 were digested according to the classic and accelerated method 
described above and identified by the PMF procedure by MALDI-TOF-MS. 
Three different concentrations of proteins, 1, 0.5, and 0.1?g/?L, were tested. The 
classic method was done using the protocol depicted in figure III.1. The accelerated method 
was done as follows: proteins were reduced and alkylated in the sonoreactor (5min + 5min). 
Then the samples were diluted with Ambic, and 10?L of the sample was taken and digested 
in the sonoreactor (50% amplitude and 5 min of sonication time). The protein/trypsin ratio 
equal to 20:1 was constant for all cases. Positive identification was only possible for the 
higher protein concentration using any of the methods described above. Results are reported 
in table III.1. As can be seen, positive identification was always achieved, with similar 
results for both approaches. Furthermore, the number of peptides matched and the protein 
sequence coverage were also comparable. In addition, equivalent signal-to-noise ratios and 
intensities were observed, as it is shown in the figure III.5. 
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Figure III. 5. MALDI-TOF-MS spectra of zinc resistance-associated protein precursor from D. 
desulfuricans strain G20 and split-soret cytochrome c from D. desulfuricans ATCC27774 obtained 
after in-solution protein digestion according to the classic treatment (A and C, respectively) or to 
the accelerated method using sonoreactor for protein alkylation, protein reduction, and protein 
digestion (B and D, respectively). For ultrasonic conditions refer to the text. Protein/enzyme ratio 
was 20:1 (w/w). Expected protein in the MALDI spot: 0.1 µg. 
The zinc resistance associated protein precursor from D. desulfuricans strain 
G20was identified using MSDB or NCBInr databases, because no conclusive result can be 
obtained from the Swiss-Prot database. This fact is related with the presence or absence of 
the protein in the database used. Thus, zinc resistance-associated protein precursor from D. 
desulfururicans is not included in the Swiss-Prot database, but it is in the MSDB or NCBInr 
databases. These results confirm that comparable digestion yields to those obtained by 
previous time-consuming published methods could be attained in only 15 min with the new 
sample treatment. 
III.6 Conclusions 
It has been demonstrated that ultrasonic probe and sonoreactor can be used for 
accelerating the sample treatment for protein digestion for protein identification by PMF 
using MALDI-TOF-MS from 24h to 15min, without compromising the number of peptides 
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matched or the protein sequence coverage obtained. The protein alkylation, protein 
reduction, and protein enzymatic digestion times were reduced to 5min for each step, 
respectively. Therefore, the new methodology represents a good alternative to the classic 
protocol. In addition, with the new proposed methodology, sample handling has been 
enormously simplified. The following proteins, in the mass range 16.7-71.2kDa, α-
lactalbumin, ovalbumin, aldolase, BSA, catalase, carbonic anhydrase, and 
chymotrypsinogen A were correctly identified with the new accelerated method using the 
sonoreactor device. The identification of the zinc resistance-associated protein precursor 
from D. desulfuricans strain G20 and split-soret cytochrome c from D. desulfuricans 
ATCC27774 demonstrates that (a) parameters tested on standard samples can be also 
applied to complex biologic samples and (b) the method provides important advances in 
fast protein recognition. The findings reported in this work open a new way of sample 
treatment for in-solution protein digestion, of easy implementation, for on-line procedures, 
and tandem mass spectrometry. Thus, the advances here described are at present being 
implemented in our laboratory for on-line high-throughput protein identification from 
complex mixtures.  
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III.9 Supporting information 
Figure III. SM. 1. MALDI-TOF-MS spectra for α-lactalbumin after protein digestion in 
the ultrasonic bath: A: frequency 35KHz, 100% amplitude and 5min sonication time; B: 
frequency 35KHz, 100% amplitude and 15min sonication time; C: frequency 130KHz, 
100% amplitude and 5 min sonication time; D: frequency 130KHz, 100% amplitude and 
15min sonication time. 
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IV.1 Resumo 
No presente trabalho realizamos um estudo acerca das capacidades de uma nova 
multi-sonda de ultra-sons para utilização em proteómica. Foram avaliados parâmetros como 
robustez facilidade de manuseamento reprodutibilidade. O estudo foi realizado aplicando a 
multi-sonda a duas velocidades diferentes fluxos de trabalho proteómica. O método 
“clássico" de digestão de proteínas (12h) foi utilizado como procedimento padrão. Este 
trabalho demonstra claramente a importância da optimização prévia de parâmetros como 
amplitude de ultra-sons e o tempo sonicação quando se pretende utilizar um determinado 
protocolo com um novo sistema de ultra-sons. Os resultados apresentados demonstram e 
confirmam as vantagens da utilização conjunta da energia de ultra-sons e uma placa de 96 
poços para o tratamento em grande escala de amostras para identificação de proteínas. Os 
métodos estudados e comparados apresentam resultados semelhantes em termos de 
robustez, mas o método “desalting-free” provou ser o mais rápido, requerendo apenas 
2min/amostra. Este método demonstrou também, ser o mais simples em termos de 
manuseamento, uma vez que não requer nenhum passo para remoção de sais. As proteínas, 
albumina de plasma bovino, α-lactalbumina, ovalbumina, anidrase carbónica, fructose-
bisfososfatase aldolase A, catalase e quimotripsinogen A foram identificadas com sucesso 
utilizando os métodos estudados. Adicionalmente a proteína Split-Soret citochromo c 
isolada da bactéria D. desulfuricans ATCC 27774 foi também identificada com sucesso. 
Palavras-chave: “Desalting free”, PMF, Ultrasonicação, MALDI, Split-Soret citocromo c 
A minha contribuição para este trabalho consistiu na optimização de todas as variáveis 
experimentais, análise de proteínas por MALDI-TOF-MS e o processamento e 
interpretação dos dados. 
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IV.2 Abstract 
We studied in this work the performance of the new ultrasonic multiprobe in terms 
of throughput, handling and robustness. The study was conducted using the multiprobe to 
speed two different proteomics workflows. The “classic” method relaying on overnight 
protein digestion (12h), was used as the standard procedure. This work clearly shows the 
importance of testing variables such as ultrasonic amplitude and ultrasonic time when 
adapting an ultrasonic-based treatment to a new ultrasonic device. The results here 
presented also shown and confirm the advantage of speed up sample treatment workflows 
with the aid of ultrasonic energy in combination with a 96-well plate. The methods 
compared were similar in terms of robustness, but the desalting free method was the fastest, 
requiring only 2 min/sample for completion. In addition it was also the simplest in terms of 
handling, since no desalting step was needed. The following standard proteins were 
successfully identified using the methods studied: bovine serum albumin, α-lactalbumin, 
ovalbumin, carbonic anhydrase, fructose-bisphosphate aldolase A, catalase, 
chymotrypsinogen A. As case study, the identification of the protein Split-Soret 
cytochrome c from D. desulfuricans ATCC 27774 was carried out. 
Keywords: Desalting free, PMF, Ultrasonic, MALDI, Split-Soret cytochrome c 
My contribution to this work was the optimization of all experimental variables, MALDI-
TOF-MS analysis and data processing and interpretation. 
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IV.3 Introduction 
The enzymatic cleavage of proteins is regularly used in proteomics for protein 
identification through peptide mass fingerprint and mass spectrometry-based techniques 
[1]. 
Nowadays high throughput in sample treatment is generally recognized for the 
scientific community as a priority demand in proteomics approaches. Over the last years we 
have witnessed the reporting of different strategies to (i) reduce the time needed to perform 
protein digestion and to (ii) simplify the handling for protein identification [2]. Thus, 
warming [3], ultrasonic energy [4–6], infrared radiation [7,8], high pressure [9] or spinning 
[10] are recent strategies that allow performing sample treatment for protein identification 
of complex mixtures in a fast, efficient and reproducible manner. From the strategies 
mentioned above, the utilization of ultrasonic energy as a way to speed the enzymatic 
kinetics of protein cleavage from overnight (hours) to minutes was first reported in 2005 [4] 
and it was soon validated by different research groups [11,12]. Later, the use of ultrasonic 
energy was successfully extended to the different steps of the sample handling for protein 
identification, namely protein solubilization/denaturation, protein reduction and protein 
alkylation [13]. The most recent sample treatment reported in literature making use of 
ultrasonic energy to accelerate sample handling for protein identification claims a time to 
complete the process of 8min in a clean method that avoids desalting procedures [14]. 
The present work shows a step forward in the application ultrasonic energy in 
proteomics workflows, since high sample throughput is obtained by jointing for the first 
time an ultrasonic multiprobe, allowing the treatment of four samples at once, with a 96-
well plate. The comparison study was conducted through the identification of seven target 
proteins by mass spectrometry and peptide mass fingerprint using three different sample 
treatment workflows. In addition, as a case study, the identification of Split-Soret 
cytochrome c from D. desulfuricans ATCC 27774 was carried out using the three methods 
compared in this work. 
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IV.4 Experimental 
IV.4.1 Apparatus 
Protein digestion was done in a 96-well plate (Digilab-Genomic Solutions, USA). A 
vacuum concentrator centrifuge from UniEquip (Martinsried, Germany) model UNIVAPO 
100H with a refrigerated aspirator vacuum pump model Unijet II was used for (i) sample 
drying and (ii) sample pre-concentration. A minicentrifuge, model Spectrafuge-mini, from 
Labnet (Madrid, Spain), and a minicentrifuge-vortex, model Sky Line, from ELMI (Riga, 
Latvia) were used throughout the sample treatment, when necessary. A SimplicityTM 185 
from Millipore (Milan, Italy) was used to obtain Milli-Q water throughout the experiments. 
IV.4.2 Ultrasonic devices 
An ultrasonic multiprobe from Branson Ultrasonics Corporation (USA), model 
SLPe (150 W, 40 kHz ultrasonic frequency, 1mm diameter probe). The ultrasonic generator 
SLPe is equipped with a multiprobe detachable horn (model 4c15), with four tips for 
simultaneous ultrasonication of four samples and it was used in conjunction with a 96-well 
plate, as it is depicted in figure IV1. 
 
Figure IV. 1. This figure shows the new ultrasonic multiprobe coupled to the 96-well plate. 
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IV.4.3 Standards and reagents 
The following protein standards were used: α-lactalbumin from bovine milk 
(≥85%), bovine serum albumin (>97%) and carbonic anhydrase (>93%) from Sigma 
(Steinheim, Germany), albumin from hen white (>95%) from Fluka (Buchs, Switzerland). 
Chymotrypsinogen A, catalase bovine and fructose-bisphosphate aldolase from rabbit were 
standards for gel filtration calibration kit high molecular weight from Amersham 
Biosciences (Piscataway, USA). Trypsin enzyme, sequencing grade was purchased from 
Sigma. All materials were used without further purification. α-Cyano-4-hydroxycinnamic 
acid (α-CHCA) puriss for MALDI-MS from Fluka was used as MALDI matrix. 
ProteoMassTM Peptide MALDI-MS Calibration Kit (MSCAL2) from Sigma was used as 
mass calibration standard for MALDI TOF-MS.The following reagents were used for 
protein digestion: acetonitrile, iodoacetamide (IAA) and dl-dithiothreitol (DTT) (99%) 
were purchased from Sigma; formic acid and ammonium bicarbonate (>99.5%) were from 
Fluka; trifluoroacetic acid (TFA, 99%) were from Riedel-de Haën (Seelze, Germany); and 
urea (99%) was from Panreac (Barcelona, Spain). 
IV.4.4 Sample treatments 
The sample treatments summarized below are based in works previously developed 
in our laboratory. However, they are applied for the first time with an ultrasonic multiprobe 
in a 96 well plate. 
IV.4.4.1 Classic method 
The overnight digestion was performed after protein denaturation with 6.5M urea 
and reduction with 10mM DTT in 12.5Mm ammonium bicarbonate at 37ºC for 1h. 
Iodoacetamide was then added to a final concentration of 50mM. The resulting mixture was 
incubated at room temperature in darkness for 45 min. The mixture was then diluted 4-fold 
to reduce urea concentration and an aliquot of 50?L was taken to perform the enzymatic 
digestion. 
After trypsin addition (1:20, w/w trypsin-to-protein ratio), all samples were 
incubated at 37ºC overnight (12h). Then, 1?L of formic acid 50% (v/v) was added to stop 
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the trypsin activity (final formic acid concentration in sample 5%). Finally, to avoid high 
saline concentration in the MALDI, desalting using ZipTips® was done as follows: 
(a) Activation: aspirate and dispense, A&D, 10?L of acetonitrile (×1), then A&D 
10?L of [50% acetonitrile/0.1% TFA] (×1), and then A&D 10?L of 0.1% TFA (×2), 
(b) Peptide binding: 10?L of sample (A&D the sample 20 cycles), 
(c) Washing: A&D 10?L of 0.1% TFA (×3), 
(d) Peptide elution: 10?L of [90% acetonitrile+0.1% TFA] (A&D the sample 20 
cycles). 
IV.4.4.2 Accelerated urea method 
In brief, the method described above and referred as “classic method” was followed 
but protein alkylation, protein reduction, and protein digestion were done in 10, 10, and 
4min respectively, under the effects of an ultrasonic field [15]. ZipTip® were used 
thorough the sample treatment to avoid high saline concentration in the MALDI as 
described above. 
IV.4.4.3 Accelerated clean method 
This method was recently reported by our group [14]. In brief, the proteins were 
dissolved in mixed acetonitrile/aqueous solutions, and (i) denaturation, (ii) reduction and 
(iii) alkylation of proteins were done in steps of 1min whilst protein digestion was done 
during 4min. Ultrasonic energy was used in all steps. 
IV.4.5 A case study 
IV.4.5.1 D. desulfuricans ATCC 27774 
D. desulfuricans ATCC 27774 cells were cultured in sulfate–lactate medium. Cells 
were collected by centrifugation (8000×g during 15min at 4ºC), resuspended in 10mM 
Tris–HCl buffer and ruptured in a French press at 9000 psi. After centrifugation (10,000×g, 
45min) and ultracentrifugation (180,000×g, 60 min) the supernatant was dialyzed against 
10mM Tris–HCl buffer. The soluble extract was loaded in a DEAE-CelluloseTM and then 
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in a Q-SepharoseTM column both equilibrated with 10Mm Tris–HCl and eluted with a 
linear gradient to 250mM Tris–HCl. 
The third purification step included a hydroxyapatite column equilibrated with 
100mM Tris–HCl and eluted with a potassium phosphate linear gradient from 1 to 200mM. 
Finally, the fraction containing the haemic-protein was concentrated in a diaflow system 
(membrane YM 10) and loaded in a Superdex 200 column (Pharmacia) equilibrated with 
300mM Tris–HCl. The purity of the proteins was evaluated by SDS-PAGE and UV–vis 
spectroscopy. All purification procedures were performed under aerobic conditions at 4ºC 
and pH 7.6. 
IV.4.6 MALDI-TOF-MS analysis 
A MALDI-TOF-MS model Voyager DE-PRO Biospectrometry Workstation 
equipped with a nitrogen laser radiating at 337nm from Applied Biosystems (Foster City, 
USA), was used to obtain the PMF. MALDI mass spectra were acquired as recommended 
by the manufacturer and treated with the Data ExplorerTM software version 4 series. Prior 
to MALDI-TOF-MS analysis, the sample was mixed with the matrix solution. α-CHCA 
matrix was used throughout this work and was prepared as follows: 10mg of α-CHCA was 
dissolved in 1mL of Milli-Q water/acetonitrile/TFA (1ml+1ml + 2?L). Then, 2?L of the 
aforementioned matrix solution was mixed with 2_l of sample and the mixture was shaken 
in a vortex for 30s. Finally, 1?L of the sample/matrix mixture was spotted on a well of a 
MALDI-TOF-MS sample plate and was allowed to dry. 
Measurements were done in the reflector positive ion mode, with a 20kV 
accelerating voltage, 75.1% grid voltage, 0.002% guide wire and a delay time of 100ns. 
Two close external calibrations were performed with the monoisotopic peaks of the 
Bradykinin, Angiotensin II, P14R and ACTH peptide fragments (m/z: 757.3997, 
1046.5423, 1533.8582 and 2465.1989, respectively). Monoisotopic peaks were manually 
selected from each of the spectra obtained. Mass spectral analysis for each sample was 
based on the average of 500 laser shots. Peptide mass fingerprints were searched with the 
MASCOT[http://www.matrixscience.com/cgi/search_form.pl?FORMVER=2&SEARCH=P
MF] search engine with the following parameters: (i) SwissProt. 2006 Database; (ii) 
molecular weight (MW) of protein: all; (iii) one missed cleavage; (iv) fixed modifications: 
carbamidomethylation (C); (v) variable modifications: oxidation (M); (vi) peptide tolerance 
up to 150 ppm. 
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A match was considered successful when the protein identification score is located 
out of the random region and the protein analyzed scores first. 
IV.4.7 Statistical analysis 
The t-test was used to determine differences between the ultrasonic-based methods 
and the classic overnight methods. Statistical analysis was performed with the significance 
level of 5%, using the software Statistica 6.0 (StatSoft, Inc. 1984–2001, Tulsa, OK, USA). 
IV.5 Results and discussion 
IV.5.1 Classic method 
Table IV.1 show that all the target proteins were identified when the classic method 
was carried out. The target proteins scored always first and out of the random region in all 
replicates done in this study (n = 4). The number of peptides matched and the sequence 
coverage obtained for each protein were used to compare performance with the other two 
methods studied in this work. 
IV.5.2 Accelerated urea method 
Next, we carried out a set of experiments to compare the performance of the 
ultrasonic multiprobe in the acceleration of the classic method. Previous research developed 
in our group has shown that the classic method can be accelerated using ultrasonic energy 
in the different steps of its workflow [5,6,13–15]. A pitfall of this procedure when the 
treatment is done with single probe is that samples must be handled one by one. In other 
words, sample throughput is still a bottleneck in the application of ultrasonic-based 
approaches for the acceleration of methods commonly used for protein identification. 
Nevertheless, the ultrasonic-probe-based devices have evolved in such a way that 
multiprobes for the simultaneous treatment of samples ranging from 4 to 12 are nowadays 
available [16]. Their performance for proteomics applications has not been tested yet, to the 
best of our knowledge. 
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Table IV.1. Protein sequence coverage and number of peptides matched for the in-solution 
protein digestion: overnight method, accelerated method with urea and ZipTip® and clean method 
in H2O/acetonitrile (n=4, pt=0.05a).  
* Initial Protein concentration: 0.3μg/μl. Accelerated method with urea: protein reduction and 
protein alkylation were done with 10 min ultrasonication time and 25% ultrasonication amplitude 
each one, whilst protein digestion was done with 4 min ultrasonication time and 10% 
ultrasonication amplitude. Accelerated clean method with acetonitrile: protein reduction and 
protein alkylation were done with 1 min ultrasonication time and 25% ultrasonication amplitude 
each one, whilst protein digestion was done with 5 min ultrasonication time and 10% 
ultrasonication amplitude. apt= theoretical significance level. bexperimental significance level. 
 
It must be stressed that it is necessary to adequately address the challenges of high 
sample throughput while maintaining data quality. Therefore, the most important variables 
affecting ultrasonic-based sample treatments, namely amplitude and time of ultrasonication 
[16] were studied. This set of experiments was carried out in a 96-well plate which is the 
regular plate used in robotic platforms. It must be noteworthy that when a single probe is 
used to speed proteomics workflows, the diameter of the tip regularly used is 0.5mm, whilst 
the new multiprobes are manufactured with a diameter of 1mm [16]. This difference is 
important since the lower is the sample container and the ratio sample volume/probe 
diameter, the higher is the risk of to lose sample by aerosol formation and subsequent 
sample spreading out of the sample container. In addition, aerosol formation can led to 
cross-contamination among the wells of the 96-well plate. For those reasons, testing the 
changes in sample treatment performance any time that a new ultrasonic device is tested is 
Chapter IV. Ultrasonic multiprobe for proteomics 
73 
very important. Figure IV.2 shows the results obtained for the identification of BSA and α-
lactalbumin under different conditions of ultrasonication.  
Figure IV. 2. Number of peptides matched and sequence coverage for bovine serum albumin and α-
lactalbumin as a function of time, and amplitude of ultrasonication. Sequence coverage and peptides 
matched for the overnight method was 61±5 and 39±4 for bovine serum albumin and 47±2 and 11±1 
for α-lactalbumin, respectively. 
For both proteins studied, the results suggest that jointing long times of 
ultrasonication (i.e. 240 s) with low ultrasonication amplitudes, the number of peptides 
matched and the protein coverage obtained allow protein identification at the same 
confidence level that with the classic protocol, as it is also showed in table IV.1. This 
conclusion may be also observed for higher amplitudes. This result suggests that amplitude 
of ultrasonication is not an important variable in order to accelerate the in-solution 
digestion of proteins, at least for the ultrasonic multiprobe here assessed. This finding is 
important since high ultrasonic amplitudes can degrade the protein with the result of failing 
in protein identification. 
More important, to use amplitudes as low as possible when working with a 96-well 
plate, is also advantageous because it avoids the spreading out of the sample through drops 
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or aerosol formation, overcoming cross-contamination. As an example, it is noteworthy that 
when we assayed an ultrasonic amplitude of 75%, sample was lost, being withdrawing from 
the well as an aerosol due to the effects of the high ultrasonic amplitude used. As 
consequence, cross-contamination caused by the aerosol formation was also verified, being 
detected peptides of BSA protein in well plates that in theory only contained protein α-
lactalbumin and vice versa. Consequently the highest amplitude used in further experiments 
was 10%. Moreover, the maximum volume of sample recommended to work with is 50?l, 
higher volumes can lead to random cross contamination. 
Regarding ultrasonication time, as may be seen in figure IV.2, this variable was 
found to affect the results; since the number of peptides matched and their respective 
sequence coverage for either BSA or α-lactalbumin were slightly improved when this 
variable was increased in the digestion step from 60 to 240s. These findings are consistent 
with data previously reported in the literature [14,15]. We hypothesize that a complex 
relation between the type of enzyme, the type of substrate, the ultrasonic amplitude and the 
ultrasonic time, influences the efficiency of the enzymatic process when it is carried out 
under the effects of an ultrasonic field. Thus, Sakakibara et al. have shown an enhancement 
in the reaction’s kinetic for the hydrolysis of sucrose, when it was used the enzyme 
invertase in conjunction with ultrasonication [17]. Nevertheless, other authors have pointed 
out, that ultrasonic energy can inactivate enzymes. Thus, Bracey et al. have reported an 
inhibitory effect in the activity of the enzyme subtilisin when the subtilisin catalyzed 
interesterification reaction in an organic solvent was studied under the effects of 
ultrasonication [18]. As further example, although the enzyme protease XIV was 
inactivated towards casein substrate after 2 min of ultrasonication with probe, the same 
enzyme in the same conditions was active towards mussel tissue substrate after 4min of 
ultrasonication [19]. 
Next, with the best conditions found in the set of experiments above described, we 
proceed to identify other proteins, as showed in table IV.1, The number of peptides 
matched and the protein coverage were statistically compared with those obtained with the 
classic method and no differences were found at a significance level of p > 0.05 (test t, n1 
=4, n2 = 4). This result indicates that with the right conditions chosen the multiprobe can be 
used in conjunction with a 96-well plate to obtain fast and high throughput sample 
treatment for protein identification. 
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IV.5.3 Accelerated clean method 
A drawback of the classic method is that, prior to MS analysis, ZipTip® tips or 
other kind of home-made mini-columns containing C18 beads are often used as peptide 
micro extraction and purification columns. It has been demonstrated; however, that sample 
loss can be as high as 90%, when ZipTips® columns are used [20]. This loss depends on 
the absolute concentration of the initial peptide digest loaded into the ZipTips® and is 
peptide type-dependant [20]. In addition, using ZipTips® sample handling becomes time 
consuming, labor intensive and expensive. Therefore we also tested the performance of the 
multiprobe in a clean method relaying in the use of a mixture of water/acetonitrile to solve 
the sample. The initial trials were done applying ultrasonic energy in the reduction, 
alkylation and digestion steps of our proteomic workflow (25% ultrasonic amplitude and 
5min ultrasonic time in each step). Results, however, were unexpectedly low in terms of 
protein sequence coverage and peptides matched, especially for protein α-lactalbumin. This 
can be explained because amino acid residues valine and isoleucine has the potential to 
sterically hinder trypsin binding when an incomplete protein denaturation has been done. 
Therefore, a step was added in which protein denaturation was done by applying ultrasound 
to the sample before proceed with the subsequent protein reduction. Remarkably, after this 
change, the results obtained in terms of peptides matched and protein coverage for BSA, α-
lactalbumin and for the other proteins used in this study, as showed in table IV.1, were as 
good as for the classic or the accelerated urea methods. The number of peptides matched 
and the protein coverage obtained were statistically compared with those of the classic 
method and differences were not found (test t, p > 0.05, n1 =4, n2 = 4). 
IV.5.4 MALDI spectra 
MALDI spectra of the sample treatments here compared are presented in figure IV.3 
for BSA and α-lactalbumin. For both proteins, the spectrum belonging to the classic method 
shows a different pattern of peak intensities, when compared to the ultrasonic-based ones. 
This could suggest that under the effects of an ultrasonic field some peptides are 
preferentially formed. Furthermore, when the spectra of the accelerated method are 
compared with the ones of the clean method, some differences in peak intensities are also 
observed that can be attributed, in this case, to the differences between both sample 
treatments: the use of urea/Zip Tips or organic solvents respectively. It is also possible that 
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the different reagents used in the sample treatments might influence the peptide distribution 
within the matrix spot. It must be pointed out that, despite of the differences in peak 
intensities, when the optimum conditions find out for each method were used, protein 
identification was always possible. 
Figure IV. 3. MALDI spectra obtained of in-solution digestion of 3?g/?l of bovine serum 
albumin and α -lactalbumin. Panel A, B and C, spectrum of digested bovine serum albumin 
with classic method (A), accelerated urea method (B) and (C) accelerated clean method. Panel 
D, E and F, spectrum of digested α-lactalbumin with classic method (D), accelerated method 
(E) and (F) accelerated clean method. 
IV.5.5 Application to a case study 
To compare the sample treatments studied in this work, we test the identification of 
a cytochrome produced by D. desulfuricans ATCC 27774. This organism, which is a 
facultative nitrate/sulfate bacterium, considerably expresses a protein named Split-Soret 
[21] in the presence of nitrate. This fact suggests that this protein can be involved in the 
nitrate metabolism [22]. The production and purification of this protein was explained in 
section IV.4.5.1. A sample containing 0.3?g/?l of Split-Soret cytochrome c was used in this 
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set of experiments. The samples containing the protein were then submitted to the three 
methods studied in this work and the results presented in table IV.1 clearly demonstrate that 
the classic method and the accelerated classic method provided protein coverage and 
peptides matched that were not found statistically different (test t, p > 0.05, n1 =4, n2 = 4). 
Figure IV.4 shows the spectra of the Split-Soret cytochrome c for the three sample methods 
used. 
Figure IV. 4. MALDI spectra of Split-Soret cytochrome c from D. desulfuricans, (A) classic 
method, (B) accelerated urea method and (C) accelerated clean method. 
IV.5.6 Final remarks 
Table IV.2 shows the differences in time and handling for the three sample 
treatments compared in this work. As may be seen, if we consider the workflow as 
composed of five main steps as follows: (i) denaturation, (ii) reduction, (iii) alkylation, (iv) 
digestion and (v) desalting, handling is not the same. The clean method avoids the use of 
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ZipTips or any other kind of desalting processes. This means that it becomes also 
economically cheaper, since ZipTips are an expensive reagent. In terms of time consumed, 
the best is again the clean method, being necessary only 2min/sample to complete the 
workflow. The new ultrasonic multiprobe-device can work as efficiently as the single 
probe. In terms of throughput, however, it allows to work 4–12 times faster, depending on 
the multiprobe chosen to work with. 
Table IV. 2. Comparison of handling and time consumed for the three methods studied in this 
work. 
a Total time needed to complete the analysis for 96 samples (96-well plate).  
It must be stressed that whilst an analysis runned using all the wells of a 96-well 
plate takes 12 h with the classic protocol, it last only for 3 h with the ultrasonic clean 
method. Due to simplicity of use and high throughput, it may be advanced that the 
ultrasonic multiprobe-device will be implemented in robotic platforms. 
IV.6 Conclusions 
The new ultrasonic multiprobe-device has been studied in conjunction with a 96-
well plate in the acceleration of two different proteomic workflows in terms of speed, 
throughput, handling and robustness. We have demonstrated that to avoid cross 
contamination between samples in this approach, low amplitudes must be used. For the six 
standard proteins studied, the two workflows accelerated with ultrasound give results that 
were found similar in terms of robustness, as their utilization provide results comparable 
with a classic non-ultrasonic method. The clean fast method has the best performance in 
terms of speed and handling since only 2min/sample are necessary to complete it, being 
desalting not necessary, thus diminishing the total number of steps. 
Regarding throughput, it has been proven that the combination of a 96-well plate 
and an ultrasonic multiprobe is a potential powerful tool in sample treatment for 
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proteomics, allowing high sample throughput. The methods proposed allow for rapid 
processing, minimizing the risk of contamination and reducing the chance of application 
errors. In addition, a potentially enormous number of different proteomics applications are 
advanced, such as fast and high throughput protein quantification using isotopic labeling 
[23]. Sample preparation steps, including reduction and alkylation, digestion, spotting on 
MALDI targets or transfer to LC/MS input plates can potentially be combined on a single 
automated platform making use of ultrasonic energy provided by ultrasonic multiprobes. 
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V.1 Resumo 
A ferramenta “Decision Peptide-Driven” consiste numa aplicação bioinformática 
que tem como principal função assistir o utilizador no tratamento de dados para 
quantificação de proteínas seguindo os seguintes passos: (1) separação de proteínas por 
eletroforese em gel; (2) digestão em gel; (3) marcação isotópica directa e inversa com 18O; 
(4) A análise das amostras marcadas por MALDI-TOF-MS. O software DPD, compara os 
resultados experimentais de marcação directa e inversa e identifica os péptidos que 
apresentam perdas reprodutíveis durante os diferentes passos do tratamento de amostra. 
Os péptidos previamente seleccionados pelo programa DPD são posteriormente 
utilizados para quantificação exacta de proteínas. A interpretação manual dos dados de 
marcação directa e inversa obtida por MALDI-TOF-MS requer muito tempo. O software 
DPD reduz e simplifica significativamente o tempo necessário para a interpretação dos 
dados. Deste modo, com a introdução de vários espectros de MALDI no programa, o 
investigador é conduzido na comparação, automática, de dados de marcação isotópica 
directa e inversa calculando os rácios correspondentes. Numa segunda fase os rácios 
calculados são comparados de modo a identificar os péptidos que apresentam perdas 
paralelas. Os péptidos identificados podem posteriormente ser utilizados como padrão 
interno para quantificar proteínas de forma exacta. 
Neste trabalho, o software DPD, é apresentado e explicado através da quantificação 
da proteína anidrase carbónica. 
Palavras-chave: Quantificação de proteínas, eletroforese em, MALDI-TOF-MS, marcação 
isotópica com 18O, DPD software. 
A minha contribuição para este trabalho consistiu na execução da parte experimental, 
análise de MALDI-TOF-MS, processamento de dados, interpretação e 
desenvolvimento/teste do software. 
 
 
 
Chapter V. Decision peptide-driven: a free software tool for protein quantification 
86 
V.2 Abstract 
The Decision Peptide-Driven tool implements a software application for assisting 
the user in a protocol for accurate protein quantification based on the following steps: (1) 
protein separation through gel electrophoresis; (2) in-gel protein digestion; (3) direct and 
inverse 18O-labeling and (4) Matrix assisted laser desorption/ionization time-of-flight mass 
spectrometry, MALDI. The DPD software compare the MALDI results of the direct and 
inverse 18O-labeling experiments and quickly identifies those peptides with paralleled loses 
in different sets of a typical proteomic workflow. Those peptides are used for subsequent 
accurate protein quantification. The interpretation of the MALDI data from direct and 
inverse labeling experiments is time-consuming requiring a significant amount of time to 
do all comparisons manually. The DPD software shortens and simplifies the searching of 
the peptides that must be used for quantification from a week to just some minutes. To do 
so, it takes as input several MALDI spectra and aids the researcher in an automatic mode (i) 
to compare data from direct and inverse 18O -labeling experiments, calculating the 
corresponding ratios to determine those peptides with paralleled losses throughout different 
sets of experiments; and (ii) allow to use those peptides as internal standards for subsequent 
accurate protein quantification using 18O-labeling. In this work the DPD software is 
presented and explained with the quantification of protein carbonic anhydrase. 
Keywords: Protein quantification, gel electrophoresis, MALDI-TOF-MS, 18O, labeling, 
DPD software. 
My contribution to this work was the execution of the experimental, MALDI-TOF-MS 
analysis, data processing, interpretation and software development/testing. 
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V.3 Introduction 
Protein quantification methods based on protein separation by 1D gel 
electrophoresis and matrix assisted laser desorption/ionization time-of-flight mass 
spectrometry, MALDI, have a number of drawbacks that make reliable quantification 
difficult. The differences in the yields of protein digestion obtained in different sets of in-
gel digestions, the variation observed in the recovery yields of individual peptides within a 
set of in-gel digest, the biased losses of peptides that might occur during the post-digestion 
sample processing of in-gel digests when are used ZipTip pipette tips to clean the sample or 
the speed vacuum pump to dry down and preconcentrate the sample. The aforementioned 
drawbacks can cause loss of peptides ranging in between 30% to 90% depending on the 
amount of sample loaded in the gel and on the type of peptide studied [1-3].  
If for a given protein was possible to identify a certain number of peptides that had 
low and paralleled loses through a typical proteomic workflow entailing 1D-gel protein 
separation and in-gel protein digestion, then such peptides would allow robust and accurate 
protein quantification. The experimental method that could allow to extract and to identify 
the number of peptides that remains constant in expression level through a typical in-gel 
digestion workflow should be based in a peptide differential analysis. A variation of the 
method proposed by Wang et al. and called “inverse labeling” can be used to do such 
analysis [4]. With this procedure it is easily detected if a peptide is randomly loosed, or the 
observed yields of individual peptides vary strongly within a set of in-gel digests. This 
methodology can be used to unambiguously verify the yield of peptides obtained during in-
gel protein digestion at different concentrations, and thus clearly illustrates which peptides 
can be used for quantification through a given dynamic range of differential quantification.  
The application of the “inverse labeling” methodology requires the use of mass 
spectrometry. MALDI can be used for this purpose. The comparison of MALDI spectra 
makes this approach for protein quantification tedious and time-consuming. 
To speed the treatment of data the software “Decision Peptide Driven”, DPD, has 
been developed based on previous software developed for medical applications [5] as a 
computer tool to extract and to identify the peptides that remains constant in expression 
level through different sets of a typical in-gel digestion workflow. 
The present manuscript described in detail the software tool DPD, explaining 
through a real example how to use it. This software is freely source code available, and it 
can be run as a multiple platform.  
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V.4 Materials and Methods 
V.4.1 Apparatus 
Gel Electrophoresis was performed with an electrophoresis system, model Mini-
PROTEAN Tetra Cell, from Biorad (Hercules, CA, USA), following the manufacturer 
instructions.  Protein digestion and labeling were done in safe-lock tubes of 0.5 ml from 
Eppendorf (Hamburg, Germany).  
A minicentrifuge, model Spectrafuge-mini, from Labnet (Madrid, Spain), and a 
minicentrifuge-vortex, model Sky Line, from ELMI (Riga, Latvia) were used throughout 
the sample treatment, when necessary. A vacuum concentrator centrifuge from UniEquip 
(Martinsried, Germany) model UNIVAPO100H with a refrigerated aspirator vacuum pump 
model Unijet II was used for (i) sample drying and (ii) sample pre-concentration. 
Milli-Q natural abundance (H216O) water was obtained from a SimplicityTM from 
Millipore (Milan, Italy). An ultrasonic bath, model Transsonic TI-H-5, from Elma (Singen, 
Germany) with control of temperature and amplitude was used to speed up the gel washing, 
the protein reduction and the protein alkylation steps, and a sonoreactor model UTR200, 
from Dr. Hielscher (Teltow, Switzerland), was used to accelerate the enzymatic digestion 
step. 
All materials were used without further purification. α-Cyano-4- hydroxycinnamic 
acid, α-CHCA, puriss for MALDIfrom Fluka (Buchs, Switzerland) was used as MALDI 
matrix. ProteoMass Peptide MALDI-MS Calibration Kit (MSCAL2) from Sigma was used 
as mass calibration standard for MALDI-TOF-MS. 
V.4.2 Standards and reagents 
Reduction and alkylation were carried out, respectively, with D,L-dithiothreitol 
(DTT, 99%) and iodoacetamide (IAA) from Sigma. The following reagents were used 
during sample digestion: ammonium bicarbonate buffer (AmBic, pH 8.5, ≥99.5%) and 
formic acid (FA, ~98%) from Fluka (Buchs, Switzerland); and labeling: ammonium acetate 
(>99.0%) from Fluka, calcium chloride (~97%, anhydrous) from Sigma, Mag-Trypsin from 
Clontech (USA) and H218O (97 atom%) from IsotecTM (Miamisburg, USA). Trifluoroacetic 
acid (TFA, 99%) was obtained from Riedel-de Haäen (Seelze, Germany).  
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V.4.3 In-gel protein digestion 
Ultrasonic in-gel enzymatic digestion was done according to the ultrafast proteolytic 
digestion protocol previously developed in our laboratory [6, 7]. Protein bands were 
manually excised from the gel and placed in safe-lock tubes of 0.5 mL. Gel pieces were 
washed, first with AmBic 25mM/acetonitrile (100μL) and then with acetonitrile (100μL), in 
an ultrasonic bath operating at 35kHz (60% amplitude) for 5min for each step. Then, the gel 
pieces were dried in a vacuum concentrator centrifuge for 5min. Protein reduction and 
alkylation steps were done as follows: disulfide bonds from cystine residues were reduced 
with DTT in an ultrasonic bath operating at 35kHz (60% amplitude) for 5 min at room 
temperature, and then, the reduced cysteines were blocked with IAA in an ultrasonic bath 
operating at 35kHz (60% amplitude) for 5min at room temperature. After reduction and 
alkylation steps, the gel was submitted again to the washing procedure in the same way as 
described above, followed by another dry step of 10min. Afterward, the dried gel pieces 
were incubated with trypsin (375 ng in 25μL) in an ice bath for 60min to rehydrate the gel 
and to allow enzyme penetration into it. Subsequently, in-gel protein digestion was 
performed in a sonoreactor operating at 50% amplitude for 4min. Next, trypsin activity was 
stopped by the addition of 20μL of formic acid 5% (v/v).  
V.4.4 18O labeling: the decoupled procedure 
For the 18O-labeling, the digested peptides were reconstituted with 10μL of 25mM 
calcium chloride and 10μL of (acetonitrile 20% v/v + 50 mM ammonium acetate, pH 6.75) 
Then the samples were vacuum dried again, and after evaporation the dried samples were 
reconstituted in 5μL of natural abundance water or 97% 18O-enriched water and 5µL of a 
5% suspension of Mag-Trypsin in H216O or H218O were added. The digested peptides were 
labeled during 15 min of vortexing and centrifugation and finally trypsin were removed by 
a magnetic separation. A detailed explanation of this procedure can be found elsewhere [8].  
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V.4.5 Inverse 18O labeling of peptides 
Proteins were separated by 1D-PAGE and then submitted to the protocols described in 
V.4.3 and 2.4 and then the inverse 18O labeling protocol as described by Wang et al. [4] 
was then used. 
V.4.6 Quantification of peptides 
Quantification of peptides through 18O was done with the mathematical algorithm 
for deconvolution described by Yao et al. [8] Eq. 1, Reduction of the spectra to a centroided 
plot was done using the centroiding option function of the Data ExplorerTM software 
(version 4.0) from Applied Biosystems. This function is an advanced peak filtering method 
that improve mass spectral data quality and reduce data file size. Profile data, in which 
many points are used to delineate a mass spectral peak, is converted into mass-centroided 
data by a data compression algorithm. The centroided mass peak is located at the weighted 
center of mass of the profile peak. The normalized area of the peak provides the mass 
intensity data. 
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 (Eq. 1) 
where M0, M2 and M4 correspond to the theoretical relative intensities of the monoisotopic 
peak and the monoisotopic peaks with masses 2Da and 4Da higher, respectively; and I0, I2 
and I4 are the measured relative intensities of the first, the third and the fifth peaks in the 
isotopic cluster. 
V.4.7 Case study 
To explain how to work with the DPD program we have follow a real example based in the 
standard protein carbonic anhydrase. 
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V.4.8 MALDI analysis 
Prior to MALDI analysis, the sample was mixed with the matrix solution. α-CHCA 
matrix was used throughout this work and was prepared as follows: 10mg of α-CHCA was 
dissolved in 1mL of Milli-Q water/acetonitrile/TFA (1mL/1mL/2μL). Then, 4μL of the 
aforementioned matrix solution was mixed with 4μL of sample and the mixture was shaken 
in a vortex for 30s. One micro liter of each sample was hand-spotted on a well of a MALDI 
sample plate and was allowed to dry. A MALDI system model Voyager DE-PRO 
Biospectrometry Workstation equipped with a nitrogen laser radiating at 337nm from 
Applied Biosystems (Foster City, CA) was used to acquire the PMFs. 
Measurements were done in the reflector positive ion mode, with a 20kV 
accelerating voltage, 75.1% grid voltage, 0.002% guide wire and a delay time of 100ns. 
Two close external calibrations were performed with the monoisotopic peaks of the 
bradykinin, angiotensin II, P14R, and ACTH peptide fragments (m/z: 757.3997, 1046.5423, 
1533.8582, and 2465.1989, respectively). Monoisotopic peaks were manually selected from 
each of the spectra obtained. Mass spectral analysis for each sample was based on the 
average of 500 laser shots.  
V.4.9 Software distribution 
Current versions of the software and their supporting user manuals are freely 
available for downloaded and use, without restriction, via the internet at 
http://sing.ei.uvigo.es/DPD. This program operates on excel comma-separated values, CSV, 
files with centroid mass and relative intensity data extracted from the Data ExplorerTM. 
The program was developed based on previous work related to cancer diagnosis [23] and 
on the suggestions given by the Bioscope group. 
V.4.10 Decision peptide-driven experimental workflow 
A schematic diagram illustrating the sequential steps of the sample treatment 
workflow is presented in Figure. V.1. In brief, 1?g and 2?g, four replicates each, are loaded 
and separated by 1D-SDS-PAGE. The bands are then excised from the gel and the proteins 
are in-gel tryptic digested with the aid of ultrasonic energy as reported by Galesio et al. [6]. 
The pool of peptides thus obtained is then dried and finally, reconstituted in normal water 
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or in 97% 18O water [7, 10-14]. Following the pipeline of figure V.1, after protein 
separation, in-gel protein digestion and peptide labeling, the next step is to perform the so-
called inverse labeling protocol [4]. With this procedure two converse labeling experiments 
are performed in parallel as follows. In the “direct” labeling, the sample is reconstituted in 
normal water whilst its counterpart of higher amount (i.e. 1:2) is reconstituted in 18O-water 
as described in 2.4. In the «inverse» method the labeling is done conversely. Finally, an 
equal sample volume of non-labeled and its labeled counterpart are mixed and analysed 
through MALDI-TOF-MS. The 16O/18O peak ratios (MALDI relative peak intensity) are 
used then in the final step of the workflow, as it is shown in figure. V.1. In this step, the 
software DPD (Decision Peptide Driven) is used to find out which peptides are adequate for 
protein quantification within a given accuracy. In brief, this software compares the labeled 
to unlabeled ratios of the same peptides obtained in the “direct” and “inverse” methods. 
Only those peptides having the “direct” and “inverse” ratios within a given p significance 
level (t-test) are selected for quantification. 
 
Figure V. 1. Experimental workflow for the identification of DPD (decision peptide driven) 
peptides and subsequent protein quantification. 
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V.5 Results and Discussion 
The DPD software is explained in detail in the following sections. The data which is 
needed to enter in each step of the software, the reasons why, and the information which is 
obtained once each step is completed is described below. To run the program, real data is 
provided in the supplementary material, V.9.SM.1. This example is based in the 
quantification of carbonic anhydrase. 
V.5.1 Preparing theoretical data 
V.5.1.1 How to obtain the in-silico protein digestion 
After 1D-Gel electrophoresis separation, the protein is in-gel digested with the aid 
of an enzyme, generally trypsin. This process will generate a pool of peptides which can be 
previously known, because the enzymes used to digest proteins do the cleavage always in 
the same residues of the peptide chain. For instance, the enzyme trypsin cleavages the 
proteins in the amino acids arginine and lysine, if they are not followed by a proline 
residue. In other words, if the protein to be quantified and the enzyme to be used are 
known, the pool of peptides expected can be obtained in advance. Nowadays there are 
powerful software tools that can provide the above mentioned theoretical pool of peptides 
(http://www.expasy.org/sprot/). When the DPD program is used, the first step consists in 
the introduction of this theoretical pool of peptides. This is necessary because the program 
will compare the masses of those theoretical peptides with the masses of the peptides 
obtained using MALDI. This comparison has the goal to assign the experimental masses 
obtained with the MALDI with their corresponding (theoretical) peptides. A step-by-step 
description of how to obtain the in-silico protein digestion is provided in supplementary 
material V.9.SM.2.  
V.5.1.2 How to obtain the isotopic mass distribution of the peptides 
The in-silico digestion of the protein provides a list of theoretical peptides. The 
IMD, isotopic mass distribution, of those peptides, M0, M2, M4, is required for the 
subsequent calculation of the ratios between the 18O-labeled and the non-labelled peptides 
in following parts of the workflow, as it is shown in Eq. 1 (see above). 
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For each peptide the IMD is calculated in an automated mode in the following 
webpage http://prospector.ucsf.edu/cgi-bin/msform.cgi?form=msisotope.  
A step-by-step description of how to obtain the isotopic mass distribution of the 
peptides is provided in supplementary material, V.9.SM.3. 
V.5.2 Finding out the DPD peptides 
V.5.2.1 First step: loading the in-silico data 
With the data obtained in V.5.1.1 and V.5.1.2 a CSV excel file is created containing 
six columns. The first column has the theoretical masses of the peptides, the second column 
contains the theoretical peptide amino acid sequences, and the third column contains the 
possibility of carboxyamidomethilations on cysteine due to alkylation. The fourth, fifth and 
sixth columns, contains the IMD of the M0, M2 (M0+2Da) and M4 (M0+4Da) masses 
respectively obtained for each peptide. Figure V.2 shows an example of an in-silico file 
from carbonic anhydrase. 
 
Figure V. 2. In-silico file -excel CSV- containing peptide masses, the theoretical peptide sequence 
assigned to each mass, carboxyamidomethilations present (yes-true or no-false) and the isotopic mass 
distribution for the protein Carbonic Anhydrase. 
Chapter V. Decision peptide-driven: a free software tool for protein quantification 
95 
When the DPD program is started the interface shown in figure V.3 appears in the 
screen. By clicking in the “load in-silico data” button we are asked to introduce the CSV 
excel file containing the in-silico information. 
 
Figure V. 3. By clicking in “load in-silico data” the data created as described in sections V.5.1.1 
and V.5.1.2 is introduced in the form of a CSV excel sheet. 
In our example the file to input is the one named as “in silico carbonic anhydrase” 
given in the supplementary material, and prepared as described in sections V.5.1.1 and 
V.5.1.2. In addition, the user must introduce an “overlapping mass” value that indicates the 
mass difference considered critical between two peptides whose isotopic mass distribution 
can potentially be overlapped, in our case 5Da is the value chosen. This concept can be 
explained with the simplest case of overlapping as follows: the in-silico digestion of 
carbonic anhydrase predicts the occurrence of YGDFGTAAQQPDGLAVVGVFLK 
(2253.16 m/z) and RMVNNGHSFNVEYDDSQDK (2254.98m/z), their isotopic mass 
distribution are overlapped, after isotopic labeling, if both are present in the experimental 
data . Nevertheless, could also happen that the peak 2253.16 m/z is present in the 
experimental data but not the peak 2254.98 m/z or vice versa. In this case, the peptide 
virtually could be used for quantification. Therefore those peaks will be assigned as 
potential overlapped (“true”) by the program and they must be checked in the spectrum to 
assess whether overlapping occurs or not. 
V.5.2.2 Second step: loading experimental data 
It was explained in the experimental section that two converse experiments are done 
to identify the peptides that have paralleled loses in different sets of experiments. Of each 
set of direct (n=4) and inverse (n=4) labeling experiments, MALDI spectra are obtained, 
showing the typical pattern of labeled and non-labeled peptides (see figure V.4). Those 
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spectra are converted in a CSV excel file in which one column contents the peak mass 
values whilst other contents their corresponding intensities, as shown in figure V.5. By 
clicking in “load labeling data”, see figure V.6, the program asks for the introduction of the 
files corresponding to the direct labeling. In our example, those files are named in the 
supplementary material as direct 1, direct 2, direct 3 and direct 4.  
Figure V. 4. MALDI spectra of carbonic anhydrase obtained for the direct (1µg of unlabeled 
protein and 2 µg of 18O-labeled protein, samples were mixed in a 1:1 ratio before MALDI analysis) 
and inverse labeling (2µg of 18O-labeled protein and 1µg of unlabeled protein, samples were mixed 
in a 1:1 ratio before MALDI analysis).The symbol(“?”) denotes the peptides assigned by the DPD 
software 
Once the direct files have been loaded, then the files corresponding to the inverse 
labeling are also loaded. In supplementary material the corresponding files are named as 
inverse 1, inverse 2 inverse 3 and inverse 4. The DPD program has an algorithm that allows 
the user to choose the minimum peak intensity from which the masses will be considered 
different of instrumental noise. In other words, it is possible to select the minimum intensity 
from which a peak will be considered as belonging to a peptide. This value will depend on 
the quality of the MALDI spectra. In our example the recommended value is 3%, which 
represents the percentage of the maximal relative peak intensity. 
Mass (m/z) 
%
 In
te
ns
ity
 
A- Direct labeling 
B- Inverse labeling 
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Figure V. 5. CSV excel sheet in which one column contents the peak mass values whilst other 
contents their corresponding MALDI intensities. 
 
Figure V. 6. By clicking in “load labeling data” the data created as described in sections 3.3 for the 
direct (n=4) and inverse (n=4) experiments are introduced in the form of a CSV excel sheet. The 
user is also asked to introduce a value for the minimum peak intensity for which a peak will be 
considered as different from noise. 
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V.5.2.3 Third step: creating a label experiment 
At this stage, the list of in-silico peptide masses and the list of experimental m/z 
values (corresponding most likely to peptides) of the direct and inverse experiments have 
been loaded in the program. In the next step, by clicking in “create labeling experiment” a 
dialog box will appear and the user is asked to define an error margin via the “peptide 
tolerance” box. This parameter is instrument dependent and is directly linked to the 
accuracy that it is expected to obtain in the MALDI system. In our conditions, a typical 
value to be assigned to this parameter is 0.25 (corresponding to an accuracy of 0.25Da). 
Once a experimental peptide mass is matched with its theoretical value, M0, the system 
checks if the spectrum also contains that mass plus 2Da , M2, and 4Da, M4, corresponding 
to one and two 18O incorporations, respectively. The ratio between the intensities of M0 and 
M4 (Ratio I4/I0 in the dialog box) is used to discharge natural occurring peptides. This is 
because the peptides that we are comparing correspond to mixtures of labeled and non 
labeled peptides, the intensity ratios between M0 and M4 are different of the natural 
occurring M0 and M4 ratios. A typical value assigned to this parameter is 0.15. Every time 
that M0, M2 and M4 are found within the given values of 0.25 for peptide tolerance and 
0.15 for ratio M0/M4, the peptide is selected as a candidate to be considered a reproducible 
peptide. Otherwise, the mass is discharged. 
V.5.2.4 Fourth step: intersect peptides 
At this stage, the lists of masses from the direct and inverse experiments include 
only the peptide masses that (i) have matched the corresponding in-silico mass, (ii) that 
have the masses corresponding to the 2 and 4Da shift caused by the single and double 18O 
incorporation, within a given peptide mass tolerance of 0.25Da and a experimental 
overlapping of 1.00Da and (iii) that have a I4/I0 ratio over a given threshold, 0.15 in this 
case. Now the direct and inverse lists are compared to select the common masses, this is, 
the masses corresponding to peptides that are found in both direct and inverse experiments. 
In addition, a labeling ratio (
16
18
O
O
) is calculated as explained in Eq. 1 for these peptides 
taking into account the isotope mass distributions M0, M2 and M4, and the corresponding 
intensities measured in the experimental data I0, I2 and I4, respectively. By following this 
criterion, DPD software generates a list of common peptides for both direct and inverse 
Chapter V. Decision peptide-driven: a free software tool for protein quantification 
99 
samples, along with their corresponding non-label to label ratios. The ratio must reflect the 
relation between the amount of label and non-label protein as established at the beginning 
of the experiment. In our example, the amount of protein labeled was twice the amount of 
protein non-labeled, therefore the direct ratio is 0.5 (1/2), whilst the inverse ratio is 2 (2/1). 
To facilitate the comparison the DPD program shows the inverse ratio as (inverse ratio)-1, 
thus the expected values in our case are 0.5 for both ratios. In addition, the average amount 
of protein ratios is given with their corresponding relative standard deviations, RSDs. 
Finally, to find the peptides that have similar ratios in the direct and in the inverse method, 
it is needed to click in the “execute experiment” tool bar. Now the program asks which 
threshold level of RSD is required. The program compares the medium values and provides 
a relative standard deviation, RSDD&I, that arise the difference in % between the medium 
values. Thus, the peptides with direct and inverse values within a chosen difference (for 
instance less than 10%) can be easily selected for quantification, as showed in figure V.7. 
 
Figure V. 7. This figure shows the result of the execution which is a report containing the values of 
the input parameters and the generated output data including: (i) a list of peptides identified in the 
raw data input files, (ii) a list of non-labeled peptides, (iii) a list of filtered peptides, (iv) a list of 
intersection peptides and finally (v) a list of reproducible peptides, those that can be used for 
quantification.  
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In addition, the program also provides a p value. This p is obtained by comparing 
the direct and inverse ratios for each peptide. If p>0.05, then both values can be considered 
statistically non-different, and the peptide can be considered valuable for protein 
quantification. 
The software, allows the user to change the experiment parameters in order to 
perform multiple analyses on the same data. Every time the user selects the “Execute 
Experiment” button, a new result is added to the experiment containing all the information 
generated during the process. In this manner the variables “peptide mass tolerance”, 
“experimental overlapping” and ratio I4/I0 can be changed as desired. Before starting the 
execution, the user must specify the RSD threshold parameter used to highlight those 
peptides that are useful (under the statistical threshold) and those that are invalid (over the 
threshold). In our example the peptides recovered with a RSD between direct and inverse 
methods below 10% correspond to peptides YAAELHLVHWNTK and 
AVVQDPALKPLALVYGEATSR. If the RSD chosen is changed to 50% the peptides are 
now YAAELHLVHWNTK, AVVQDPALKPLALVYGEATSR, DFPIANGER and 
RMVNNGHSFNVEYDDSQDK. It is noteworthy that only two peptides can be used to 
accurately (below 10%) quantify the protein. 
V.5.3 Quantification experiment  
The user can proceed to load the data to be used for protein quantification through 
the “Load Quantification Data” toolbar button (please be sure that the file containing the in-
silico data of the protein has been introduced). The noise level (as peak intensity) parameter 
and the files containing the spectra are introduced in this step. Following our example, the 
recommended peak intensity value is 3 and the files to be introduced are named as 
Direct_1, 2, 3 and 4 corresponding to MALDI data of four independent samples of carbonic 
anhydrase provided in supplementary material. Now, by clicking in “create quantification 
experiment” the amount of internal standard used for quantification, peptide tolerance, 
ratio I4/I0 and the experimental overlapping are introduced as displayed in figure V.8. In 
our case, the following parameters were introduced: Peptide tolerance, 0.25; Ratio I4/I0, 
0.15; amount of internal standard 2.08µg. 
The detailed description of how this sample was treated is explained in the 
experimental section. Once the quantification experiment was done, a list of peptides and 
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the corresponding calculated amount of protein are generated by clicking in “execute 
experiment”.  
As in the labeling experiment, the application allows the user to change the 
experiment parameters in order to perform multiple analyses using the same data. Every 
time the user selects the “Execute Experiment” button, a new result is added to the 
experiment containing all the information generated during the process.  
Figure V. 8. DPD application showing a ready-to-run quantification experiment where the user-
defined parameters can be specified. 
The result of the execution is a report containing the values of the input parameters 
and the generated output data including: (i) a list of peptides identified in the raw data input 
files, (ii) a list of non-labeled peptides, (iii) a list of filtered peptides, (iv) a list of 
intersected peptides and (v) the protein quantification ratios. Figure V.9 shows the results of 
the experiment in the working zone panel. 
Now it is necessary only to check the peptides that have been previously identified 
as the DPD peptides, this is, the peptides that can be used for quantification. In our example 
using peptides YAAELHLVHWNTK (1581.82 m/z) and, 
AVVQDPALKPLALVYGEATSR (2198.21 m/z) the amounts of protein calculated are 
1.12µg and 0.90 µg respectively, corresponding to the amount of protein loaded into the 
gel. 
Table V.1 shows the amount of protein found for the different peptides selected in 
this work.  
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Figure V. 9. Protein quantification results computed by the DPD application once an experiment is 
executed 
Table V. 1. Peptides assigned by the DPD software as candidates for quantification of carbonic 
anhydrase. Direct labeling: 1.04µg of unlabeled protein and 2.08µg 18O-labeled protein, samples 
were mixed in a 1:1 ratio before MALDI analysis. The expected direct ratio is 0.5 corresponding to 
the unlabeled/labeled ratio (1.04/2.08). Inverse labeling: 1.04µg of 18O-labeled protein and 2.08µg 
of unlabeled protein, samples were mixed in a 1:1 ratio before MALDI analysis. Software 
parameters: Peak intensity - 3; Peptide mass tolerance ±0.25Da; experimental overlapping - 1; Ratio 
I4/I0 - 0.15. ?Significant differences between D&I ratios (p<0.05, t-test); ‡ Expected values. 
V.5.4 Merits and limitations 
The present program has been developed specifically for proteins separated by 1D-
gel electrophoresis. However the program can be potentially used for proteins separated 
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through 2D-gel electrophoresis or for proteins separated by HPLC. Another merit is the 
possibility to adapt the program to other type of labeling. The main limitation of this 
program is that it has been developed for MALDI ionization systems. 
V.6 Conclusions 
We have developed a friendly software to help in an automated mode to identify 
those peptides that have paralleled loses through a typical proteomic workflow. The use of 
such peptides allow robust and accurate quantification of proteins using 1D-gel 
electrophoresis an matrix assisted laser desorption ionization time of flight mass 
spectrometry. Those peptides have been named as “decision peptide driven”, DPD peptides.  
The software presented in this work allows for the identification of DPD peptides 
and is based in a series of steps entailing different algorithms that perform in an automated 
mode a peptide differential analysis to extract and to identify the number of peptides that 
remains constant in expression level through different sets of a typical in-gel digestion 
workflow as the one described in this work. The DPD software saves times, allowing the 
user to accurate quantify proteins in an automated mode, overcoming the long time needed 
when the treatment of data is done manually. In addition the DPD software has a wizard 
easy to follow for its installation. Furthermore, the interface has been done in an easy-to-
follow mode, and therefore the skills required for any potential operator are reduced to 
know how to apply the sample treatment procedure.  
The installation wizard is available from the DPD web site as an executable file that 
depends on the final user operating system: Windows, Linux or MAC. By executing the 
setup file, the installation wizard will be automatically launched. If the user does not have 
the required Java Runtime Environment (JRE) installed in the computer, the installation 
wizard will first install this component, and then it will continue with the DPD installation. 
The user has to simply follow the instructions on the screen to successfully complete the 
installation. 
V.7 Acknowledgements 
H. M. Santos acknowledges the doctoral grant SRFH/BD/38509/2007 provided by 
FCT (Fundação para a Ciência e a Tecnologia - Portugal). This work was partially funded 
by the project Research on Translational Bioinformatics (08VIB6) from University of 
Chapter V. Decision peptide-driven: a free software tool for protein quantification 
104 
Vigo. D. Glez-Peña was supported by a María Barbeito contract from Xunta de Galicia. M. 
Reboiro-Jato was supported by a PhD grant from Xunta de Galicia. Dr. José-Luis Capelo-
Martínez and Dr. Carlos Lodeiro are grateful to the Xunta de Galicia (Spain) for the 
program Isidro Parga Pondal and the University of Vigo for financial support under 
projects InOu-Univ.Vigo 2009-K915 and K914. Xunta de Galicia (Spain) is also 
acknowledged for financial support under project 09CSA043383PR-2009. The research 
findings here reported are protected under patent pending PCT/IB2006/052314 and PT 103 
303. 
V.8 References 
[1] J. Havlis, A. Shevchenko, Anal. Chem. 76 (2004) 3029–3036. 
[2] I. I. Stewart, T. Thomson, D. Figeys, Rapid Commun. Mass Spectrom. 15 (2001) 2456–
2465. 
[3] K. Speicher, O. Kolbas, S. Harper, D. Speicher, J. Biomol. Tech. 11 (2000) 74–86. 
[4] Y. K. Wang, Z. Ma, D. F. Quinn, W. F. Emil, Anal. Chem. 72 (2001) 3742–3750. 
[5] The Artificial Intelligence workBench [http://www.aibench.org/]. 
[6] M. Galesio, D.V. Vieira, R. Rial-Otero, C. Lodeiro, I. Moura, J. L. Capelo, J. Proteome 
Res. 7 (2008) 2097–2106. 
[7] R. Carreira, C. Lodeiro, M. S. Diniz, I. Moura, J. L. Capelo, Proteomics 9 (2009) 4974–
4977. 
[8] X. Yao, A. Freas, J. Ramirez, P.A. Demirev, C. Fenselau, Anal. Chem. 73 (2001) 2836–
2842. 
[9] D. Glez-Pena, F. Diaz, J.M. Hernandez, J.M. Corchado, F. Fdez-Riverola BMC 
Bioinformatics, In press. doi:10.1186/1471-2105-10-187 
[10] C. A. White, O. Nicomedus, A. Emili, J. Proteome Res. 7 (2009) 3653–3665. 
[11] X. D. Yao, C. Afonso, C. Fenselau, J. Proteom. Res. 2 (2003) 147–152.  
[12] J. L. Capelo, R. J. Carreira, L. Fernandes, C. Lodeiro, H. M. Santos, J. Simal, Talanta 
80 (2010) 1476–1486. 
[13] R. J. Carreira, R. Rial-Otero, D. López-Ferrer, C. Lodeiro, J. L. Capelo, Talanta, 76 
(2008) 400–406  
[14] H. M. Santos, C. Mota, C. Lodeiro, I. Moura, I. Isaac, J. L. Capelo, Talanta 77 (2008) 
870–857. 
Chapter V. Decision peptide-driven: a free software tool for protein quantification 
105 
V.9 Supplementary material 
V.9.SM.1 Step by step description for the preparation of the data to use in the 
DPD software. 
Files description:  
The file named as CA, it contains (i) the theoretical list of peptides of carbonic 
anhydrase after the in-silico digestion with trypsin and (ii) the theoretical isotopic 
distribution of those peptides.  
 
 The files named as direct 1, direct 2, direct 3 and direct 4 corresponds to 4 
different sets of carbonic anhydrase digestions (direct method 1:2).  
 The files named as inverse 1, inverse 2, inverse 3 and inverse 4, corresponds to 
different sets of carbonic anhydrase digestions (inverse method 2:1). 
 This information is free available to download on http://sing.ei.uvigo.es/DPD  
V.9.SM.2 How to obtain the in-silico digestion of a target protein 
The program you are going to work with has been specially designed for the 
quantification of target proteins through MALDI-TOF-MS. The following steps given 
below must be followed to obtain a maximum performance of the program. 
The first thing to be done is to obtain the in-silico digestion of the targeted protein. 
To proceed do as follows:  
(i) Go to swissprot data base: http://www.expasy.org/sprot/ and introduce the name 
of your protein (carbonic anhydrase II bovine) and then click go. 
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(ii) Then a new interactive menu appears, click on the accession number of the target 
protein. 
(iii) Once you had clicked in the accession number you will be prompted to the following 
menu.  
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(iv) Scroll down, until you reach “sequences”, then chose “PeptideMass” in tools and click 
“go” 
 
(v) Once you are in the page named “PeptideMass”, the following parameters are chosen: 
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The criteria to select each option, it will depend on the sample preparation used. In 
this case, protein reduction and alkylation were done so “peptide masses are with cysteines 
treated with”: Iodoacetamide. The presence of acrylamide adducts may result because of 
protein separation by SDS-PAGE. The methionines can be oxidized as a result of the 
presence of oxygen in the sample/lab atmosphere. Because we are working with MALDI 
ionization with positive polarity, the peptide peaks are mainly formed with [M+H]+ forms. 
We want to obtain the peaks as monoisotopic. The enzyme used to do the protein digestion 
was trypsin. The number of missed cleavages allowed is 1 and the preferred peptides 
masses to be obtained are bigger than 500 Da. Finally we also ask for all known 
translational modifications. Once you have introduced all the parameters of your searching, 
click in “perform”. 
The system gives you back the in-silico digestion of the protein you are interested 
in. Copy the information that is needed to create the “in-silico file”, namely the masses and 
sequences of all potential peptides formed after trypsin digestion. 
Chapter V. Decision peptide-driven: a free software tool for protein quantification 
109 
(vi) Now you should be able to prepare you excel CSV file with the columns as follows 
(this is going to take some time). You will use this file any time you need to quantify the 
targeted protein. 
 
Column A contains all the theoretical m/z values originated from the peptides obtained after 
a complete digestion of carbonic anhydrase with trypsin (including those with 1 missed 
cleavage). Column B contains the in-silico peptide sequence and Column C contains, as a 
true or false entry values, the presence (true) or not (False) of carboxyamidomethilations. 
(vii) As you may see, the excel CSV file, with the in-silico digestion also includes the 
predicted intensities of the isotopic distributions M0, M2 and M4 corresponding to each 
peptide. This information in needed for the algorithms that will calculate the isotope ratios 
of labeled to non labeled peaks. 
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V.9.SM.3 How to obtain the predicted isotopic mass distribution of the peptides  
To calculate the predicted isotopic distribution for each peptide sequence, go to: 
http://prospector.ucsf.edu/prospector/cgi-bin/msform.cgi?form=msisotope. 
For each peptide sequence there are different possibilities: normal peptide; peptide 
with carbamidomethylations (carbamidomethyl C), peptides with methionines oxidized 
(oxidation M) and peptides with acrylamide adducts (propionamide C). Do not forget, to 
indicate in the constant mode of the web page (see below) the presence of modifications. 
 
 
 
Remember to check that the monoisotopic m/z value is in agreement with the one obtained 
in the in-silico digestion for the target peptide. Copy the Values for M0, M2 and M4 and 
paste them next to the corresponding peptide in the excel CSV file of the in-silico digestion. 
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The above mentioned process to obtain the M0, M2 and M4 masses must be done for all 
peptides and for their respective modifications. The final in-silico file you should look like 
the print screen present below. 
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VI.1 Resumo 
No presente trabalho apresentamos um novo protocolo para quantificação de 
proteínas separadas por eletroforese em gel e análise por MALDI-TOF-MS. O protocolo 
proposto supera os inconvenientes da digestão em gel e analise por MALDI-TOF-MS, 
mantendo os seus benefícios. Baseando-se na separação de proteínas por eletroforese em 
gel, digestão acelerada de proteínas, marcação com 18O, quantificação com os péptidos 
previamente seleccionados através de marcação directa e inversa e por último como mais 
valia apresenta um software dedicado à escolha dos péptidos que vão guiar a quantificação 
de proteínas de modo automático  
As seguintes proteínas foram quantificadas de forma precisa, albumina de plasma 
bovino, ovalbumina, anidrase carbónica, inibidor de tripsina e α-lactalbumina. Como 
aplicação da metodologia proposta procedeu-se à quantificação de vitelogenina de Ciprinus 
carpio após exposição a níveis elevados de estrogénio. O protocolo proposto foi validado 
por comparação com ELISA, ambos apresentaram resultados comparáveis (teste não 
paramétrico Mann-whitney U). 
Palavras-chave: Quantificação de proteínas, software DPD, exactidão, vitelogenina, 
eletroforese em gel, biomarcador. 
A minha contribuição para este trabalho consistiu na elaboração do design experimental, 
execução experimental da separação de proteínas por eletroforese em gel, digestão gel, 
análise de MALDI-TOF-MS, processamento de dados, interpretação e 
desenvolvimento/teste do software. 
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VI.2 Abstract 
In the present work we report on a novel and fast protocol for accurate bottom-up 
protein quantification that overcomes the drawbacks of in-gel digestion and MALDI 
analysis, whilst maintaining their benefits. It relies on the following steps: (i) gel 
electrophoresis separation of proteins, (ii) fast in-gel protein digestion with trypsin, (iii) 
18O-labeling through the decoupled method, (iv) quantification through selected peptides 
previously chosen using the 18O-inverse labeling approach and that, finally, (v) it takes 
advantage of software specifically developed to select the peptides that will drive the 
quantification of the protein in an automated mode. We have accurately quantified the 
following six proteins: glycogen phosphorylase, bovine serum albumin, ovalbumin, 
carbonic anhydrase, trypsin inhibitor, and α-lactalbumin. As a case study we have 
quantified the protein vitellogenin in plasma of Ciprinus carpio exposed to high levels of 
estrogens. The proposed new protocol was validated against the traditional ELISA method; 
both were found to provide comparable results (non-parametric Mann-Whitney U-test).  
Keywords: Protein quantification, DPD software, accuracy, Vitellogenin, gel 
electrophoresis, biomarker. 
My contribution to this work was the elaboration of the experimental design, experimental 
execution of gel electrophoresis, in-gel digestion, MALDI-TOF-MS analysis, data 
processing, interpretation and software development/testing. 
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VI.3 Introduction 
Since the sequencing of the human genome, quantification of proteins through mass 
spectrometry, MS,-based approaches has become an important research topic in chemistry, 
biology, medicine and even chemical engineering [1-7]. The sample treatments currently 
used for protein quantification can be classified into those relying on the isotopic labeling 
of proteins and peptides or others termed as label-free approaches [4,8]. Concerning 
labeling strategies, different methods can be found in the literature. The 18O-labeling for 
quantitative proteomics is a method that has refocused the attention of the scientific 
community over recent years [9-12]. Some of the benefits claimed for 18O-labeling in 
protein quantification are the following: (i) it is a universal tag, since (theoretically) all 
peptides present in a sample are labeled; (ii) post-translational modifications remain 
unaltered; (iii) reagents involved in the labeling are not expensive; (iv) the marked peptides 
and their non-marked pairs are eluted at the same time in HPLC. However some drawbacks 
are reported: (i) the method can compare only pairs of samples, e.g. normal state versus 
disease state; (ii) the labeling cannot be done at the protein level; (iii) the degree of labeling 
depends on the reagents present in the sample and on the type on labeling done and (iv) 
back exchange with 16O may occur when labeled peptides are mixed with their unlabeled 
counterparts [13,14]. 
Recently, the use of an 18O-labeled reference sample in conjunction with high 
resolution liquid chromatography - MS has been proposed as a universal internal standard 
for quantitatively analyzing proteins in large sample sets [15]. Protein quantification with 
18O is regularly done through MS with either ESI (Electrospay Ionization) or MALDI 
(Matrix Assisted Laser Desorption Ionization) as the ionization methods [16,17]. One 
method often employed uses gel electrophoresis as protein fractionation step. After in-gel 
protein digestion the obtained peptides are labeled and used for protein identification and 
quantification It has been claimed in the literature that in-gel digestion of proteins 
compromises the accuracy of quantification by affecting the recovery of individual peptides 
and, therefore, protein estimates might be strongly influenced by the selection of the 
peptides used in the quantification process [18]. In a typical LC-ESI-MS/MS quantification 
experiment peptides are detected, selected and fragmented in real time. In the most 
common instruments MS and MS/MS scan times are selected at the beginning of a run as a 
compromise between peak intensity and the capability to analyze as many peptides as 
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possible in a chromatographic window [19,20]. In an opposite way, MALDI data 
acquisition of MS and MS/MS data is decoupled from the separation steps (2D-gel 
electrophoresis or peptide separation by Liquid Chromatography - LC). Typically, after a 
MS scan, the precursor ions are selected for MS/MS based on signal intensity, signal-to-
noise ratio or resolution, minimizing the possibility to collect redundant data [19,20]. 
However manual examination of MS spectra is recommended to improve the quantification 
accuracy [21]. Whilst literature reports that both MALDI-MS and ESI-MS produce 
consistent results, it has been also reported that ESI produce more accurate results and 
allow relatively straightforward quantification [18]. Despite some drawbacks of MALDI 
ionization, related to sample/matrix deposition and crystallization [22], preferent ionization 
of R-terminated peptides [23] and arginine-containing peptides [24], more recently it has 
been reported that LC-MALDI-MS/MS is quite accurate for quantitative proteomics using 
iTRAQ labeling in addition to be a complementary strategy to LC-ESI-MS/MS. [20] 
In the present work we report on a novel workflow for protein quantification that 
overcomes the drawbacks of in-gel digestion and MALDI analysis, whilst maintains their 
benefits. Our new method relies on the following steps: (i) SDS-PAGE separation of 
proteins, (ii) ultrasonic in-gel tryptic digestion, (iii) 18O-labeling through the decoupled 
method, (iv) quantification through selected peptides previously chosen using the 18O 
inverse labeling approach [25] and that, finally, (v) it takes advantage of software 
specifically developed to select the peptides that will drive the quantification of the protein 
in an automated mode. The proposed quantification method is presented here in a case-
study. For validation purposes a non-MS-based approach, ELISA, was also used. 
VI.4 Materials and Methods 
VI.4.1 Apparatus 
Gel Electrophoresis was performed with an electrophoresis system, model Mini-
PROTEAN Tetra Cell, from Biorad (Hercules, CA, USA), following the manufacturer’s 
instructions. Protein digestion and labeling were carried out in safe-lock tubes of 0.5 ml 
from Eppendorf (Hamburg, Germany). A minicentrifuge, model Spectrafuge-mini, from 
Labnet (Madrid, Spain), and a minicentrifuge-vortex, model Sky Line, from ELMI (Riga, 
Latvia) were used throughout the sample treatment, when necessary. A vacuum 
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concentrator centrifuge from UniEquip (Martinsried, Germany) model UNIVAPO100H 
with a refrigerated aspirator vacuum pump model Unijet II was used for (i) sample drying 
and (ii) sample pre-concentration. Milli-Q natural abundance (H216O) water was obtained 
from a SimplicityTM from Millipore (Milan, Italy). 
An ultrasonic bath, model Transsonic TI-H-5, from Elma (Singen, Germany) with 
control of temperature and amplitude was used to accelerate the gel washing, the protein 
reduction and the protein alkylation steps, and a sonoreactor model UTR200, from Dr. 
Hielscher (Teltow, Germany), was used to accelerate the enzymatic digestion step. All 
materials were used without further purification. α-Cyano-4- hydroxycinnamic acid, α-
CHCA, puriss for MALDI-TOF-MS from Fluka (Buchs, Switzerland) was used as MALDI 
matrix. ProteoMass Peptide MALDI-MS Calibration Kit (MSCAL2) from Sigma was used 
as mass calibration standard for MALDI-TOF-MS. 
VI.4.2 Standards and reagents 
Standard protein mixtures of glycogen phosphorylase 97kDa; bovine serum 
albumin, 66kDa; ovalbumin, 45kDa; carbonic anhydrase, 30kDa; trypsin inhibitor, 
20.1kDa; and α-lactalbumin, 14.4kDa; were purchased from Amersham Biosciences 
(Piscataway, USA, part number 17-0446-01). α-lactalbumin from bovine milk (≥85%) and 
trypsin, sequencing grade, were purchased from Sigma (Steinheim, Germany). Reduction 
and alkylation were carried out, respectively, with D,L-dithiothreitol (DTT, 99%) and 
iodoacetamide (IAA) from Sigma. The following reagents were used during sample 
digestion: ammonium bicarbonate buffer (AmBic, Ph 8.5, ≥99.5%) and formic acid (FA, 
~98%) from Fluka (Buchs, Switzerland); and labeling: ammonium acetate (>99.0%) from 
Fluka, calcium chloride (~97%, anhydrous) from Sigma, Mag-Trypsin from Clontech 
(USA) and H218O (97 atom%) from Isotec (Miamisburg, USA). Trifluoroacetic acid (TFA, 
99%) was obtained from Riedel-de Haäen (Seelze, Germany). 
VI.4.3 Gel electrophoresis 
Amounts of protein ranging from 0.8 to 3.6μg were dissolved in 5μL of water plus 
5μL of sample buffer (5mL of Tris-Base 0.5M, 8mL of SDS 10% w/v, 1mL of β-
mercaptoethanol, 2mL of glycerol, and 4mg of bromophenol blue in a final volume of 
20mL in water) and then boiled for 5 min to denature the proteins for sodium dodecyl 
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sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The denatured proteins were 
loaded in 10% polyacrylamide gels with 0.75mm thickness. Proteins were separated at 
120V and 400mA for 65 min. 
VI.4.4 Stain and image analysis 
The stain solution was prepared dissolving 1g of Coomassie blue R-250 in 200mL 
of a mixture of 45% (v/v) methanol, 7.5% (v/v) glacial acetic acid and 47.5% (v/v) water. 
After gel electrophoresis, gels were rinsed with Milli-Q water and then incubated for 1 h in 
the staining solution at room temperature. After incubation, the staining solution was 
removed, and the gel was rinsed with Milli-Q water and then incubated for 1.5 h at room 
temperature in the destaining solution (45% v/v methanol, 7.5% v/v glacial acetic acid, and 
47.5% v/v water). Gel imaging was carried out with a ProPicII-robot (Digilab-Genomic 
Solutions, USA), and when necessary, the robot was also used to excise the spots 
containing the proteins. 
VI.4.5 In-gel protein digestion 
Ultrasonic in-gel enzymatic digestion was done according to the ultrafast proteolytic 
digestion protocol previously developed in our laboratory [26-28]. Protein bands were 
manually excised from the gel and placed in safe-lock tubes of 0.5mL. Gel pieces were 
washed, first with AmBic 25mM/acetonitrile (100μL) and then with acetonitrile (100μL), in 
an ultrasonic bath operating at 35 kHz (100% amplitude) for 5 min for each step. 
Afterwards, the gel pieces were dried in a vacuum concentrator centrifuge for 5 min.  
Protein reduction and alkylation steps were included in the protocol to facilitate the 
enzymatic action and to increase the protein sequence coverage (%). To do so, disulfide 
bonds from cysteine residues were reduced with DTT in an ultrasonic bath operating at 
35kHz (100% amplitude) for 5min at room temperature, and then, the reduced cysteines 
were alkylated with IAA in an ultrasonic bath operating at 35kHz (100% amplitude) for 
5min at room temperature.  
After the reduction and alkylation steps, the gel was submitted again to the washing 
procedure in the same way as described above, followed by another drying step of 10min. 
Afterwards, the dried gel pieces were incubated with trypsin (375ng in 25μL) on ice for 
60min to rehydrate the gel and to allow enzyme penetration into it. Subsequently, in-gel 
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protein digestion was performed in a sonoreactor operating at 50% amplitude for 4min. 
Next, trypsin activity was stopped by the addition of 20μL of formic acid (5% (v/v)). 
VI.4.6 18O labeling: the decoupled procedure 
For the 18O-labeling, the digested peptides were reconstituted with 10μL of 25mM 
calcium chloride and 10μL of acetonitrile 20% v/v + 50mM ammonium acetate pH 6.75. 
Then the samples were vacuum re-dried, and after evaporation the dried samples were 
reconstituted in 5μL of natural abundance water or 97% 18O-enriched water and 5µL of a 
5% suspension of Mag-Trypsin in H216O or H218O were added. The digested peptides were 
labeled during 15min of vortexing and centrifugation, and finally trypsin was removed by 
magnetic separation. A detailed explanation of this procedure can be found elsewhere [28]. 
VI.4.7 Inverse 18O labeling of peptides 
Proteins were separated by 1D-PAGE and then submitted to the protocols described 
in VI.4.5 and VI.4.6. The inverse 18O labeling protocol as described by Wang et. al [25] 
was then used.  
VI.4.8 Analytical and biological sample replicates 
Eight commercial vials containing 6 standard proteins were used and two gels were 
run. For each gel, eight lines were run (one line for vial). For each protein a total of sixteen 
bands were obtained that were excised and treated. Eight bands were labeled and mixed 
with their non-labeled counterparts, giving a total of eight mixtures of label to non label 
proteins, which were grouped in two sets of four direct and four inverse samples as 
depicted in figure VI.1. Each biological replicate corresponds to nine different Cyprinus 
carpio specimens as follows: 3 control males named as Control male I, II and III; 6 exposed 
males named as Exposed male I, II, III, IV, V and VI. Plasma collected from each specimen 
was prepared in triplicate. 
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VI.4.9 Quantification of peptides 
Quantification of peptides through 18O was done with the mathematical algorithm 
for deconvolution described by Yao et al. [29]. Reduction of the spectra to a centroided plot 
was done using the centroiding option function of the Data ExplorerTM software (version 
4.0) from Applied Biosystems. This function is an advanced peak filtering method that 
improves the quality of mass spectral data and reduce data file size. Profile data, in which 
many points are used to delineate a mass spectral peak, is converted into mass-centroided 
data by a data compression algorithm. The centroided mass peak is located at the weighted 
center of mass of the profile peak. The normalized area of the peak provides the mass 
intensity data. 
 
Figure VI. 1. Schematic diagram illustrating steps of the sample treatment workflow including 
gel electrophoresis, labeling, protein identification, DPD analysis of the D&I data that allows 
the best choice of peptides for quantification and finally the DPD quantification experiment. 
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VI.4.10 Case study 
VI.4.10.1 Plasmatic vitellogenin from Cyprinus carpio 
Vitellogenin (Vtg) is an egg yolk phospholipo-glycoprotein that is secreted by the 
liver of oviparous vertebrates. It is usually restricted to females but it can be induced in 
males and juveniles by exposure to estrogens. Vtg is a large (300 to 600kDa native or 160 
to 200kDa subunit) serum phospholipo-glycoprotein that serves as the major precursor to 
the egg-yolk proteins of oviparous vertebrates [30].  
Carp (Cyprinus carpio) males were placed indivudually in 15L polyestyrene tanks 
supplied with de-chlorinated tap water (temperature: 15±2ºC; pH 7.4±0.2; dissolved oxygen 
>6mgL-1). Vtg synthesis was induced by a single intraperitoneal injection of 17?-estradiol 
(Sigma, USA),dissolved in PBS (1% absolute ethanol) at a concentration of 5mg/Kg body 
weight (bw; positive control), and vehicle (negative control), respectively. After 48hours, 
blood was taken from the caudal vein of each treated fish using a heparinized syringe, 
treated with 4TIU/mL of Aprotinin (Sigma, USA), and centrifuged immediately for 15min 
at 4,000xg (4ºC) to obtain the plasma. Samples were stored at –80ºC until further analysis 
of Vtg. 80μL of plasma from Cyprinus carpio was diluted to 100μL with cold PBS 
(Phosphate Buffer Solution). 300μL of -20ºC cold acetone was added to the diluted plasma 
solution and kept overnight on ice. The sample was centrifuged at 10000g, 4ºC for 30min. 
The supernatant was removed and the pellet was suspended in 100μL of buffer (10mM 
Tris-HCl pH 7.4; 2% of SDS; 1% of β-mercaptoethanol). 
Amounts of precipitated plasma (5μL) were mixed with 5μL of sample buffer (5mL 
of 0.5M Tris-Base + 8mL of 10% SDS + 1mL of β-mercaptoethanol + 2mL of glycerol + 
4mg of bromophenol blue in a final volume of 20mL in water) for analysis by sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) (7.5% 0.75mm 
thickness). After gel electrophoresis (65min, 120V, 400mA), the gel was stained with 
Coomassie blue R-250 and destained in order to visualize the proteins bands. Vitellogenin 
was in-gel digested according to the accelerated method described in VI.4.5.
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VI.4.10.2 ELISA vitellogenin quantification in Cyprinus carpio fish 
plasma 
The synthesis of vitellogenin (Vtg) was confirmed and quantified by direct enzyme 
linked immunosorbent assay (ELISA) as described in Diniz et al. [31]. Briefly, following 
dilution, at least 1:200 for males and 1:1000 for females, the samples were pipetted (50?L) 
in triplicate into a Maxisorp F96 microtiter plate (Nunc-Roskilde, Denmark) and incubated 
overnight at 4ºC. After that, the microplate was washed with PBS-Tween and 280?l of 
blocking buffer (1% BSA in PBS with 0.02% sodium azide) was added to microplate wells 
to block free binding sites. The microplate was incubated overnight (4ºC) and then re-
washed. The microplate was coated (50?l) with a monoclonal antibody against carp Vtg 
(Biosense, Bergen, Norway), diluted to an appropriate concentration (0.1-5?g/mL), and 
then incubated overnight at 4ºC. After plate washing, 100?L of a secondary antibody (goat-
antimouse  immunoglobulin-IgG conjugated to alkaline phosphatase, Sigma, USA), diluted 
in a blocking buffer (1:1000), was added to each well and incubated for a further 60 min. at 
38ºC. 
After a final washing step, 100?L of the substrate (p-nitro-phenylphosphate – 
PNPP, SIGMA-Aldrich) was added to each microplate well and incubated at room 
temperature (10-30min) in the dark. A standard carp Vtg (Biosense, Norway) was diluted to 
give a range from 15 to 1000ngmL-1 and a calibration curve was constructed allowing the 
quantification of Vtg in plasma samples. Then the enzyme reaction was stopped by adding 
50?L of stop solution (3N NaOH). The plates were read in a 96-well microtiter plate reader 
(BioRad-Benchmark, USA) at 405nm. 
VI.4.11 MALDI-TOF-MS analysis 
Prior to MALDI-TOF-MS analysis, the sample was mixed with the matrix solution. 
α-CHCA matrix was used throughout this work and was prepared as follows: 10mg of α-
CHCA was dissolved in 1mL of Milli-Q water/acetonitrile/TFA (1mL/1mL/2μL). Then, 
4μL of the aforementioned matrix solution was mixed with 4μL of sample and the mixture 
was shaken in a vortex for 30s. One microlitre of each sample was hand spotted in a well of 
a MALDI-TOF-MS sample plate and allowed to dry. 
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A MALDI-TOF-MS system model Voyager DE-PRO Biospectrometry Workstation 
equipped with a nitrogen laser (λ= 337 nm) from Applied Biosystems (Foster City, CA) 
was used to acquire the PMFs. Measurements were done in reflector positive ion mode, 
with a 20kV accelerating voltage, 75.1% grid voltage, 0.002% guide wire and a delay time 
of 100ns. Two close external calibrations were performed with the monoisotopic peaks of 
the bradykinin fragment 1-7, angiotensin II, P14R, and ACTH peptide fragments (m/z: 
757.3997, 1046.5423, 1533.8582, and 2465.1989, respectively). Monoisotopic peaks were 
manually selected from each of the spectra obtained. Mass spectral analysis for each sample 
was based on the average of 500 laser shots.  
VI.4.12 Software distribution 
Current versions of the software and their supporting user manuals are freely 
available for downloading and use with Windows, Mac or Linux software, without 
restriction, via internet at http://sing.ei.uvigo.es/DPD. This program operates on MS Excel 
CSV files with centroid mass and relative intensity data extracted from the Data 
ExplorerTM. The program was developed based on previous work related to cancer 
diagnosis [32] and on suggestions given by the Bioscope group. 
VI.5 Results and Discussion 
VI.5.1 Sample treatment workflow 
A schematic diagram illustrating the sequential steps of the sample treatment 
workflow is presented in figure VI.1. Proteins were separated through 1D gel 
electrophoresis. Samples were loaded into the gel at different concentrations covering a 
range inclusive of the commonly accepted thresholds for defining biological significance 
and they were 1:2, 2:1 and 1:5 [33]. After ultrasonic protein digestion [26,27] the pool of 
peptides was dried and reconstituted in normal water or in 97% 18O water[13,34]. Labeling 
of peptides can be done faster by doing the so called proteolytic labeling [35]. However, 
work previously developed in our laboratory has shown that the post-proteolysis labeling of 
peptides performs better since both the ratio of total peptides labeled (single+doubled) and 
the ratio of peptides double labeled are higher [28,35]. Finally the labeled samples are 
mixed as described in figure VI.1 to perform the so-called inverse labeling [25]. With this 
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procedure two converse labeling experiments are performed in parallel as follows. In the 
“direct” labeling, the sample is reconstituted in normal water whilst its counterpart of 
higher amount (i.e. 1:2, 1:5) is reconstituted in 18O-water. In the “inverse” method the 
labeling is done conversely. Finally, an equal sample volume of non-labeled and its labeled 
counterpart are mixed and analysed through MALDI-TOF-MS. The ratios of the relative 
intensities of the 16O peaks and the 18O peaks are used then in the final step of the 
workflow, as it is showed in figureVI.1. In this step, the software DPD (Decision Peptide 
Driven) compares the labeled to unlabeled ratios of the same peptides obtained in the 
“direct” and “inverse” (D&I) methods. Only those peptides having the D&I ratios within a 
given RDS and p significance level (t-test) are used for protein quantification. 
VI.5.2 Finding out the best peptides for protein quantification 
Protein quantification which relies on the in-gel digestion of proteins presents 
several pitfalls. Thus, it has been demonstrated that the recovery of in-gel digestion was 
rather low when compared to in-solution digestion and enabled no accurate absolute or 
relative estimates of proteins [18]. Furthermore, the observed recoveries of individual 
peptides vary strongly within a set of in-gel digests, leading to a high RSD of the measured 
amounts of proteins. In addition to these drawbacks, it has been stressed in the literature 
that biased losses of peptides might occur during the post-digestion sample processing of 
in-gel digests. [18,36,37]. Despite these problems and based on our own work and that from 
other laboratories we hypothesised that, for each protein, it might be possible to identify a 
certain number of peptides that might have low and paralleled loses through a typical 
proteomic workflow, and that therefore, using these, a robust and accurate protein 
quantification might result. 
Since the goal of our approach was a peptide differential analysis and to extract and 
to identify the number of peptides remaining constant in expression level through a typical 
in-gel digestion workflow, any method that enables analysis of peptide signals within 
replicates would be of great value. 
The approach that best fits the goal described above is the method proposed by 
Wang et al. and called “inverse labeling” [25]. With this procedure it is easily detected if a 
peptide is randomly lost, or the observed recoveries of individual peptides vary strongly 
within a set of in-gel digests. In addition, further information is also provided with this 
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approach as follows. One underlying assumption of 18O labeling is that the digestion 
efficiency remains constant regardless of the amount of protein loaded in the gel. 
Otherwise, the amount of protein derived from different samples would be falsified. 
Comparing the media value of the “direct” and “inverse” (D&I) experiments this 
methodology can be used to unambiguously verify the recovery of peptides obtained during 
in-gel protein digestion at different concentrations, and thus it can clearly illustrate which 
peptides can be used for quantification through a given dynamic range of differential 
quantification. 
To facilitate the comparison of the D&I labeling, a dedicated software, named 
Driven Peptide Decision, DPD, was developed as a computer tool to extract and to identify 
the peptides which remain constant in expression level throughout a typical in-gel digestion 
work-flow. It allows rapid identification of target marked peptides and unambiguous 
identification of peptides that exhibit the characteristic inverse labeling pattern of a 4Da 
mass shift. The DPD software analyzes the experimental data to identify the peaks that 
match with the in-silico (theoretical) digestion of the protein within a given m/z tolerance 
and intensity threshold. The program also uses an algorithm to find out the peaks 
corresponding to unlabeled peptides, which are consequently discharged. Another 
algorithm also rejects overlapping peptides resulting from the 4Da gained in the labeling 
process.  
In the following example we demonstrate how our sample treatment and the 
associated DPD software work together. Glycogen phosphorylase was submitted to the 
workflow depicted in figure VI.1, and the obtained MS-data was used as input to the DPD 
program. The complete list of peaks and their intensities obtained with the MALDI for this 
set of experiments is given in the web page http://sing.ei.uvigo.es/DPD (supplementary 
material VI.9.SM.1, n=4, files are named as “inverse” and “direct”). 
The list of peaks (a total of 13) belonging to peptides that might be used for 
quantification by the DPD program, are shown in table VI.1. Since the ratio used when the 
protein was loaded in the gel was 1:2 for the “direct” experiment and 2:1 for the “inverse” 
experiment, the expected ratios should be 0.5 and 2 respectively. For simplicity, the 
“inverse” ratio is given in table VI.1 as (inverse ratio)-1. In this way both ratios are expected 
to be the same, 0.5, and therefore the comparison between the D&I methods is more easily 
carried out. We have defined a, RSDD&I, that expresses (in %) the difference between the 
values obtained for the D&I ratios. 
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As can be seen in Table VI.1, the relative standard deviation of the ”direct” or 
“inverse”, RSDD&I, ratios can be used to track the robustness of the sample treatment for 
each peptide. 
Table VI. 1. Peptides assigned by the DPD software as candidates to be used for quantification of 
glycogen phosphorylase, muscle from Oryctolagus cuniculus. Direct labeling: 0.84µg of unlabeled 
protein and 1.68µg of 18O-labeled protein, samples were mixed in a 1:1 ratio before MALDI 
analysis. The expected direct ratio is 0.5 corresponding to the unlabeled/labeled ratio (0.84/1.68). 
Inverse labeling: 0.84µg of 18O-labeled protein and 1.68µg of unlabeled protein, samples were 
mixed in a 1:1 ratio before MALDI analysis. The expected inverse ratio is 2 corresponding to the 
unlabeled/labeled ratio (1.68/0.84). (note: the inverse ratio is expressed in the table as (inverse 
ratio)-1 for simplicity. In this way the direct and inverse ratios may be compared easily since both 
have the same value of 0.5). For the direct method the amount of protein calculated was the lower 
of 0.84µg whilst for the inverse method was the higher of 1.68µg. DPD software parameters: Peak 
intensity - 5; Peptide mass tolerance ± 0.25Da; experimental overlapping - 2; Ratio I4/I0 - 0.15. 
?Significant differences between D&I ratios (p<0.05, t-test). n=4; ‡ Expected values. 
 
Thus the peptides IGEEYISDLDQLR, QRLPAPDEK, ARPEFTLPVHFYGR, and 
LLSYVDDEAFIR are recovered with a reproducibility of within a relative standard 
deviation, RSDD&I, of less that 15% (n=4) and no statistical differences were found between 
both D&I experiments (p>0.05, t-test.). Those results indicate that these peptides have 
losses and average yields of digestion that are paralleled through different sets of in-gel 
digestions and that the yields of digestion are the same within ratios of 1:2 or 2:1. Peptides 
IGEEYISDLDQLRK, GYNAQEYYDRIPELR and EIWGVEPSR are recovered with a 
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RSDD&I of between 30% and 45% and significant differences were found from the D&I 
labeling experiments (pD&I<0.05), whilst peptides QIIEQLSSGFFSPK, 
GLAGVENVTELKK, TCAYTNHTVLPEALER, DYYFALAHTVR are recovered with a 
RSDD&I of between 45% and 50% and significant differences were also found from the 
D&I labeling experiments (pD&I<0.05). Finally, peptides VAAAFPGDVDR and 
DIVNMLMHHDRFK are recovered with a RSDD&I higher than 60% and significant 
differences were found from the D&I labeling experiments (pD&I<0.05).The high RSDs and 
the low p-values obtained for the aforementioned peptides reveal that they cannot be used 
as potential peptides for the quantification of glycogen phosphorylase, as shown in Table 
VI.1. The advantage of the proposed approach is easily shown by comparing protein 
quantification by the DPD method, with the quantification commonly done by approaches 
relying on the peptides with the highest intensities in the MALDI spectra. Thus, taking the 
four peptides showing the most intense peaks in the MALDI spectrum of glycogen 
phosphorylase, see figure VI.2. 
 
Figure VI. 2. MALDI-TOF-MS spectra of glycogen phosphorylase obtained for the direct (0.84µg 
of unlabeled protein and 1.68µg of 18O-labeled protein, samples were mixed in a 1:1 ratio before 
MALDI analysis) and inverse labeling (0.84µg of 18O-labeled protein and 1.68µg of unlabeled 
protein, samples were mixed in a 1:1 ratio before MALDI analysis). ?peptides assigned by the DPD 
software, § indicates the peptides used for the quantification with the most intense peaks and ?§ 
indicates peptides that were simultaneously assigned by DPD and are the most intense peaks. 
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The experimental values calculated for 0.84µg and 1.68µg of protein are 1.0±0.2µg 
(RSD 20%), and 2.1±0.7µg (RSD 33%) respectively whilst using the DPD program the 
values obtained are 0.79±0.06 (RSD 8%) and 1.7±0.02 (RSD 12%). 
As a further example, Table VI.2 shows the differences in the accuracy obtained 
calculating the amount of six different proteins using (i) the peptides addressed by the DPD 
approach or (ii) the four peptides with the most intense peaks in the MALDI spectrum. Data 
shown in table VI.2 further confirms that only the DPD approach can guarantee accuracy. 
In addition table VI.9.SM.2 of supplementary material, shown the peptides used for 
quantification for each protein for the DPD and the most intense peaks-based method 
respectively, along with their relative intensities. In supplementary material VI.9.SM.3 
shown the peptides assigned by the DPD software as candidates of bovine serum albumin, 
ovalbumin, carbonic anhydrase, trypsin inhibitor and α-lactalbumin. 
Table VI. 2. Amounts of different proteins loaded into the 1D-gel for the direct and inverse labeling 
and the respective quantification using (i) the DPD methodology, (ii) the most intense peak of the 
mass spectra and (iii) the four most intense peaks of the mass spectra. For the quantification done 
with the DPD methodology the number of peptides used is indicated between branches. 
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The strength of the DPD procedure lies in that, instead of looking for the ±2/4Da 
isotope pair and quantitatively calculating the ratio 16O to 18O signals for every peptide, one 
only needs to compare the two data sets and identify those peptides whose ratios ”direct” 
and ”inverse” remains unaltered. This is achieved rapidly and automatically using the DPD 
approach. In addition, this experiment is required only once for a given protein, since the 
selected peptides will drive the quantification of the protein from which they originated. 
Figure VI.3 shows the number of peptides obtained with the DPD approach for the 
proteins bovine serum albumin, ovalbumin, carbonic anhydrase, trypsin inhibitor and α-
lactalbumin. The accuracy and precision of the quantification was excellent for all cases, 
when the peptides with p>0.05 (those included in groups named as I) were used, indicating 
the robustness of the procedure. One finding was that, as the size of the protein increases, 
so does the number of “DPD peptides” as well. 
VI.5.3 The use of “DPD peptides” as internal standards 
As explained above, the DPD method allows for fast and unambiguous 
identification of peptides that can be used for the accurate quantification of proteins. Such 
peptides have losses and yields of digestion that are paralleled in different sets of the same 
sample treatment workflow within a given range amount of protein loaded in the gel.  
Once the peptides are known, they can be used as internal standards in further 
quantifications of the protein. This means that the DPD method is required only once for 
each protein of interest. It should be noted that an internal standard must have some crucial 
intrinsic properties, such as that it behaves in a similar manner to the authentic sample 
although the conditions of sample preparation may change over a wide range [38]. This is 
the case for the “DPD peptides”. They can be used as internal standards because their 
recoveries after digestion, their losses and their sample deposition and crystallization 
behaviour in MALDI remain constant over a wide range of protein concentration. 
To demonstrate this, 0.4, 1 and 2µg of BSA, carbonic anhydrase and α-lactalbumin 
were loaded into a 1D-gel. 2µg of each protein was also loaded to act as internal standard in 
the labeling experiments. Then proteins were separated by electrophoresis, the gel bands 
were excised and in-gel digested. A three-fold or greater difference in expression levels is 
generally considered to be statistically significant [39]. 
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Figure VI. 3. Results obtained with the DPD approach for glycogen phosphorylase, bovine serum 
albumin, ovalbumin carbonic anhydrase, trypsin inhibitor and α-lactalbumin. Panels A, C, E, G, I 
and K: x-axes shows the RSD of the direct (blue colour) and inverse experiments (red colour), 
RSDD&I. Peptides are grouped as a function of the RSDD&I and only those included in the group 
named (I), can be used for accurate quantification. As an example in panel A, (I) means that four 
peptides can be used for accurate quantification. The expected direct and inverse ratios are 0.5 for 
all proteins except for α-lactalbumin for which the expected ratio is 0.75. Insets B, D, F, H, J and 
L show the quantification results obtained for each protein using the peptides included in each 
group. For instance, in inset B, the amount of protein is calculated four times. Each value is 
named as (I), (II), (III) and (IV) and correlates with the group of peptides with the same letters that 
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were used for the calculation. 
We chose, however, a higher difference. Equal volumes of digested protein (0.4, 1 
and 2µg) and their corresponding internal standard (2µg) were mixed obtaining 1:5, 1:2 and 
1:1 mixtures of protein/18O-labeled internal standard. As can be seen in figure VI.4 the 
calculated amounts of protein were in excellent agreement with their expected values. 
 
Figure VI. 4. DPD protein quantification of 2, 1 and 0.4µg of (1) bovine serum albumin, 
(2) carbonic anhydrase and (3) α-lactalbumin. The quantification was carried out with 
different ratios of protein/18O-labeled internal standard, 1:1, 1:2, 1:5. No statistical 
differences were found between the calculated value and the amount of protein loaded on 
the 1D-gel (p>0.05, t-test, n=4). 
VI.5.4 A case study: quantifying 17?-estradiol-induced vitellogenin in fish 
Endocrine disruptor compounds, EDCs, are a group of chemicals present in sewage 
effluents [31,40]. EDCs can simulate the action of estrogens in some living organism, such 
as fish. One of the most sensitive responses to estrogens in fish is the induction of 
vitellogenin (Vtg), which is used as a biomarker of exposure to estrogenic chemicals in an 
aquatic environment [41]. Vtg is a phospholipoglycoprotein synthesized in all oviparous 
liver vertebrates. It serves as the major precursor to the egg yolk proteins [31]. In other 
words, this protein is expected to be at high concentration in mature females. The gene for 
Vtg is found in the liver of females but also in males, so Vtg production can be activated 
when males are exposed to EDCs [30]. 
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The effects of the estrogen in the exposed males can be seen in figure VI.5, as an 
increment in the intensity of the gel band corresponding to a plasma sample of exposed 
males (lanes G and H), if the Vtg band is compared to its counterpart in non-exposed males 
(lanes E and F). This indicates a clear Vtg over-expression response to a single 
intraperitoneal injection of 17?-estradiol.  
 
Figure VI. 5. 1D-gel electrophoresis of A- molecular weight marker; B-1µg of Cyprinus carpio 
vitellogenin standard; C- Precipitated plasma with MgCl2/EDTA method (250µL of plasma were 
precipitated and the resulting pellet was reconstituted in 5µL of sample buffer and loaded on the 
gel); D- Plasma precipitated with the acetone method (80µL of plasma were precipitated and the 
resulting pellet was reconstituted in 100µL of sample buffer and diluted 1:2 before loading on the 
gel); E and F- Plasma from control males (non-exposed) precipitated by the acetone method; G and 
H- Plasma from exposed males precipitated by the acetone method (dilution 1:50). 
To show the great potential of the proposed DPD method, we studied the effects of 
EDCs in fish, focusing on the identification and quantification of the Vtg protein. Plasma 
from male Cyprinus carpio exposed and non-exposed to EDCs was collected as described 
in the ample treatment section. Since plasma is a complex protein mixture, we followed two 
protocols of protein precipitation, one with Cl2Mg/EDTA and other with acetone, to obtain 
the best subsequent separation of the target protein by 1D-PAGE. Both methods are 
described in detail in the supplementary material section (VI.9.SM.4). 1D-PAGE of 
Cyprinus carpio plasma submitted to both protein precipitation protocols is shown in figure 
VI.5, where it may be seen that the most intense bands of Vtg were obtained after protein 
precipitation with the acetone protocol, which was consequently chosen for further 
Chapter VI. A novel 18-O inverse labeling-based workflow  
137 
experiments. Next, the DPD approach was run using standards of Vtg to identify the 
peptides that could be used to perform subsequent accurate Vtg quantification. The results 
of the DPD software for Vtg are shown in table VI.3. 
Table VI. 3. Peptides assigned by the DPD software as candidates for quantification for 
vitellogenin from Cyprinus carpio. Direct labeling: 1µg of unlabeled protein and 2µg 18O-
labeled protein, samples were mixed in a 1:1 ratio before MALDI analysis. The expected 
direct ratio is 0.5 corresponding to the unlabeled/labeled ratio (1/2). Inverse labeling: 1µg 
of 18O-labeled protein and 2µg of unlabeled protein, samples were mixed in a 1:1 ratio 
before MALDI analysis. The expected inverse ratio is 2 corresponding to the 
unlabeled/labeled ratio (2/1). (note: the inverse ratio is expressed in the table as (inverse 
ratio)-1 for simplicity. In this way the direct and inverse ratios may be compared easily 
since both have the same value of 0.5). For the direct method the amount of protein 
calculated was the lower of 1µg whilst for the inverse method was the higher of 2µg. DPD 
software parameters used: Peak intensity - 5; Peptide mass tolerance ±0.25Da; experimental 
overlapping - 2; Ratio I4/I0 - 0.15. ?Significant differences between D&I ratios (p<0.05, t-
test). 
Peptides with RSDD&I below 15% used for quantification were 
AYLAGAAADVLEIGVR, LELEVQVGPR, ALHPEVR, FLGNAVPPVFAVIAR and 
FVQLIQLLR. Finally, we proceeded to quantify the Vtg protein in exposed and non-
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exposed males using the peptides obtained through the DPD method as internal standards. 
Therefore, we run in the same gel a Vtg standard of known concentration to be used as 
internal standard, along with plasma samples of exposed and non-exposed males. Gel 
pieces of the same size were then excised and treated as described in the sample treatment 
section. Samples were reconstituted in 16O water, unless the Vtg standard that was 
reconstituted in 18O-water. Then, the 18O-label Vtg peptides were used as internal standards, 
by mixing them with the same volume of unlabeled samples. The MALDI mass spectrum 
thus obtained (figure VI.6), was used for Vtg quantification. This can be automatically done 
with the DPD program.  
Figure VI. 6. MALDI mass spectrum obtained for the quantification of Vtg (0.5µg of 18O-labeled 
internal standard).? DPD-peptides 
The advantage of this procedure, as explained throughout all this manuscript, is that 
using the “DPD peptides” any selective peptide extraction, different yields of digestion or 
biased losses of peptides due to digestion or post-digestion sample processing are paralleled 
for all samples. To further validate the proposed methodology, we developed in parallel the 
analysis of the same samples through the traditional ELISA procedure. Results of Vtg 
quantification for exposed and non- exposed males using both DPD and ELISA procedures 
are shown in Table VI.4.  
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Table VI. 4. Quantification of Vtg from Cyprinus carpio fish plasma by enzyme-linked 
immunosorbent assay (ELISA) and by DPD. Nonparametric Mann-Whitney U-test: no 
statistical differences were found between both quantitation methods. 
 
 In literature has been described non-parametric statistics tests-based approaches to 
compare results from differential protein abundance by MS and liquid chromatography, 
[42,43]. In our case, a nonparametric Mann-Whitney U-test shows that no statistical 
differences between both quantitation methods were present. As a further example, if the 
Paired t-test is here applied considering each Cyprinus carpio as a test sample, we may 
think in nine independent samples with 3 replicates for each one, and therefore we may use 
the paired t-test to compare the methods. The paired t-test described above does not require 
that the precision of the two methods are equal, as it is our case. Results reveals a calculated 
t value of 0.088 well below the critical value of 4.30 (P = 0.05). This means that the 
methods do not give statistically different media for the vitellogenin concentrations. The 
above cited results are excellent and reveal the great potentiality of the DPD approach. One 
further point worth remembering - the ELISA method can only be performed if the 
antibody of the protein to be quantified exists. The DPD approach is without such a 
limitation. The results confirm that the amount of protein obtained using the two 
methodologies are of the same magnitude. 
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VI.5.5 Merits and limitations 
The method described in this work, named as DPD, allows the identification of 
peptides for which selective extraction, different recoveries after digestion or biased losses 
due to digestion or post-digestion sample processing of gel bands are paralleled in different 
experimental sets. In addition, as demonstrated by the experimental data, the DPD peptides 
behave in the same manner in MALDI, so shot-to-shot, region-to-region and sample-to-
sample reproducibility are guaranteed. Those peptides allow for accurate quantification of a 
target protein in an automatic mode. The DPD strategy can be extended to other labeling 
methods to achieve the same goal of fast and accurate protein quantification. Although 18O-
labeling has the drawbacks that isotope enrichment may not be 100%, and that 
incorporation of the isotope may never go to completion. In our laboratory, however, we 
have demonstrated [35] that the decoupled labeling approach offers a unique method to 
obtain almost complete labeling. This is that the case since labeling is carried out in an 
environment 97% rich in 18O-water, and that when the peptides are reconstituted in this 
environment, the double oxygen incorporation reaches a value higher than 90% for almost 
all peptides, as shown in table VI.5. Therefore, the concentration of peptides that are not 
labeled or that only incorporate one oxygen may be considered residual, and therefore the 
accuracy of the method does not suffer. In addition, the utilization of algorithms to correct 
failed or incomplete labeling, necessary when the oxygen incorporation is done directly, are 
not necessary here. 
A further advantage of this protocol is the total automation of the quantification 
process, once the “DPD peptides” have been selected. A minor but ever present constraint 
is decidedly the 2-fold reduction in sensitivity, since two experiments (direct and inverse) 
are necessary thus halving the available sample. However, the advantages cited above 
overwhelmingly outweigh this loss in sensitivity. Furthermore, in typical proteomic studies 
the limiting factor is often handling capacity rather than material supply.  
VI.6 Conclusions 
A new method for bottom-up protein quantification termed decision peptide driven, 
DPD, has been established and experimentally validated. The methodology, which employs 
the combination of in gel-protein separation, in-gel proteolytic digestion, 18O peptide 
labeling and the inverse labeling strategy, has been demonstrated successfully in the fast 
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and accurate quantification of seven different proteins. Furthermore, the DPD approach has 
been applied with success to study the effects of high concentration levels of estrogens on 
Ciprinus carpio males. To do so, protein Vtg, a biomarker of exposure to high levels of 
estrogens, was accurately quantified using the DPD method. The DPD method necessitates 
only the identification of peptides with paralleled losses and similar digestion yields 
through different in gel-digestion sets. Using these peptides accurate quantification of the 
protein is achieved. Suitable software has been also developed to automate the task. The 
methodology described here can be used to provide a quick and automated quantification of 
proteins that are differentially expressed, to elucidate drug action mechanisms or to study 
drug toxicity. Proteins that are differentially expressed upon a drug treatment are also 
potentially quantified. Finally, this approach can be also applied to other bottom-up 
strategies with off-gel based protein separation. 
Table VI. 5. Relative labeling efficiency of peptides formed by the tryptic digestion of 
vitellogenin and postdigestion labeling in the presence of 97% H218O. 
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VI.9. Supplementary material 
VI.9.SM.1 Glycogen phosphorylase muscle from Oructolagus cuniculus 
Data to run the DPD software for glycogen phosphorylase. The in-silico data (mass, 
in-silico peptide sequence, presence of carbamidomethylation of cysteines, and values of 
the isotopic distribution of the peptide I0, I2 and I4 used to calculate the ratios). 
This information is available in the web page http://sing.ei.uvigo.es/DPD  
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VI.9.SM.2. Comparison of the DPD peptides and the 4 most intense peaks in the 
mass spectra for all the proteins studied. Peak intensities of each peak are shown in 
branches 
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VI.9.SM.3 Peptides assigned by the DPD software as candidates of bovine 
serum albumin, ovalbumin, carbonic anhydrase, trypsin inhibitor and α-lactalbumin 
VI.9.SM.3. 1. Peptides assigned by the DPD software as candidates for quantification of BSA. 
Direct labeling: 1.04µg of unlabeled protein and 2.08µg 18O-labeled protein, samples were mixed in 
a 1:1 ratio before MALDI analysis. The expected direct ratio is 0.5 corresponding to the 
unlabeled/labeled ratio (1.04/2.08). Inverse labeling: 1.04µg of 18O-labeled protein and 2.08µg of 
unlabeled protein, samples were mixed in a 1:1 ratio before MALDI analysis. Software parameters: 
Peak intensity - 3; Peptide mass tolerance ±0.25Da; experimental overlapping - 2; Ratio I4/I0 - 
0.15. ?Significant differences between D&I ratios (p<0.05, t-test); ‡ Expected values 
 
 
VI.9.SM.3. 2. Peptides assigned by the DPD software as candidates for quantification of 
ovalbumin. Direct labeling: 1.84µg of unlabeled protein and 3.68µg 18O-labeled protein, samples 
were mixed in a 1:1 ratio before MALDI analysis. The expected direct ratio is 0.5 corresponding to 
the unlabeled/labeled ratio (1.84/3.68). Inverse labeling: 1.84µg of 18O-labeled protein and 3.68µg 
of unlabeled protein, samples were mixed in a 1:1 ratio before MALDI analysis. Software 
parameters: Peak intensity - 5; Peptide mass tolerance ±0.25Da; experimental overlapping - 2; Ratio 
I4/I0 - 0.15. ?Significant differences between D&I ratios (p<0.05, t-test); ‡ Expected values 
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VI.9.SM.3. 3. Peptides assigned by the DPD software as candidates for quantification of carbonic 
anhydrase. Direct labeling: 1.04µg of unlabeled protein and 2.08µg 18O-labeled protein, samples 
were mixed in a 1:1 ratio before MALDI analysis. The expected direct ratio is 0.5 corresponding to 
the unlabeled/labeled ratio (1.04/2.08). Inverse labeling: 1.04µg of 18O-labeled protein and 2.08µg 
of unlabeled protein, samples were mixed in a 1:1 ratio before MALDI analysis. Software 
parameters: Peak intensity - 2; Peptide mass tolerance ±0.25Da; experimental overlapping - 2; Ratio 
I4/I0 - 0.15. ?Significant differences between D&I ratios (p<0.05, t-test); ‡ Expected values 
 
 
VI.9.SM.3. 4. Peptides assigned by the DPD software as candidates for quantification of trypsin 
inhibitor. Direct labeling: 1.0µg of unlabeled protein and 2.0µg 18O-labeled protein, samples were 
mixed in a 1:1 ratio before MALDI analysis. The expected direct ratio is 0.5 corresponding to the 
unlabeled/labeled ratio (1.0/2.0). Inverse labeling: 1.0µg of 18O-labeled protein and 2.0µg of 
unlabeled protein, samples were mixed in a 1:1 ratio before MALDI analysis. Software parameters: 
Peak intensity - 2; Peptide mass tolerance ±0.3Da; experimental overlapping - 2; Ratio I4/I0 - 0.15. 
?Significant differences between D&I ratios (p<0.05, t-test); ‡ Expected values 
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VI.9.SM.3. 5. Peptides assigned by the DPD software as candidates for quantification of α-
lactalbumin. Direct labeling: 2.18µg of unlabeled protein and 2.90µg 18O-labeled protein, samples 
were mixed in a 1:1 ratio before MALDI analysis. The expected direct ratio is 0.75 corresponding 
to the unlabeled/labeled ratio (2.18/2.90). Inverse labeling: 2.18µg of 18O-labeled protein and 
2.90µg of unlabeled protein, samples were mixed in a 1:1 ratio before MALDI analysis. Software 
parameters: Peak intensity - 2; Peptide mass tolerance ±0.3Da; experimental overlapping - 2; Ratio 
I4/I0 - 0.15. ?Significant differences between D&I ratios (p<0.05, t-test); ‡ Expected values 
VI.9.SM.4 Protein precipitation methods 
VI.9.SM.4.1 Precipitation with Cl2Mg/EDTA 
A 250 µl of plasma sample were gently mixed with 1 ml of 20 mM Na2EDTA and 
80 µl of 0.5 M of MgCl2 and centrifuged at 2500g for 15 min. The supernatant was 
discarded and the pellet containing vitellogenin was suspended in 150 µl of 1M NaCl, 50 
mM TriS-HCl (pH 7.5) and then centrifuged at 2500g for 30 min. The supernatant was 
removed to another centrifuge tube, and the vitellogenin was precipitated with 1.24 ml of 
water and centrifuged at 2500g for 15 min. The resulting pellet of purified vitellogenin was 
suspended in 5 µl of buffer (10 mM Tris-HCl pH 7.4; 2% of SDS; 1% of ?-
mercaptoethanol). (Wiley, H. S., Opresko, L., Wallace, R. A. (1979) New methods for the 
purification of vertebrate vitellogenin, Anal. Biochem. 97,145-152) 
VI.9.SM.4.2 Acetone precipitation 
80 µl of plasma was diluted to 100 µl with cold PBS. 300 µl of -20 ºC cold acetone 
were added to the diluted plasma solution and kept overnight on ice. The sample was 
centrifuged at 10000g, 4 ºC for 30 min. The supernatant was removed and the pellet was 
suspended in 100 µl of buffer (10 mM Tris-HCl pH 7.4; 2% of SDS; 1% of ?-
mercaptoethanol).
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VII.1 Resumo 
Neste trabalho, foi efectuado um estudo sobre macacão isotópica com 18O em 
amostras de tecidos biológico após digestão. A metodologia proposta apresenta-se como 
uma forma fácil de distinguir péptidos de outros componentes presentes num tecido. A 
digestão enzimática foi alcançada ao fim de 3h após aplicação manual de tripsina na 
superfície do tecido. Após a digestão, a marcação isotópica foi efectuada em 20min de 
incubação com 18O. O método proposto, é rápido e reprodutível, e abre uma nova linha de 
trabalho em espectrometria de massa aplicada a tecidos biológicos. Adicionalmente, 
apresenta-se pela primeira vez, a aplicação da energia de ultra-sons para acelerar a digestão 
enzimática de tecidos biológicos. 
Palavras-chave: Espectrometria de massa aplicada a tecidos, marcação isotópica com 18O, 
aceleração por ultra-sons.  
A minha contribuição para este trabalho consistiu na execução da parte experimental, 
incluindo preparação dos tecidos e analise por MALDI-TOF/TOF-MS  
 
 
 
 
 
Chapter VII. On-tissue 18-O labeling for mass spectrometry-based applications  
153 
VII.2 Abstract 
In this work we report the on-tissue 18-O labeling of peptides after tryptic digestion 
as a powerful tool for the rapid mass spectrometry differentiation of peptides from other 
tissue components. Successful digestion was achieved in 3 h after the on-tissue pipette 
spotting of trypsin, following 18-O labeling of peptides for 20 min. The method is fast and 
reproducible and opens a new line of work in mass spectrometry of tissues because the 
principle can be potentially expanded to other type of labeling protocols. In addition we 
report for the first time on the ultrafast digestion, 30 s, of tissues using ultrasonication. 
Taken together this new findings will allow higher throughput and faster sample treatment 
for any tissue mass spectrometry-based application. 
Keywords: Tissue mass spectrometry, 18-O labeling, ultrasonic enhancement. 
My contribution to this work was the execution of the experimental including tissue 
preparation and direct tissue MALDI-TOF/TOF-MS analysis. 
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VII.3 Introduction 
When applied over a sample as complex as a tissue, laser energy promotes the 
formation of a plume of molecules including, but not limited to, peptides and proteins [1,2]. 
Molecule identification after laser desorption from a tissue section through mass 
spectrometry, MS, is a task that presents many challenges because the MS tissue analysis is 
severely affected by a great number of factors that require careful optimization to obtain 
reliable results. The way by which the tissue is attached to the MALDI glass slide 
(including tissue thickness, chemical tissue coating, and temperature of the cryostat 
microtome chamber); the type of tissue cleaning previous matrix coating (including 
composition of the cleaning solution); the type of tissue (fatty versus non fatty); the type of 
matrix (including matrix concentration, matrix solution composition and matrix 
application) and finally the adequate tuning of the instrument settings to maximize signal 
quality across the entire spectrum are variables that need to be carefully optimized for each 
tissue section [3-5]. 
There has been substantial effort directed towards optimizing the sample preparation 
methods, including washing protocols, matrix application and software development [6-9]. 
However, even for the case of an optimized tissue analysis, the ions reaching the detector 
cannot be directly assigned to a given type of molecule, being not possible to unequivocally 
assign a given ion mass to, for instance, a peptide.  
In the present work we report, to the best of our knowledge for the first time, on the 
direct on-tissue 18O labeling of proteins as a fast, simple and reproducible manner to 
unequivocally assign ions reaching the detector as peptides in MS tissue analysis.  
VII.4 Materials and Methods 
VII.4.1 Material 
All reagents used were HPLC-grade or higher. CHCA was purchased from Sigma–
Aldrich. Sequence Grade Modified Trypsin from Promega, TFA, ammonium bicarbonate 
and ammonium acetate from Fluka Bio-Chemika, H218O (97 atom%) from IsotecTM. Water 
was purified in Millipore’s Milli-Q Synthesis system. 
Tissue sections, 12μm thick, were cut on a Leica CM 3000 cryostat (Leica Microsystems, 
Nussloch, Germany) at -20 °C.  
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VII.4.2 Tissue preparation 
Livers from adult Mus musculus were dissected and stored at – 80°C until analysis. 
Thin (12μm) tissue sections were prepared and thaw mounted onto a conductive, 
transparent glass slides (75x25mm) coated with an indium tin oxide (ITO) layer (Bruker 
Daltonics, Bremen, Germany) and frozen on dry-ice and stored at -80 °C. Tissue section 
were dried and equilibrated to room temperature during 2h in a desiccators followed by a 
series of ethanol/water washes. The glass slide was dipped in ethanol/ water (70:30% v/v) 
and gently agitated for 30s followed by a 30s wash in ethanol. Excess solvent were 
removed by a gentle blow of N2. 
VII.4.3 On-tissue enzymatic digestion 
A solution containing 125ng/μl of trypsin in 12.5mM of ammonium bicarbonate 
was manually spotted onto the liver sections by pipette deposition to obtain 40ng of 
trypsin/mm2. Two interactions of 500nL were used. Each digests spot appeared to dry 
completely between each successive spotting iteration. The trypsin spotting proceeded at 
room temperature (21 °C). After trypsin application the sample were placed in a humidified 
chamber at 37ºC and digested for 3h.  
VII.4.4 On-tissue 18O labeling and matrix coating 
For the 18O-labeling, to the digested peptides 1μL of H218O/ 50mM of ammonium 
acetate pH 6.75 was added to the array of tryptic spots and incubated at room temperature 
for 20min. Following digestion and labeling, a solution containing 20 mg/ml of CHCA in 
1:1 acetonitrile/0.5% TFA was spotted directly onto the array of tryptic spots over 
1x500nL. 
VII.4.5 Mass spectrometry of peptides 
The tissue profiles were acquired using an Ultraflex II MALDI-TOF TOF 
instrument (Bruker-Daltonics Billerica, MA) equipped with a LIFT cell and Smartbean 
laser. For peptides, the mass spectrometer was operated with positive polarity in reflectron 
mode and spectra were acquired in the range of m/z 1000-4000. A total of 3000 spectra 
were acquired at each spot position at a laser frequency of 100 Hz. 
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VII.5 Results and Discussion 
VII.5.1 Preliminary experiments 
The digestion of tissue proteins through the addition of a solution containing an 
enzyme has been previously reported, and it is generally referred as on-tissue enzymatic 
digestion [10-17]. In order to verify if the working conditions were adequate in our 
workflow, as depicted in figure VII.1, including the correct tuning of the instrument 
settings, we devised a set of experiments in which we added a standard intact protein, 
carbonic anhydrase, CA, in different quantities over tissue sections taken from the same 
sample, liver from adult Mus musculus. 
 
Figure VII. 1. Schematic diagram of the sample treatment workflow including: tissue 
washing, on-tissue trypsin digestion, 18O labeling and matrix application. 
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Then a trypsin solution was pipette spotting over the tissue twice as described in the 
experimental section. It was allowed the trypsin to cleavage the tissue´s proteins during 3 h, 
in a humidified chamber, under controlled temperature conditions, 37 ºC. The reaction 
chamber was continuously monitored to control the drying process, to ensure that the 
enzyme solution was not immediately dried after deposition, what would hamper the 
protein cleavage [10]. 
As may be seen in figure VII.2, the peptides belonging to carbonic anhydrase can be 
only detected for protein amounts deposited over the tissue higher than 0.5µg.  
Figure VII. 2. MALDI spectra of a liver tissue from Mus musculus spiked with carbonic 
anhydrase (0, 0.1, 0.5, 2.5?g) and digested with 40ng/mm2 of trypsin in a humidified 
chamber for 3h at 37ºC. ? Indicate the m/z peaks from carbonic anhydrase. 
The changes observed in the signal intensities as a function of the amount of protein 
deposited can be easily followed comparing the ratios for m/z peaks 2198, from carbonic 
anhydrase, and tissue´s m/z peak 1759, which are 40%, 30% and 20% for 0.5 µg, 1 µg and 
2.5 µg respectively. This experiment allowed us to conclude that with our conditions 
effective digestion was achieved not only for the standard protein but also for the tissue´s 
proteins. In addition, this experiment clearly showed the ion suppression effect in MALDI, 
because, as it is noted following all spectra from figureVII.2, as the amount of CA is 
increased so the intensity of the peak ions belonging to the tissue is decreased.  
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VII.5.2 Influence of the digestion time 
Once it was verified that the working conditions were appropriated we devised a set 
of experiments to study the influence of the digestion time. Digestion time is a variable that 
must be carefully optimized for each type of tissue. Therefore we tested two different 
digestion times 60min and 180min. The results showed that to obtain a good quality 
digestion the tissue needs to be in contact with the enzyme for at least 180min (data not 
shown). This results is in agreement with previously published data, where digestion times 
varying among 2h and 4h have been reported [12,14]. 
VII.5.3 Direct on-target proteolytic labeling 
Once it was verified that the working conditions were adequate, we devised a set of 
experiments to proof that the labeling of the peptides formed after protein cleavage could 
be used to distinguish them of other tissue components. From the many methods available 
to label peptides we have chosen 18O due to a number of benefits that we have described 
elsewhere [18]. It is well known that 18O labeling can be accomplished following two 
different ways. The fastest and simplest consists in to do the protein digestion and the 
labeling at the same time [18]. This method lacks in labeling efficiency. The second way is 
done in two steps. First the proteins are digested, and then are labelled. Although it allows a 
labeling efficiency for most peptides higher than 90%, it is a labour intensive and time 
consuming approach [18]. Due to simplicity we chose to develop the labeling with the 
direct method. Therefore, we deposited spots of CA through the slides typically used for 
mass spectrometry of tissues, and they were submitted to trypsin digestion as follows: (i) 
with the enzyme dissolved in 16O water, (ii) dissolved in a 1:1 16O/18O water mixture and 
(iii) dissolved in pure 18O water. The results shown in figure VII.3 demonstrate that the 
protein cleavage was successfully achieved, yet the peptide labeling was not obtained. As 
an example of the clearly resolved molecular species in the digest spectra, it is shown in 
figure VII.3, the isotopic distribution of m/z peaks 1013 and 1018, respectively; those 
indicating that digestion were well done in the three cases studied. However, it can be also 
seen that the isotopic distribution has not been altered with the presence of 18O, therefore, 
and after careful inspection of all the spectra, it was concluded that under the conditions we 
used the labeling was not achieved.  
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Figure VII. 3. MALDI spectra of 0.5?g of carbonic anhydrase digested over ITO-coated glass slide 
(trypsin 40ng/mm2) in H216O, 1:1 H216O/ H218O and H218O. 
We hypothesise that the 16O water used to maintain the constant conditions of 
humidity inside the chamber, where the digestion was done, was interchanged with the 18-
O of the enzyme solution during the digestion time (3h) and so this could be the cause of 
the lack in labeling efficiency. Another explanation to the lack in labeling could be the long 
time contact between the trypsin and the 18O water, because trypsin has been described as 
the primary mechanism by which the isotopic label is lost [19].  
VII.5.4 Decoupled on-target labeling 
Due to the lack in labeling using the direct approach, the next set of experiments 
was conducted doing the protein cleavage and the 18O labeling in different steps. This 
approach has previously been successfully described in literature [18-20] for the labeling of 
proteins separated in-gel or through off-gel approaches [21,22]. Therefore the sample 
treatment was divided in two parts. The first part was focused in the enzymatic digestion of 
proteins whilst the second one was addressed to study the 18O labeling of the peptides. This 
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set of experiments was done on an array of CA spots prepared in a glass slide. Since we 
have obtained, as explained above, good results in the digestion of tissues´ proteins, this 
step was done with exactly the same digestion conditions than in the direct approach. Once 
the digestion was considered completed, a solution of 18O water was then pipette spotted 
over the CA spots as described in the experimental section. The results of this approach 
may be seen in figure VII.4, where the peptides from CA with m/z peaks 1013, 1018 and 
1198 are presented.  
 
Figure VII. 4. MALDI spectra of 0.5?g of carbonic anhydrase digested over ITO-coated glass slide 
(trypsin 40ng/mm2) followed by 20min of labeling with H216O/trypsin 125ng/?L/ammonium acetate 
50mM and H218O/ trypsin 125ng/?L/ ammonium acetate 50mM. 
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The characteristic mixture pattern of single (18O1) and double (18O2), labelled 
peptides were observed when 18O water was used. For peptide with m/z peak circa 1013, 
the main peaks corresponding to a single label (m/z circa 1015) and double label (m/z circa 
1017) have almost the same intensity, thus indicating that the double labeling was not 
complete. Yet this result is useful if we consider that the identification of a peptide will be 
done easiest if an isotopic distribution as the one here reported is obtained. This is because 
in terms of identification a complete labeling will not help to distinguish peptides from 
other tissue´ components.  
VII.5.5 The influence of trypsin concentration in the labeling efficiency 
Many researchers have claimed that the presence of trypsin even in trace amounts 
can negatively affect the double labeling efficiency. The presence of any remaining trypsin 
after the digestion step will accelerate the 16O/18O carboxyl oxygen exchange. To avoid this 
problem some authors have suggested lowering the pH of the solutions below 2, since the 
activity of trypsin and other proteases at that pH is negligible [18,23,24]. By this way the 
problem of oxygen interchange is reduced to a minimum. However, other authors have 
claimed indeed that lowering pH, even below 2, is not enough to overcome this problem. 
Thus, Staes et al. [25,26] have found necessary to destroy the trypsin structure by covalent 
modification of its thiol group using trypsin inhibitors, to avoid any re-naturation at every 
step of the subsequent peptide isolation procedure. To complicate things further, Sevinsky 
et al. reported the failure of covalent trypsin inhibitors in their approach to quantitative 
proteomics making use of 18O labeling [27,28]. In fact the aforementioned authors have 
proposed the use of immobilized trypsin in the digestion step as the best method to avoid 
the subsequent chemical exchange, due to residual trypsin. Therefore to investigate the 
effects of trypsin in the labeling of peptides, a set of experiments was done in which 18O 
water-based solution of trypsin was spotted on arrays of CA prepared in glass slide. Results 
showed in figure VII.5 demonstrate that trypsin has no influence in the labeling step, at 
least for the amounts assayed in this work. This fact is highlighted trough the m/z peak 
1013 and 1018 included in figure VII.5, where is clearly seen that no influence is observed 
neither in the ratios of the peaks corresponding to isotopic distributions nor in their 
respective intensities. Therefore for further experiments no trypsin was used during the 
labeling. 
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Figure VII. 5. MALDI spectra of 0.5?g of carbonic anhydrase digested over ITO-coated glass slide 
(trypsin 40ng/mm2) followed by 20min of labeling with H218O/ ammonium acetate 50mM with 
0.1?g, 0.05?g, 0.01?g and 0?g of trypsin. 
VII.5.6 On-tissue digestion and post-proteolytic labeling 
The next step was to apply the treatment to several tissue sections that were first 
digested following the above described process, and then treated with (i) 16O water, (ii) a 
mixture of 16O/18O water and (iii) pure 18O water. The results are presented in figure VII.6.  
Figure VII. 6. MALDI spectra of a liver tissue from Mus musculus digested with 40ng/mm2 of 
trypsin in a humidified chamber for 3h at 37ºC followed by 20min of labeling at room temperature 
with H216O/ 50mM ammonium acetate, H216O/H218O/ ammonium acetate 50mM and H218O/ 50mM 
ammonium acetate. 
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As may be seen the patterns are difficult to distinguish to naked eye, as they seem 
the same. However, and thanks to the labeling, a closest view of the single peaks obtained 
allows to clearly differentiating the peaks corresponding to peptides. As an example the 
peptide with m/z peak 2745 is also shown in figure VII.6. As for the case of the CA the 
typical pattern of single and double labeled peaks were obtained.  
VII.5.7 The influence of time in the on-tissue post-digestion labeling 
Time of labeling is an important factor that influences the efficiency in the single 
and double oxygen incorporation [18] and therefore must be carefully controlled to obtain 
reproducible results. In our case two times were studied 10min and 20min. figure VII.7 
shows the results of this experiments and may be seen that for longer times the 
incorporation of 18O (single and double) is higher. A time of 20 min was chosen for further 
experiments. 
Figure VII. 7. MALDI spectra of a ovary tissue from Mus musculus digested with 40ng/mm2 of 
trypsin in a humidified chamber for 3h at 37ºC followed by 20 min of labeling at room temperature 
with H216O/ 50mM ammonium acetate, 10 min of labeling with H218O/ ammonium acetate 50mM 
and 20min of labeling with H218O/ 50mM ammonium acetate. 
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VII.5.8 Effect of ultrasonic energy on tissue digestion 
It is well known that ultrasonic energy can accelerate the enzymatic digestion of 
proteins [18,24]. Furthermore, it also has been demonstrated that it can also speed the 
isotopic labeling of peptides in the direct method [21,26]. Therefore we tried to speed the 
tissue´ digestion with the aid of ultrasonic energy in a trial to overcome the bottleneck of 
low sample throughput in tissues´ handling. The first problem to be overcome was the 
technical design in order to apply ultrasonication over the tissue. After careful consideration 
we decide to use ultrasonic energy in an indirect way. Based on our expertise with 
ultrasonication for sample treatment [28], the sonoreactor was the device chosen. The 
arrangement used is shown in the video provided in the supplementary material. This 
arrangement was done to allow indirect ultrasonication over the tissue. The sonoreactor acts 
as a small yet powerful ultrasonic bath. The ultrasonic energy is transmitted from the 
sonoreactor´ base, where the ultrasonic transducer is situated, to the water, and from here to 
the face of the slide in contact with the water. The ultrasonic energy is then transmitted 
through the slide to the tissue situated in the opposite size of that one in contact with the 
water. A video showing the effects of ultrasonic energy in the degasification of some drops 
of coca-cola in the same arrangement is showed in supplementary material as a proof-of-the 
concept. 
To ensure that water was not in contact with the tissue during the ultrasonication a 
set of experiments was done where the amplitude of the sonoreactor was varied among 10 
and 100%. Amplitudes higher than 60% produced too much agitation as consequence of 
which the slide was cover completely with water. Therefore, ultrasonication amplitude of 
50% was set in further experiments. Once the technical method was optimized to ensure 
that no water was in contact with the tissue, the digestion was done at different times 
ranging from 30s to 300s under the effects of an ultrasonic field. As may be seen in figure 
VII.8, excellent results in terms of digestion were obtained in just 30s whilst when no 
ultrasonication was used the cleavage was almost negligible, even for the longest time 
assayed (300s). 
It was therefore concluded that ultrasonication indeed can boost the digestion 
process. This set of experiments clearly showed that ultrasonic energy can act promoting 
the contact between the solution containing the enzyme and the tissue. This effect is 
probability due to the vibration caused by the ultrasonic waves crossing the glass slide and 
finally reaching the tissue and the solution containing the enzyme. To this effect it must be 
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added the cavitation phenomena caused by the ultrasonic wave in the solid-liquid interface. 
The tiny bubbles created by the ultrasonic energy act as micro-reactors with cumulative 
effects such as increasing chemical reaction rates, increasing bulk temperature and 
increasing the surface of contact available to the enzyme by disrupting the tissue surface. 
Although this was a remarkably finding, its applicability needs to be further investigated. 
As an example, although ultrasonication can be used to boost the digestion of tissues for 
biomarker discovery, the viability of this method for imaging, may become useless because 
ultrasonication will probably lack in maintain spatial distribution.  
 
Figure VII. 8. MALDI spectra of a liver tissue from Mus musculus digested with 40ng/mm2 of 
trypsin in sonoreactor with 50% of Sonication amplitude for 30s, 90s, 180s, 300s and for 
comparative purposes the same experiments were carried out without ultrasonication. 
VII.6 Conclusions 
It has been demonstrated for first time the possibility to perform the 18-O labeling 
of peptides directly on a tissue. The labeling can be done decoupling the steps of protein 
digestion and peptide labeling. It was found that no complete labeling was possible, which 
can facilitate the automation (software) recognition of peptides from other tissue 
components. In addition it has been also demonstrated that ultrasonication can boost the 
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digestion of tissue´s protein in seconds, thus opening for the first time sample treatment of 
tissues to high throughput. 
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The undertaken research presented in this dissertation involves, in its totality, some 
alternative approaches to the typical workflows for the identification and quantification of 
proteins. The link between the different chapters of this thesis, the ultrasonic energy applied 
to proteomics. 
Ultrasonic energy was used in some of the different steps of the regular in-solution 
and in-gel protein digestion protocols used to indentified proteins by PMF of PFF. In 
addition to the new approaches for protein identification, a novel workflow based on 18O-
isotopic labeling was also developed for protein quantification. Furthermore dedicated 
software to deal with this type of data sets was also created. Finally, a new method for the 
fast in-tissue 18O-isotopic labeling of peptides was created. As a general role the new 
sample treatment protocols are not only faster than the ones they come to replace but they 
are also less labor intensive. 
Below are going to be presented in more detail the main goals accomplished during 
the making of this research work. 
Chapter III. It has been demonstrated that ultrasonic probe and sonoreactor can be 
used to accelerate the sample preparation for protein identification by PMF using MALDI-
TOF-MS. The workflow including protein reduction, alkylation and tryptic digestion was 
reduced from 24h to 15min, without compromising the number of peptides matched or the 
protein sequence coverage obtained. Each step, reduction and alkylation, usually done in 
60min and 45min were reduced to 5min for reduction plus 5 for alkylation. Concerning 
tryptic digestion the classic overnight incubation at 37ºC was reduced to bust 5min under 
the effects of ultrasonic field applied by an ultrasonic probe or the sonoreactor. 
The new proposed method represents and good alternative to the classic method, 
especially when a fast protein screening is needed. In addition, with the new proposed 
methodology, sample handling has been enormously simplified. Proteins in the mass range 
16.7-71.2kDa including α-lactalbumin, ovalbumin, aldolase, BSA, catalase, carbonic 
anhydrase, and chymotrypsinogen A were successfully identified with the new accelerated 
method using the sonoreactor device. In addition the zinc resistance-associated protein 
precursor isolated from D. desulfuricans strain G20 and split-soret cytochrome c purified 
from D. desulfuricans ATCC27774 demonstrates that the parameters optimized on standard 
can be also applied to complex biologic samples. The new ultrasonic-based method 
provides itself, important advances in fast protein identification for protein screening. The 
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findings reported open a new way in sample treatment for in-solution protein digestion, of 
easy implementation, for on-line procedures, and tandem mass spectrometry. 
 
Chapter IV. Following the previously described research and having in mind the 
goal of automation, a new ultrasonic multiprobe-device was studied in conjunction with a 
96-well plate in the acceleration of two different proteomic workflows. The method was 
evaluated in terms of speed, throughput, handling and robustness.  
It was demonstrated that, in order to avoid cross contamination between samples, 
low amplitudes should be used to avoid aerosol formation and sample spreading. For the 
two methods using ultrasonic multiprobe and a 96-well plate, the accelerated urea method 
and the accelerated clean method, all the standards proteins were identified and the results 
were found similar in terms of robustness in comparison with the classic overnight method. 
The clean method has the best performance in terms of speed and handling since 
only 2min/sample are required to complete it. Since the clean method do not use urea, 
desalting is not required thus diminishing the total number of steps. 
Regarding throughput, it has been proven that the combination of a 96-well plate 
and an ultrasonic multiprobe is a potential powerful tool in sample treatment for 
proteomics, allowing high sample throughput. Sample preparation steps, including 
reduction and alkylation, digestion, spotting on MALDI targets or transfer to LC/MS input 
plates can potentially be combined on a single automated platform making use of ultrasonic 
energy provided by ultrasonic multiprobes. 
Chapter V. A new method for bottom-up protein quantification termed decision 
peptide driven, DPD, has been established and experimentally validated. The proposed 
method which combines SDS-PAGE separation of proteins, in-gel proteolytic digestion, 
18O peptide labeling and the inverse labeling strategy, has been demonstrated successfully 
in the fast and accurate quantification of seven different proteins. Furthermore, the DPD 
approach has been applied with success to study the effects of high concentration levels of 
estrogens on Ciprinus carpio males. To do so, protein vitellogenin, a biomarker of exposure 
to high levels of estrogens, was accurately quantified using the DPD method. The DPD 
method onllyneeds the identification of peptides with paralleled losses and similar digestion 
yields through different in gel-digestion sets. Using these peptides accurate quantification 
of the protein is achieved. Suitable software has been also developed to automate the task.  
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Chapter VII. A friendly software to help in an automated mode to identify those 
peptides that have paralleled loses through a typical proteomic workflow was described. 
The use of such peptides allows robust and accurate quantification of proteins using 1D-gel 
electrophoresis and MALDI-TOF-MS. The software presented, allows for the identification 
of reproducible peptides and is based in a series of steps entailing different algorithms that 
perform in an automated mode a peptide differential analysis to extract and to identify those 
peptides that systematically remains constant in expression level through different sets of a 
typical in-gel digestion workflow. The DPD software saves times, allowing the user to 
accurate quantify proteins in an automated mode, overcoming the long time needed when 
the treatment of data is done manually. In addition the DPD software has a wizard easy to 
follow for its installation.  
Chapter VII. It has been demonstrated for the first time the possibility to perform 
the 18O-labeling of peptides directly on tissue sections. The labeling can be done 
decoupling the steps of protein digestion and peptide labeling. It was found that no 
complete labeling was achieved, which can facilitate the automation (software) recognition 
of peptides from other tissue components. In addition it has been also demonstrated that 
ultrasonication can boost the digestion of tissue´s protein in seconds, thus open for the first 
time sample treatment of tissues to high throughput. 
Future prospects 
Regarding the use of ultrasonic energy to enhance the cleavage of proteins it is 
expected soon the development of on-line applications in shot-gun proteomics. In addition, 
the application of this methodology to robotic platforms is already a reality in the PropecII 
from Digilab and it is expected to be implementing in platforms from other companies. It 
remains unclear the mechanism by which UE can boost the enzymatic digestion of proteins. 
Therefore research in this point is also expected. Furthermore, the comparison of 
ultrasonication with other tools to speed protein cleavage, such as microwave energy, 
infrared irradiation or high pressure will surely soon appear in literature. 
As far as the protein quantification concerns, the methodology developed in this 
thesis is easily adaptable to electrospray ionization and therefore this approach will be soon 
developed, including also new software. Furthermore, off-gel approaches accomplished 
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with shotgun proteomics will also take advantage of our quantification approach, opening 
the possibility to quantify hundreds of proteins from complex mixtures at the same time. 
 
